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SUMMARY
There is now considerable evidence for a close association 
between human papillomavirus (HPV) infection and genital 
neoplasia. These data are based upon epidemiological, 
colposcopic, cytological, histological,
immunohistochemical and DNA hybridization studies. This 
thesis aims to study six aspects of this association.
The first approach was to establish the prevalence of HPV 
6, 11, 16 and 18 DNA sequences in human female genital 
premalignancy and malignancy in the West of Scotland.
Three tissue sources were used; namely biopsies from 
abnormal tissue (vulval and cervical premalignant and 
malignant tissue), internal control tissues from 
histologically normal adjacent tissue and external control 
tissue from the cervices of cytologically normal women.
HPV 6/11 DNA sequences were detected in only one 
premalignant lesion on the cervix (1.5%) and two external 
control tissues (6.7%). HPV 16 & 18 DNA was detected in 
69% of cervical premalignant lesions, 80% of vulval 
premalignant lesions, 58% of cervical carcinomas and 60% 
of vulval carcinomas. HPV 16 was also detected in 2 
external control tissues (6.7%). The prevalence of HPV 16 
and 18 DNA is comparable with other studies but the 
prevalence of HPV 6/11 DNA is low suggesting a geographic
variation in the prevalence of HPV DNA subtypes. This 
study confirms that HPV 16 is the subtype most frequently 
detected in these lesions (51% overall). HPV 16 DNA is 
however frequently detected in histologically normal 
tissue adjacent to neoplastic lesions (38.5% overall). 
Alternatively, HPV 18 DNA is less often detected than 
HPV 16 DNA (19% overall) but is more specific to 
histologically abnormal tissue [only one internal control 
biopsy hybridized to HPV 18 DNA, (1.5%)].
The second aspect of the association between HPV infection 
and genital neoplasia studied was the relationship between 
the different diagnostic methods used to determine the 
presence of HPV DNA on the cervix i.e. colposcopy, 
cytology, histology and immunohistochemistry. The 
sensitivity and specificity of Southern blot hybridisation 
allows this to be used as a "gold standard" for comparison 
with these other methods. The study showed that 
colposcopy was an insensitive method of identifying 
tissues which harboured HPV DNA as was
immunohistochemistry. Cytology and histology suffered 
from a lack of specificity. These findings have 
implications for the assessment of patients and the 
structure of prospective study of the natural history of 
HPV infection which are discussed fully later.
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An association between HPV infection and advancing age has 
been suggested. In this thesis, no association between 
the age of patients and the detection of HPV DNA sequences 
was established.
The high prevalence of HPV DNA subtypes in cervical 
neoplasia and the increasing data from cell line and 
cancer cell studies which suggest a mechanism for cell 
transformation by HPV DNA sequences has led to calls for 
the introduction of a screening test for HPV DNA. One 
such test utilizes dot blot hybridization. This study has 
compared Southern blot hybridization and slot (dot) blot 
hybridization. Slot blot hybridization has been shown to 
offer poor specificity, especially at low viral DNA copy 
numbers. Furthermore, this thesis shows that one third of 
patients who undergo laser ablation of the cervical 
transformation zone demonstrate persistence of the HPV 
genome following treatment. These two data, along with 
the facts that up to one third of the female population 
may harbour HPV DNA on their cervices, the prevalence of 
HPV DNA on the male penis is unknown, and a causal 
relationship between HPV DNA has not been established, 
suggest that screening for HPV DNA is not indicated at 
present in this country.
The fifth aspect of the association between HPV DNA
-15-
infection and cervical neoplasia to be studied was the 
influence of local irranunosurveillance as assessed by the 
presence of Langerhans' cells on cervical premalignancy.
An association between HPV 18 DNA and HPV 16 DNA at high 
copy numbers and local immunosuppression was identified.
It seems li kely that smoking is associated with 
depression of Langerhans' cell activity and this study has 
demonstrated a possible relationship between these two 
epidemiologically important cofactors.
Finally, a possible mechanism of cell transformation by 
HPV DNA comprises the amplification or upregulation of 
cellular oncogenes. In this thesis hybridization to the 
proto-oncogene c-myc was studied but no evidence of 
amplification of that oncogene was detected in association 
with hybridization to HPV DNA sequences. In two cases, 
however, there was some evidence to tentatively suggest a 
rearrangement of the c-mvc oncogene in association with 
HPV 16 DNA detection. This aspect requires further study.
The significance and implications of the results are 
discussed in the context of the work itself and its 
relation to the data reported by other workers. The 
implications for patient management are outlined and 
ideas for future work based on a tentative hypothesis are 
presented.
-16-
THESIS INTRODUCTION
A. REVIEW OF THE LITERATURE
1• Cervical Neoplasia
1.1 General Considerations
Cancer of the uterine cervix is a common human female 
genital malignancy. The world standardised incidence rate 
in England and Wales is 11.7/100,000 women. The reported 
world standardised incidence varies markedly around the 
world, for example, it is 86.2/100,000 women in Recife, 
Brazil but only 4.0/100,000 in Israel. The rate also 
varies within countries between ethnic groups. In New 
Zealand, the incidence is 11.8/100,000 Caucasian women but 
in Pacific Polynesian Islanders it is 64.4/100,000 women 
(World Health Organisation, 1987).
In the West of Scotland in 1986 the annual crude incidence 
rate was 16.2/100,000 and world standardised rate was 
12.4/100,000. This incidence has changed minimally in the 
last decade. It is the seventh commonest cancer and the 
second commonest genital cancer in women in this area 
(personal communication. West of Scotland Cancer 
Surveillance Unit).
There are two broad histological types of cervical 
malignancy. Squamous carcinomata arise from the squamous
-17-
epithelium and account for 90-95% of cases. 
Adenocarcinomata arise from columnar epithelium and 
account for 4-8% of cases. In the West of Scotland 
adenocarcinomata account for 7.8% of cervical cancers 
(personal communication, West of Scotland Cancer 
Surveillance Unit). The remaining cases comprise 
sarcomas, lymphomas and melanomas (Anderson, M.C., 1985).
Whereas the relatively unusual adenocarcinoma arises from 
the columnar epithelium within the cervical canal, 
squamous carcinomata almost invariably arise from the 
cervical transformation zone. The transformation zone is 
the area over which the junction between the keratinised 
stratified squamous epithelium of the ectocervix and the 
columnar epithelium of the endocervix - the 
squamo-columnar junction - migrates throughout life. The 
transformation zone is bounded within the cervical canal 
by native columnar epithelium and caudally, on the 
ectocervix, by native squamous epithelium. The 
squamo-columnar junction migrates by the process of 
squamous metaplasia. Migration of the squamo-columnar 
junction is largely influenced by oestrogen stimulation 
and squamous metaplasia is influenced by the acid vaginal 
environment (Singer, A., 1975). Thus, in utero, maternal 
circulating oestrogen crosses the placenta and promotes 
migration of the squamo-columnar junction onto the
-18-
ectocervix. After birth this stimulus is withdrawn and 
the squamo-columnar junction migrates back into the 
cervical canal. At puberty, oestrogen levels rise again 
and the squamo-columnar junction reappears at the 
ectocervix. Thereafter, the squamo-columnar junction 
migrates back and forth in response to the oestrogen 
levels which may be influenced by pregnancy and oral 
contraception; conditions on the cervix which are 
recognised clinically as "ectopy" or "pill erosion". At 
the climacteric, oestrogen levels fall, the 
squamo-columnar junction retreats within the cervical 
canal, and the typical appearance of the post-climacteric 
cervix results.
The transformation zone is thus an area of increased 
cellular mitotic activity and there are considerable 
epidemiological data to be reviewed later in the text 
which suggest that one or more sexually transmitted 
agents act on this region to produce malignant 
transformation of cells.
Pre-invasive cervical neoplasia which may have malignant 
potential was initially described as dysplasia (Reagan, 
J.W., 1953) and was divided into mild, moderate and 
severe dysplasia plus carcinoma-in-situ. Poulsen, H.E., 
et al, (1975) defined dysplasia as "a lesion in which part
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of the thickness of the epithelium is replaced by cells 
showing varying degrees of atypia". This nomenclature 
lacks precision and differentiation between severe 
dysplasia and carcinoma-in-situ has little prognostic 
relevance so the term cervical intraepithelial neoplasia 
(CIN) (Richart, R.M. , 1967) has recently been preferred. 
CIN 1 corresponds to mild dysplasia, CIN 2 corresponds to 
moderate dysplasia and CIN 3 corresponds to severe 
dysplasia and carcinoma-in-situ.
The pre-malignant status of CIN, particularly CIN 3, is 
widely accepted. Scott, R.B., and Ballard, L.A., (1962),
using cytology and biopsy, found a progression rate of
5.8 percent and a regression rate of 49.8 percent. More 
recently, Mclndoe, W.A., et al (1984) reported on 300 
women with evidence of carcinoma-in-situ who were left 
untreated. After 10 years, 18 percent of the women had 
developed invasive disease. This rose to 36 percent 
after 20 years. The reasons for this apparent discrepancy 
are probably that, firstly, the taking of a biopsy sample 
may remove small lesions completely or alter the local 
immune response to residual disease (McKay, D.G., et al, 
1959) and, secondly, the clinical, colposcopic, 
cytological and histological assessment of premalignant 
cervical lesions remains subjective to a great extent 
(Kirkup, W., et al, 1982). It is likely, however that the
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study of Mclndoe, et al, is the more accurate assessment 
of malignant potential in CIN 3 lesions. Richart, R.M.. 
and Barron, B.A., (1969) examined the natural history of
mild, moderate and severe dysplasia by prospectively 
following-up women who were assessed cytologically and 
colpo-microscopically. No biopsies were taken. They 
estimated median transit times to development of 
carcinoma-in-situ of 86 months for mild dysplasia and 12 
months for severe dysplasia. The validity of these 
estimates must be questioned on two counts however. 
Firstly, biopsies were not performed and colpomicroscopy 
and cytology were relied upon to establish a histological 
diagnosis. Walker, E.M., et al (1986) showed that 82% of 
women referred to a colposcopy clinic with cytology 
suggestive of mild atypia (equivalent to mild dysplasia) 
did in fact have CIN 2 or 3 (equivalent to moderate 
dysplasia and severe dysplasia/carcinoma-in-situ 
respectively) on histological assessment of biopsies.
Thus progression to carcinoma-in-situ in Richart and 
Barron's study may have in fact been a change from 
cytologically and colposcopically occult 
carcinoma-in-situ to cytologically and colposcopically 
overt carcinoma-in-situ. Secondly, the histological 
differentiation between severe dysplasia and 
carcinoma-in-situ is so subjective and variable
-21-
(Cocker, J., et al, 1968) that cytological and 
colposcopic differentiation between these lesions is 
artificial. Progression to invasive disease is thought to 
pass through a micro-invasive stage. There is no 
internationally accepted definition of this stage. In the 
United Kingdom, the Royal College of Obstetricians and 
Gynaecologists Study Group on Preclinical Neoplasia of the 
Cervix (Jordan, J.A., et al, 1982) defined two groups 
which comprised early stromal invasion with a depth of 
invasion of less than 1mm, and measureable lesions with a 
depth of invasion of less than 5mm and diameter of less 
than 10mm. It is assumed that micro-invasive disease does 
not regress to normal although ethically this hypothesis 
will never be tested.
As CIN is an asymptomatic precursor of invasive cancer, it 
is ideally suited for a screening programme. Papanicolau 
G.N., and Traut, H.F., (1943) demonstrated that
exfoliative cytology could detect early epithelial 
abnormalities. These early epithelial abnormalities 
comprise cell changes which are intermediate between 
normality and malignancy and are known as dyskaryosis. 
Dyskaryosis refers to cells of which the nucleus displays 
some, but not all, of the features of malignancy. The 
nucleus is enlarged with increased chromatin which may 
form clumps. The nuclear border is irregular.
-22-
multinucleation is common and cytoplasmic eosinophilia is 
seen. There is an altered nuclear-cytoplasmic ratio 
(review by Attwood M.E., 1976). Ayre, J.E., (1949) 
designed a spatula which gained wide acceptance as a 
screening tool. Recent refinements such as the Aylesbury 
spatula (Wolfendale, M.R., et al, 1987) may further 
improve the sensitivity of cytological screening.
Cervical cytology screening programmes are relatively 
cheap and are acceptable to patient and practitioner. 
Studies in British Columbia have shown that a properly 
instituted programme with effective follow-up reduces the 
incidence of invasve disease. In a review of their 
findings Boyes, D.A., and Worth, A.J., (1976) showed that
the incidence of and mortality from carcinoma of the 
cervix had declined over the twenty year period of 
cytology screening whereas this change had not been noted 
in countries in which screening was not employed.
Recently this screening programme has been reviewed after 
30 years (Anderson G.H., et al, 1988). At present 85% of 
women at risk from cancer of the cervix have been screened 
at least once. The incidence of clinically invasive 
cervical cancer has fallen by 78% and mortality from 
cervical cancer has fallen by 72%.
These data suggest that the reduction in morbidity and 
mortality from cancer of the cervix is attributable to
-2 3-
effective cervical screening. There is no satisfactory 
formula for quantifying the cost effectiveness of 
cervical screening but this study has shown a reduction in 
invasive cancer and a simultaneous rise in reported 
incidence of premalignant lesions. Premalignant lesions 
themselves have no morbidity or mortality and their 
treatment has low morbidity and mortality. Similarly, the 
detection of early malignant disease is associated with 
higher 5 year survival rates than late malignant disease.
Thus the early identification and treatment of cervical 
neoplasia seems to be the optimal method of reducing the 
morbidity and mortality associated with advanced cancer of 
the cervix.
It is difficult to compare cancer statistics in different 
parts of the world due to differences in data retrieval, 
data recording and differences in the availability and 
quality of health care. In the United Kingdom, the 
overall mortality from carcinoma of the cervix has 
declined in the last 20 years although some two thousand 
women continue to die of the disease per annum 
(Macgregor, J.E., and Teper, S., 1978). These workers 
have shown that, in areas such as Grampian and Tayside in 
which effective screening programmes have been operated, 
the reduction in mortality has been greatest. This
suggests that the experience of British Columbia could be 
repeated in the United Kingdom if adequate screening was 
instituted.
The failure of cervical screening in the United Kingdom 
has been attributed to a number of factors comprising: 
failure to screen the at risk population, laboratory 
errors, failure to follow up cases and failure to 
irradicate premalignant lesions adequately (Chamberlain, 
J., 1984). Additionally, the lack of a unified, simple 
screening strategy has led to administrative chaos and 
increased cost (Editorial, Lancet, 1986).
Successful screening strategies also require a treatment 
for the condition which is effective and associated with 
low morbidity. Initially cone biopsy of the cervix which 
was effective but caused significant morbidity was the 
only available local response to an abnormal cervical 
smear. The widespread use of colposcopy has reduced the 
requirements for cone biopsy (Donahue, L.R., & Meriwether 
W., 1972). The development of local destructive techniques 
for selected cases such as laser ablation (Evans A.S., and 
Monaghan, J.M., 1983), electro-diathermy (Nan Schuurmans,
S., et al, 1984),"cold" coagulation (Staland, B., 1978) 
and to a lesser extent cryocautery (Townsend D.E., and 
R.M. Richart, 1983) have in recent years fulfilled these
-25-
requirements of a successful screening programme.
1.2 Aetiology
Numerous aetiological factors have been implicated in 
cervical carcinogenesis. The most recently described and 
currently most intensively studied agent is human 
papillomavirus (HPV). The structure of HPV and the data 
implicating this virus in cervical malignancy will be 
reviewed in detail (Introduction, 3 & 4).
Epidemiological studies on women developing cervical 
neoplasia.
The evidence for various aetiological factors in cervical 
cancer was derived from epidemiological studies of 
demographic and sexual characteristics of cases.
Similarly, initial studies of sexually transmitted agents 
which might be implicated in carcinogenesis were 
epidemiological. These studies will be described in the 
subsections related to individual agents.
Sexual intercourse is an essential factor in the 
development of this condition. This original observation 
by Rigoni-Stern, D., (1842) has been confirmed in more
recent times (Gagnon, F., 1950). Towne, J.E., (1955)
explored the possibility that pregnancy and cervical 
trauma at child-birth, as suggested by Gagnon, might be an 
aetiological factor. Her findings that 6 cases of
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squamous cervical cancer developed in a group of 13,083 
virginal women suggested that pregnancy per se was not a 
factor. It is interesting to note that she considered the 
terms "virginal" and "nul1iparous" to be interchangeable 
and cautioned that virgins were not free from carcinoma of 
the cervix. It may be that Towne's celibate population 
was different to Gagnon's 13,000 celibate women living in 
religious seclusion.
Wynder, E.L., et al, (1954) studied environmental factors 
in different racial and ethnic groups in the United States 
and in India. They recorded a low incidence among 
Jewesses, Fijians and Moslems with a higher incidence 
among Indians and Negroes. They found that cervical cancer 
patients commenced coitus at a significantly earlier age 
than controls. They attributed the racial differences 
observed to age at first coitus, number of marriages and 
circumcisional status of the partner. The circumcisional 
state of the partner was not thought to be important by 
Stewart, H.L., et al, (1967) however, and this has been 
confirmed recently by Baram, A., and Schachter, A., (1982)
who reported an increase in cervical cancer in Israel 
which was related to the different sexual practices of 
recent Jewish immigrants who nevertheless maintained the 
tradition of circumcision.
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Alternatively the importance of early age of intercourse 
was confirmed by Boyd, J.T., and Doll, R., (1964) and
Rotkin, D., (1967). Rotkin reguarded this as the single
most important epidemiological risk factor. Blythe Smith,
D., and Jenkins, R.S., (1969) reported on a cluster of
cases of cervical cancer found in a small housing estate 
populated by women of low socio-economic status who had an 
early age of first coitus and multiple sexual partners.
The association with social class was also noted by Beral, 
V., (1974) who found that mortality rates from cervical
cancer in women from social class I were only 35% as high 
as the rates for all married women whereas the women from 
social class 5 experienced a rate of 181% of those all 
married women.
The epidemiological characteristics of patients with 
pre-invasive disease of the cervix were explored by 
Harris, R.W.C., et al (1980). They found that multiple 
sexual partners had an independent relationship with CIN. 
Their findings failed to support suggestions that 
adolescence is a period when the cervix is most vulnerable 
to the effects of sexual behaviour. They also detected an 
association with smoking. This relationship was confirmed 
by Buckley, J.D., et al (1981) who found a relative risk 
for smokers of 7.0 when compared to non-smokers. This risk
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was similar to the relative risk for multiple sexual 
partners (7.8 for 15 or more partners). Trevanthan, E., et 
al (1983) reported a case controlled study of this 
association in American black women which showed that 
cumulative exposure to cigarette smoking was strongly 
related to all grades of cervical dysplasia. Cigarette 
smoking is thus second only to genital HPV infection in 
the league of associated epidemiological features.
Harris, R.W.C., et al, (1980) also noted an independent 
association with use of the oral contraceptive pill. An 
earlier retrospective study (Boyce, J.G., et al, 1977) on 
689 patients with cervical cancer and controls showed no 
relationship between the oral contraceptive and cancer of 
the cervix with short term use. Alternatively, Vessey, 
M.P., et al (1983). in a prospective study, recorded a 
relative risk of developing cervical pre-malignancy or 
malignancy of 2.2 compared to controls with oral 
contraceptive use in excess of 8 years. This study 
controlled for cigarette smoking but did not control for 
age at first coitus. A W.H.O. Collaborative Study of 
Neoplasia and Steroid Contraception (1985) reported a 
relative risk of 1.19 for oral contraceptive users in a 
large multicentre retrospective study. This finding must 
be viewed cautiously, however, because the quality of data 
collection in these third world countries may have been
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variable; control for the confounding effect of sexual 
variables was incomplete; no consideration of smoking was 
included; and oral contraceptives of a higher strength 
than commonly prescribed in the West were frequently used. 
In Britain, a prospective study of 47,000 women was 
reported on the association between genital tract 
malignancies and oral contraceptive use (Beral, V., et al, 
1988). The other important epidemiological variables were 
controlled for in this study. An increased incidence of 
genital tract neoplasia was noted in "ever users" compared 
to "never users". Overall, the excess incidence of 
neoplasia was 37/100000 patients in the "ever users" 
group. Most of this increase comprised CIN3 lesions and 
the excess for invasive cancer of the cervix was only 
8/100000 women. Additionally, standardised mortality 
rates were equivalent in the "ever users" and "never 
users" groups.
Recently, Pater, M.M. et al, (1988) suggested a possible 
mechanism for the association between oral contraceptives 
and cervical neoplasia. They reported that primary baby 
rat kidney cells were morphologically transformed in the 
presence of HPV 16 DNA and dexamethasone. They suggested 
that the transforming activity of HPV 16 DNA was due to 
the glucocorticoid-dependent expression of a gene 
specifically present in the HPV 16 genome. This effect
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was not noted in the presence of HPV 11 DNA. They 
inferred that progestogens in the oral contraceptive pill 
might have similar effects and that this required to be 
investigated urgently. McCance, D.J. (1988) pointed out. 
however, that Pater et al did not carry out the point 
mutation studies necessary to show that the viral 
sequences which are responsive to dexamethasone are 
actually required for cell transformation. Furthermore, 
the pharmacological properties of dexamethasone and 
progestogens are quite different so extrapolation of these 
data to the effect of oral contraceptives on cervical 
cells should be viewed cautiously. In view of the great 
social benefits gained by oral contraception and the 
relatively low risk of developing cervical cancer, it 
seems unwise to condemn the pill as extremely dangerous in 
this respect. Vessey's advice that long term users of 
oral contraceptives should have regular cytological 
examination is appropriate, as rigorous cytological 
follow-up of pill users would be expected to identify the 
majority of CIN3 lesions for treatment and reduce their 
risk of developing cervical cancer further.
Epidemiological studies on the sexual partners of women 
developing cervical neoplasia
The key role of sexual activity in the development of 
cervical neoplasia led to more detailed assessment of the
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epidemiological characteristics of sexual partners of 
women. Wakefield, J., et al (1973), studying the 
relationship between both pre-invasive and invasive 
disease and social class determined by the husbands' 
occupation, and Beral, V., (1974), studying the
relationship between invasive disease alone and social 
class, agreed that the disease was more common in lower 
social class. Both authors noted that the relationship 
varied within social classes depending on occupation. Thus 
in social class IV, the wives of sailors were 3-4 times 
more likely to die of the disease than shopkeepers' wives. 
The inference is that the itinerant lifestyle of the 
sailors was associated with sexual promiscuity in the men 
and, possibly, in the wives who stayed at home. Kessler,
I.I., (1977) expanded on these observations by detecting
marital clusters of women developing cervical neoplasia 
who shared the same husband. Buckley, J.D., et al (1981) 
defined the relative risk to wives of promiscuous men as 
7.8 if their husbands had more than 15 sexual partners 
outwith marriage and Singer, A., et al, (1976), reviewing 
the data, hypothesised that certain males were at high 
risk of inducing cervical neoplasia in their sexual 
partners.
The relationship between penile cancer and cervical 
neoplasia has been explored by several workers. Graham.
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S., et al (1979) in New York State and Smith, P.G., et al
(1980) in England and Wales both detected statistically 
significant associations between the two diseases which 
were independent of other variables. Sorahan, T., & 
Crombie, I.K., (1981) reviewed the age standardised rates
of both diseased in North America and Europe and found a 
highly significant association in the black population.
An apparent lack of a significant association in the white 
population disappeared when control for population size 
was introduced. It is possible that both diseases share a 
common aetiology and the large difference in prevalence of 
cancer of the cervix and cancer of the penis depends on 
differing suscepibi1ity of the host tissues to malignant 
transformation.
The human sperm as an aetiological agent
The most obvious sexually transmitted agent at coitus is 
the sperm which led Reid, B.L. (1964) to study the 
bahaviour of human sperm in an in vitro system of cultured 
fragments of the human cervix. He noted that sperms only 
penetrated metaplastic epithelium and did not penetrate 
mature squamous epithelium. Later, he suggested that 
integration of sperm DNA into cervical cells may produce 
neoplasia but was unable to develop a model to prove this 
(Reid, B.L., 1985).
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Interest turned to the effect of sperm basic proteins on 
cervical cells (reviewed by Singer, A., et al, 1976) 
which, it was suggested, can alter the morphology of 
cultured cervical cells. Reid, B.L., et al (1978) 
developed the theory by identifying two sperm basic 
proteins, a histone and a protamine. They stated that 
mean values for these proteins in men of lower social 
class were higher than those of men in higher social 
class. Reid, B.L., (1985) drew the data together and
suggested that these proteins along with polymerised 
argenine might alter the intracellular mechanisms of the 
target cells and act as co-factors with oncogenic viruses. 
This proposition was based on the detection of profound 
disturbance of the cytoplasmic and cell surface filaments 
of cultured cervical cells following contact with proteins 
purified from the sperm head. These disturbances resulted 
in alteration of the shape of the cells, an inceased 
sensitivity to lectins and increased production of mannase 
and galactase. Such changes are also found when 
susceptible cultured cells are exposed to the oncogenic 
virus, Rous sarcoma virus. In experiments on cultured 
cells exposed to antiserum raised against papillomavirus 
antigen in rabbits the effect of polymerised arginine on 
these cell filaments was enhanced sixfold. Reid 
postulated from these in vitro data that sperm proteins
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might somehow promote the oncogenic effect of HPV. However 
there is no in vivo evidence for this mechanism.
The effect of vasectomy on the cancer risk of female 
partners might give indirect evidence for a role of human 
sperms. The data are conflicting however. Swan, J.H., 
and Brown, W.L., (1979) suggested that vasectomy was
protective for the female sexual partner but Harris, R.W., 
and Scott, W.A., (1979) criticised this study as it did
not control for other sexual variables. When the number 
of sexual partners was controlled for, Harris & Scott 
showed that the apparent difference between cases and 
controls disappeared. The aetiological role of sperms in 
cervical neoplasia is therefore unproven. The possible 
role of other components of the ejaculate e.g. prostatic 
fluid which would be unaffected by vasectomy have not been 
studied.
Herpes simplex virus (HSV)
HSV is a DNA virus which infects the lower genital tract. 
There are two serotypes, HSV-1 and HSV-2; the latter more 
commonly infecting the genital tract than the former 
(Smith, I.W., et al, 1976). The evidence for an 
aetiological role of HSV in cervical carcinogenesis is 
based on cell line studies, animal studies, serological 
data, immunohistochemical studies and the detection of
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virus specific nucleic acid in cancer specimens and 
derived cell lines.
Morphological transformation of hamster embryo cells by 
inactivated HSV-1 was demonstrated by Duff, R., & Rapp,
F., (1973). Three regions of the HSV genome were shown to
be associated with morphological transformation of 
cultured cells MTR1, MTRII and MTRIII (see Macnab,
1987, for review). Experiments on mice have shown that it 
is possible to induce cervical cancers in these rodents by 
application of HSV-2 DNA. This oncogenic effect can be 
reduced if the mice are previously immunised with HSV 
vaccine (Chen M., et al, 1986).
Naib, Z.M., et al (1966) first noted an increased 
incidence of CIN in women who also had cytologically 
detectable HSV infections. Serological evidence of an 
increased incidence of HSV infection in patients with CIN 
and invasive disease was provided by Rawls, W.E., et al 
(1968) and Nahmias, A.J., et al (1974).
HSV specific antibodies were detected in 90% of patients 
and only 10% of controls in one study (Aurelian, L., et 
al, 1973) . HSV DNA was detected in 60% to 70% of CIN 
lesions but infrequently in invasive cancers although HSV 
specific mRNA was detected in invasive tumours [McDougall, 
J.K., et al, (1980); Eglin, R.P., et al (1981)]. The
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study by Eglin et al also included normal control tissue 
and the results suggested that the viral RNA probed for 
was specific to tumour cells. The specificity of the 
radiolabelled probes was however questioned by Peden, K. , 
et al (1982), who demonstrated homology between fragments 
of the viral genome and host cell DNA. Park, M., et al
(1983) studied 8 human cervical cancers for evidence of 
HSV-2 DNA by Southern blot analysis using 70% of the HSV-2 
genome as a probe. Tumour and control tissue DNAs were 
hybridized with five different restriction fragment 
probes. Hybridization to HSV DNA sequences was observed 
in only one tumour, an adenocarcinoma, with only one 
probe, Bgllln. This demonstrated unambiguously that 
authentic viral sequences were detected in this tumour.
The Bgllln region of the HSV-2 DNA is associated with 
morphological transformation of rodent cells but is not 
retained within these cells suggesting that the DNA need 
not be retained within the cell to maintain the oncogenic 
phenotype [Galloway, D.A., & McDougall J.K. (1981), 
Cameron, I.R., et al (1985)].
The inability to consistently identify HSV DNA in tumour 
tissues has led some workers [Skinner, G.R.B., (1976);
Galloway, D.A., and McDougall, J.K., (1983)] to suggest a 
"hit and run" mechanism of carcinogenesis for HSV. Zur 
Hausen, H., (1982) hypothesised that HSV acts as an
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initiator which works synergistically with HPV and other 
co-carcinogens. Zur Hausen's model reconciles the 
conflicting evidence of the low detection of HSV DNA in 
human tumours and the other experimental evidence for a 
role of HSV in a complex process of carcinogenesis.
Human cytomegalovirus (HCMV)
HCMV commonly infects the cervix and its detection is 
associated with sexual promiscuity (Jordan, M.C., et al, 
1973). Its oncogenic potential has been demonstrated in 
vitro (Albrecht, T., and Rapp, F., 1973). Dysplasias and 
carcinomas of the mouse cervix have been induced by 
treatment with U-V inactivated HCMV (Heggie ,A.D., et al, 
1986). Melnick, J.L., et al (1978) isolated HCMV from 
cell cultures derived from two out of ten cervical cancer 
biopsies. Fletcher, K., et al (1986) detected sequences 
that hybridized to HCMV DNA in 2 out of 43 biopsies from 
patients with CIN. They suggest that HCMV may act as a 
promotor of co-carcinogens in the neoplastic process.
Thus, like HSV, there is indirect evidence for a role of 
HCMV in tumourogenesis in some cases although the possible 
role of this virus in vivo has not been clarified.
Epstein-Barr Virus (EBV)
The association between EBV and Burkitt's lymphoma
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(Burkitt, D., 1958) is well recognised as is infection of 
the oropharynx producing the clinically recognised 
condition of infectious mononucleosis (Henle, G., et al, 
1968). Sixby, J.W., et al (1986) recently detected 
shedding of EBV from the cervix and suggested a venereal 
mode of spread. The possible role of this potentially 
oncogenic virus on the cervix awaits further study.
Chlamydia and other sexually transmitted diseases
In a study of 383 women with cervical neoplasia and 500 
controls, Schachter, J., et al (1982) detected an excess 
of chlamydial antibodies in patients when other 
epidemiological factors were controlled for. Apart from 
this sero-epidemiological data, however, there is little 
evidence of a causal relationship with cervical cancer. 
Similarly, evidence for a causal relationship between the 
notifiable venereal diseases and cervical cancer remains 
epidemiological only [Beral, V., (1974), Kessler, I.I.,
(1977)]. It may be that these agents are merely markers 
of sexual promiscuity and a consequent greater risk of 
exposure to more likely agents such as HPV, HSV or HCMV.
2. Vulval Neoplasia
2■1 General considerations
The human vulva constitutes an organ which has a separate
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blood and lymphatic supply from the surrounding skin. 
Diseases affecting the vulva can therefore be considered 
as separate from those affecting other areas of the 
integument. The classification of vulval premalignant 
disease has been plagued by inconsistency in the past but 
in the last 10 years a unified classification has been 
popularised (International Society for Study of Vulvar 
Disease, 1976). In essence this classification 
comprises:-
i Hyperplastic dystrophy - without atypia
- with atypia
ii Lichen sclerosus
i i i Mixed dystrophy
iv Pagets disease of the vulva.
The cellular atypia associated with hyperplastic dystrophy 
can be mild, moderate, or severe and this corresponds to 
vulval intra-epithelial neoplasia (VIN) grades 1, 2 and 3. 
Hyperplastic dystrophy can be regarded as a pre-malignant 
lesion whereas Lichen sclerosus has low malignant 
potential. Mixed dystrophies have intermediate malignant 
potential. Paget's disease is a plastic change within the 
epithelium which is confined by the basement membrane.
Bowen's disease is a hyperplastic dystrophy and should be 
included in that classification.
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The malignant potential of VIN is low compared to CIN on 
the cervix. The disease is usually multifocal and 
characterised by change in skin colour (commonly red and 
white) and pruritis, (Douglas, C.P., 1983).
Invasive cancer of the vulva is usally squamous in origin 
(88.8%). Other histological types of tumour comprise 
melanoma, basal cell carcinoma, Bartholin's gland tumour, 
sarcoma, and adenocarcinoma (Way, S., et al, 1982). 
Squamous carcinoma commonly presents as a mass or an 
ulcer.
The incidence of vulval premalignancy is unknown in the 
population. Vulval carcinoma is increasing in incidence 
and comprises about 5% of female genital malignant 
disease. In the West of Scotland the incidence is 2.4 per 
100,000 women and at least some of the apparent increase 
is explained by increasing incidence in the older age 
group which may be related to the longevity of the modern 
population (Murdoch, J.B., & Torbet, T.E., 1986).
2.2 Aetiology
Apart from a possible role of HPV to be reviewed later 
(Introduction, 5) the aetiology of vulval cancer is 
obscure. VIN is a premalignant condition but its 
incidence in the population and therefore its true
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malignant potential is unknown because there is no 
screening test for the condition and it is frequently 
unreported. Hay, D.M., and Cole, F.M., (1961) reported an
association with tropical granulomatous disease in 
Jamaica. Way, S., et al (1982) considered that while 
toxic industrial carcinogens might play a part in 
isolated cases, vulval hygiene was probably an important 
factor in genesis of the disease. They also reported an 
association with lower social class but found no 
correlation with marital status, menstrual history or 
incidence of notifiable venereal disease.
3. Human Papillomavirus
3.1 Structure and organisation
Human papillomavirus (HPV) is the papillomavirus which 
infects man. Other papillomaviruses infect many species 
including horses, cattle, birds and rabbits. They are 
icosahedral particles approximately 45-55nm in diameter 
and consist of 72 capsomeres. They are members of the 
papovavirus family. The structure and molecular weight of 
HPV DNA was determined by Crawford, L.V. and Crawford,
E.M. (1963). HPV DNA exists as a double stranded circular 
molecule and three forms are demonstrated by velocity 
sedimentation. These forms are supercoiled circular DNA 
(form 1), nicked circular DNA (form II) and linear DNA
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Diagram of the organization of the papillomavirus genome 
comparing BPV1, HPV la, HPV 6b & CRPV. The genome is split 
into early (E) and late (L) regions. There is a common 
organization of the ORFs between species and subtypes. 
From, Pfister, H. et al (1986).
(form III). The molecular weight (M.W.) is 4.9 x 10fe 
(Gissmann, L. and Zur Hausen, H., 1976). The HPV genome 
is approximately 8 kilobase (kb) pairs long. HPV DNA 
subtypes are differentiated by nucleic acid base pair 
sequence homology. By convention HPV DNA subtypes with 
more than 50% base pair sequence homology are assigned to 
the same subtype; those with less than 50% base pair 
sequence homology are assigned to a new subtype.
Currently, over 50 HPV subtypes have been reported 
(McCance, D.J., 1988).
Although the human and animal papillomaviruses have little 
sequence homology they have a common organisation of the 
open translational reading frames (ORFs) (Fig. 1). The 
genomic organisation of bovine papillomavirus type 1 
(BPV1) has been extensively studied and general 
conclusions about other papillomaviruses can be drawn from 
this.
Unlike other members of the papovavirus family, the 
genomic organisation of papillomaviruses is such that all 
major ORFs are located on the same DNA strand (Danos, 0., 
et al, 1982). Although there is no tissue culture system 
available for propagating papillomaviruses it has been 
assumed that the genes can be functionally divided into 
early genes (El to E8) which are expressed before the
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From, Petterson, U. et al (1986).
onset of viral replication and late genes (LI and L2) 
which are expressed after viral replication commences. 
Lowy, D.R., et al (1980) showed that a fragment comprising 
69% of the BPV1 genome transformed NIH 3T3 and C127 mouse 
cells and suggested that this fragment encodes for the 
early functions of the genome and the remainder encodes 
for the late functions of the genome. Of the 8 early ORFs 
El, E2, E4, E6 and E7 have equivalent counterparts in all 
papillomavirus genomes sequenced so far (Fig. 1). A 
detailed functional mapping has been achieved by genetic 
studies of BPV1 (Fig. 2). This shows that the coding 
sequences in the ORFs of the early region of the viral 
genome are involved in the maintenance of the viral 
genome, genome replication and morphological cell 
transformation. The ORFs of the late region of the viral 
genome are related to production of capsid proteins.
The capsid proteins of HPV are structurally similar to 
histones (Pfister, H., et al, 1977). Different P.V. 
subtypes produce specific structural proteins which can be 
identified immunohistochemically (Nakai, J., et al, 1986).
Whilst viral DNA is detected in the basal layers of 
epithelium by in situ DNA-DNA hybridization (Crum, C.P., 
et al, 1986); late gene function and production of 
structural proteins are detected in the superficial layers
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of terminally differentiating keratinocytes (Coleman,
D.V., and Richman, P.I., 1985). Viral replication takes 
place in these terminally differentiating keratinocytes 
and the cytopathic effect of this process is recognised 
histologically by the presence of halo cells or koilocytes 
[Koss, L.G., and Durfee, G.R., (1956); Meisels, A., et al,
(1981)]. As the koilocyte is a dying cell, it has been 
impossible to propagate the virus in vitro.
3.2 Clinical and subclinical infections with HPV
HPV infects squamous epithelium. Different subtypes are 
associated with lesions on different parts of the body. 
Thus for example, HPV 1 is associated with plantar warts, 
(Danos, 0., et al, 1982) and HPV 11 is associated with 
laryngeal papillomas (Gissman, L., et al, 1982b).
HPV 6 (Gissmann, L. and Zur Hausen, H., 1980); HPV 11 
(Gissmann, L., et al, 1983); HPV 16 (Durst, M., et al, 
1983) and HPV 18 (Boshart, M., et al, 1984) DNAs are 
associated with the human female genital tract. HPV 31 
(Lorincz, A.T., et al, 1986) and HPV 33 (Beaudenon, S.. et 
al, 1986) have also been detected (to a lesser extent) in 
female genital tissue in some parts of the world.
Overall, HPV 6 and 11 tend to be more closely associated 
with benign lesions and HPV 16, 18, 31 and 33 are 
associated with premalignant and malignant lesions. The
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association between HPV subtypes and neoplasia will be 
discussed (Introduction, 4).
On the vulva and cervix HPV infections present clinically 
as condylomata acuminata. These lesions are easily 
diagnosed and possess characteristic histological 
appearances (Meisels, A., et al, 1977). Ferenczy, A., et 
al, (1985) demonstrated that HPV DNA was detected not only 
in condylomata acuminata but also in clinically and 
histologically normal adjacent tissue. Subclinical lesions 
have been described on the vulva at vulvoscopy (Singer, A. 
and McCance, D., 1985). On the cervix, the lesion most 
commonly detected is the atypical condyloma (Meisels, A., 
et al, 1981) which Reid, R., et al (1980) named the 
noncondylomatous cervical wart virus infection (NCWVI). 
This lesion is not apparent with the naked eye and is 
visualised as aceto-white epithelium at colposcopy. 
Atypical condylomata can be difficult to diagnose 
cytologically or histologically because they mimic, and 
frequently coexist with, dysplastic changes on the cervix 
(Meisels, A., et al, 1981). De Villiers, E-M., et al
(1987) found that 10% of women with apparently normal 
cervical cytology had evidence of HPV DNA infection using 
a dot blot hybridization technique. They suggested that 
this technique was insensitive and postulated that the 
prevalence of HPV DNA infection of the cervix in the
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female population might be as high as 309s.
On the male penis HPV infection may present as condylomata 
acuminata or subclinically as microwarts (Campion, M.J., 
personal communication). Even males with apparently 
unaffected penises have been found to harbour HPV DNA on 
the glans penis (Grussendorf-Conen, E-I., et al, 1986).
HPV DNA has also been detected in human semen (Ostrow, 
R.S., et al, 1986) indicating the presence of HPV DNA 
within the male urethra.
Human papillomavirus DNA infection is therefore a common 
finding in the genital tissues of both sexes and is 
associated with clinically or subclinically apparent 
lesions in a proportion of cases only.
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4. The association between HPV and cervical cancer
4.1 Epidemiological evidence
The strong association between sexual activity and 
cervical cancer has been described. Genital 
papillomavirus infection is a common sexually transmitted 
disease (Report of Public Health Laboratory, Scotland
1983). The incidence of clinically obvious genital warts 
in both sexes has increased dramatically in recent years 
(Oriel, J.D., 1983). Simultaneously, the reported 
prevalence of CIN in younger women has also risen by some 
60% (Roberts, A., 1982). Some workers (Bamford, P.N., et 
al, 1983) have reported that there is a subset of women 
under 35 years of age who are rapidly developing 
aggressive cervical carcinomata and Singer, A., et al,
(1984) have postulated that these three factors are 
interrelated. Recently, Silcocks, P.B.S. & Moss, S.M.
(1988) argued that this apparent increased incidence of 
disease in young women could be explained by trends in 
population structure, a general increased incidence of 
cervical cancer and an increased proportion of women being 
screened. The epidemiological evidence for a sequential 
association between HPV infection and the development of 
CIN and invasive cancer has also been challenged 
(Meanwell, C.A., et al, 1987). Similarly, Meanwell, C.A.,
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et al (1988) have found no evidence of a poorer prognosis 
in young women with invasive disease. It is true, 
nevertheless, that these epidemiological coincidences have 
led many investigators to suspect that HPV is the sexually 
transmitted agent which causes cervical cancer (Singer,
A., et al, 1984). The epidemiological case for HPV as a 
cervical carcinogen has been further strengthened by 
evidence that the "male factor" in cervical cancer might 
be HPV infection of the penis (Campion, M.J., et al,
1985).
Sero-epidemiological evidence for an association between 
HPV and cervical neoplasia was provided by Baird, P.L., 
(1983). He used disrupted BPV 2 virions in a solid phase 
enzyme linked immunosorbent assay for an IgG antibody and 
showed that patients with CIN and cervical cancer had 
significantly higher levels of serum antibody to HPV 
antigen than appropriate controls.
The natural history of cervical HPV infection has been 
studied prospectively. The major problem with prospective 
evaluation of patients with HPV infection lies in the 
criteria used for initial diagnosis. Biopsy and 
histological diagnosis of the nature of a colposcopically 
apparent aceto-white lesion is the most accurate means of 
differentiating HPV infection alone and HPV infection
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co-existing with CIN, but biopsy itself may alter the 
natural history of the disease (Syrjanen, K., et al,
1985a). In an effort to avoid this problem, Syrjanen, K., 
and his group (1985a and 1985b) studied patients using 
cytology and colposcopy alone to diagnose and 
differentiate HPV infection and CIN. Some workers would 
defend the adequacy of these two subjective tests to make 
an accurate diagnosis [Reid, R., et al, (1984); Campion, 
M.J., et al, (1986); Vaeyrynen, M., et al, (1985)]. Others 
have shown that there is a poor correlation between 
cytology, colposcopy, histology and DNA-DNA hybridization 
analysis in this respect [Kirkup, W., et al, (1982); 
Walker, P.G., et al (1983); Murdoch, J.B., et al, 1988)]. 
Evaluation of data from prospective studies of HPV 
infection is difficult if the starting point is not 
clearly defined. What may be thought to be progression 
from a pure HPV lesion to CIN might, equally, be 
progression from HPV associated with colposcopically and 
cytologica1ly occult CIN to HPV associated with 
colposcopically and cytologically apparent CIN. The 
methodological difficulties of prospective evaluation of 
HPV on the cervix are further demonstrated by Syrjanen,
K., et al (1985a). They describe rates of progression to 
carcinoma-in-situ in patients with "HPV - associated CIN" 
as diagnosed by cytology and colposcopy and offer this as
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evidence of progression from HPV infection to 
carcinoma-in-situ. These data could equally be used to 
show that CIN progresses to carcinoma-in-situ and that the 
presence of HPV DNA is quite fortuitous. In contrast, 
Cheetham, D., et al (1984) in a small controlled study 
showed that HPV infection diagnosed cytologically and 
colposcopically regressed spontaneously in 83% of cases.
In addition to this, the rates of persistence of CIN 
lesions over the study period were unaffected by the 
coexistence of HPV infection. Studies of the natural 
history of HPV infections of the cervix are important but 
the design of such studies must be meticulous to allow 
proper evaluation (Armstrong, B., et al, 1988). Mitchell, 
H., et al, (1986) demonstrated an awareness of the 
limitations of the diagnostic performance of cytological 
screening in an elegant and simple study. They showed 
that the risk of a woman being subsequently diagnosed as 
having carcinoma-in-situ was 15.6 times higher if there 
was evidence of HPV infection at cervical cytology 
compared to controls. In patients under 25 years, this 
risk was 38.7. They, therefore, demonstrated that HPV 
infection on the cervix was associated with a high risk of 
neoplastic progression without addressing the role of HPV 
in that progression. This observation is clearly of great 
practical importance in screening for CIN and identifying
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“at risk" groups. It is the most reliable available datum 
from prospective epidemiological studies.
4.2 Animal and human models for an oncogenic role of
papi1lomaviruses
Several models exist in animals and more rarely in humans 
to support an oncogenic role for papillomaviruses.
The shope papillomavirus (Shope, R.E., 1933) which infects 
cottontail rabbits in certain parts of America such as 
Kansas and California was the first to be studied. Shope 
viral DNA has been demonstrated in these tumours (Stevens, 
J.G. & Wettstein, F.O., 1979). Bovine papillomavirus 
(BPV), which has been most extensively studied, has become 
the model for research into human papillomaviruses. BPV 4 
produces papillomas in the upper alimentary tracts in 
cattle. Jarrett, W.F.H., et al (1978) showed that 
malignant transformation of these papillomata depended 
upon subsequent exposure to ingested bracken. It is 
noteworthy that although BPV appears to be necessary to 
induce papillomas, it is not necessary that the genome 
should persist for malignant transformation to occur or 
for it to be maintained (Campo, M.S., et al, 1985).
Bracken contains several chemical carcinogens and may also 
be immunosuppressive. It would seem that bracken causes 
immunosuppression which induces the spread of papillomas
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and allows their persistence beyond their average 
life-span in immunocompetent animals (Campo M.S., et al, 
1985). The fragment of the BPV genome which is capable of 
inducing cell transformation is located in a BamHl/Hind 
111 DNA fragment which represents 69% of the full length 
of the viral genome (Lowy, D.R., et al, 1980).
Nakabayashi, Y., et al (1983) showed that this region 
represents the early region of the viral genome, and 
Schiller, J.T., et al (1984) demonstrated an independent 
cell transforming region corresponding to the E6 open 
reading frame of the early region of the viral genome.
Another example of papillomaviruses and a chemical 
cofactor being implicated in tumour formation is found in 
the rodent, Mastomys natalensis (Amtmann, E., et al,
1984). In this animal extrachromosoma1 viral DNA 
increases in copy number with advancing age and 
papillomata begin to appear. If the tumour promoter 
12-0-tetradecanoylphorbol-13-acetate (TPA) is applied to 
the skin of young Mastomys this process is greatly 
accelerated compared to controls. TPA has been shown to 
induce replication and transcription of BPV1 DNA in vitro 
(Amtmann, E., & Sawer, G., 1982) and it may be that this 
effect is present in vivo in the Mastomys. Unfortunately 
Amtmann et al could not detect papillomavirus transcripts 
in this animal model.
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In humans, outwith the female genital tract, examples of 
malignancy directly associated with papillomaviruses are 
rarer. The large condylomatous Buschke-Lowenstein tumour 
on the penis has been reported to undergo malignant 
transformation to squamous cell carcinoma (Boxer, R.J., 
and Skinner, D.G., 1977). The rare skin condition 
epidermodysplasia verruciformis (E.V.) is induced by HPV 
(Green, M., et al, 1982). Malignant transformation in EV 
is associated with HPV 5, HPV 8 and HPV 14 genomes and 
cancers are clustered in areas exposed to the sun, 
suggesting that UV light is the relevant co-carcinogen in 
this case [Ostrow, R.S., et al, (1982); Lutzner, M.A., et 
al, (1984)]. Papillomaviruses, therefore, can be regarded 
as oncogenic viruses. It is important to note, however, 
that, in the examples cited above, co-factors play a 
significant part in progression to malignant disease.
4.3 Morphological evidence
The atypical condyloma or "flat wart" is the most common 
colposcopic appearance associated with cervical HPV 
infection (Meisels, A., et al, 1977). Their similarity 
to, and confusion with, CIN lesions is well documented 
(Meisels, A., et al, 1981). Colposcopic appearances 
associated with HPV infection comprise aceto-white 
epithelium with mosaicism and punctation which is usually
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multifocal (Meisels, A., et al, 1981).
Reid, R., et al (1984) described a weighed colposcopic 
index for differentiating these two lesions which in their 
hands accurately predicted the histological diagnosis in 
96% of cases. They emphasise that HPV infection and CIN 
frequently coexist and regard this as evidence that there 
is a continuous spectrum of disease. Other workers 
disagree about the diagnostic reliability of colposcopy 
and note a poor correlation between colposcopic impression 
and other diagnostic criteria [Kirkup, W., et al,(1982). 
Walker, P.G., et al,(1983)].
4.4 Electron microscopic evidence
The presence of viral particles in human genital warts was 
reported in 1968 (Dun, A.E.G., and Ogilvie, M.M., 1968). 
The presence of viral particles was also demonstrated in 
atypical condylomata (Ferenczy, A., et al, 1981). Shah, 
K.H., et al, (1980) used papilloma group specific 
antiserum to detect HPV antigen in patients with mild 
dysplasias. They showed that cells which were found to 
contain virus particles at electron-microscopy also 
stained for papilloma virus antigen. There is therefore no 
doubt that HPV is present in atypical condylomata.
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4.5 Cytological. histological and immunohistochemical 
evidence.
Koss, L.G., and Durfee, G.R., (1956) first coined the term
koilocytes to describe the cells now known to be 
associated with HPV infection. Dun, A.E.G., and Ogilvie, 
M.M. , (1968) showed that viral particles were present 
within these cells and Meisels, A., et al, (1981) defined 
the cytological and histological features associated with 
flat condylomata. The confirmation that the colposcopic, 
cytological and histological appearances were associated 
with HPV was provided by Morin, C., et al (1981) using 
pooled papillomavirus antigen in a
peroxidase-anti-peroxidase staining technique. They 
showed that 60% of atypical condylomata with koilocytes 
present contained papillomavirus antigen. The cells which 
stained for papillomavirus antigen were detected in the 
superficial layers of the epithelium which showed that the 
manufacture of HPV structural proteins occurs in 
terminally differentiating keratinocytes. They showed 
that papillomavirus antigen was largely absent from areas 
of dysplastic change characterised by a lack of terminal 
differentiation of cells. These findings were confirmed 
in other studies [Woodruff, J.D., et al, (1980); Kurman, 
R.J., et al, (1981)]. Winkler, B., et al (1984) reported 
that the lesions which contained both abnormal mitotic
forms and papillomavirus antigen were usually 
characterised by aneuploidy. They suggested that this 
subgroup might represent a transition between flat warts 
and CIN.
4.6 DNA-DNA hybridization evidence
DNA-DNA hybridization studies have provided the strongest 
evidence for an association between HPV and genital 
neoplasia. The technique was first applied to HPV 
analysis by Favre, M. , et al, (1975).
HPV 6 was the first subtype detected in female genital 
warts (Gissmann, L., and Zur Hausen, H., 1980). The HPV 6 
genome was subsequently cloned and two subgroups HPV 6a 
and HPV 6b, were identified (De Villiers, E-M., et al, 
1981). Gissmann, L., et al, (1982a) probed 44 samples 
from condylomata acuminata and detected HPV DNA in 41 
(93%). They also detected HPV 6 in 3/3 Buscke-Lowenstein 
penile tumours but failed to detect HPV 6 DNA in 54 human 
female and male genital cancers. The HPV DNA detected in 
the condylomata acuminata was found to be in the 
supercoiled plasmid form and was not integrated into the 
host cell chromosome. The same group subsequently defined 
the nuclear base pair sequence of HPV 6b and showed it to 
be similar to HPV la and BPV 1 in that all the major open 
reading frames (ORFs) were located on one DNA strand. (See
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Fig. 1; opposite p.43) Furthermore all 3 papillomaviruses 
comprise seven ORFs in the early region and two ORFs in 
the late region of the genome. Using the same clone of 
HPV 6 DNA, McCance, D.J., et al (1983) found HPV 6 DNA 
sequences in 13 out of 22 women with CIN. HPV 6 DNA was 
detected in all three grades of CIN. In a further study 
Gissmann, L., et al, (1983) probed genital and laryngeal 
papillomas with HPV 6 and HPV 11 DNA sequences, [HPV 11 
was initially cloned from viral DNA derived from a 
laryngeal papilloma (Gissman, L., et al, 1982b)]. They 
found HPV 6 DNA in 41 out of 63 condylomata acuminata and 
HPV 11 DNA in 13 out of 63 condylomata acuminata. HPV 11 
DNA was also detected in 2 invasive cervical cancers and 2 
carcinomas-in-situ. The nucleotide sequence of HPV 11 was 
subsequently found to share an 82% base pair sequence 
homology with HPV 6 (Dartmann, K., et al, 1986). These 
data suggested that HPV 6 and HPV 11 had very similar DNA 
coding regions and were associated with benign genital 
lesions.
HPV 16 DNA was detected by hybridization of DNA from a 
cervical cancer biopsy to an HPV 11 DNA probe under low 
stringency conditions. The viral DNA was cloned in phage 
lambda and the cloned DNA was used to probe other tumours 
(Durst, M., et al, 1983). In this initial study, 61% of 
cervical cancer samples from Germany hybridized to HPV 16
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DNA sequences compared to 34.8% of cervical cancer 
specimens from Kenya and Brazil. In contrast to HPV 6/11 
only 2 out of 33 condylomata acuminata contained HPV 16 
DNA sequences. These data suggested HPV 16 was more 
closely associated with invasive cancer of the cervix than 
benign lesions. Crum, C.P., et al, (1984 and 1985) 
studied the relationship between the presence of HPV 16 
DNA and abnormal mitotic figures in precancerous lesions 
of the cervix. They found a strong positive correlation 
between the two and suggested that the presence of HPV 16 
DNA was associated with an increased risk of progression 
to malignancy.
Cloned HPV 16 DNA supplied by the Heidelberg group (Durst, 
M., et al, 1983) was utilized in several studies in the 
United Kingdom. In London, McCance, D.J., et al (1985a) 
detected HPV 16 DNA in 62% of CIN and 90% of malignant 
lesions compared to 18% (3/17) of apparently normal 
control patients. They confirmed the impression that HPV 
16 was associated with more severe lesions than HPV 6/11. 
Similar findings were recorded from East Anglia (Scholl, 
S.M., et al, 1985) and the West of Scotland (Millan,
D.W.M., et al, 1985). The belief that HPV 16 was strongly 
associated with invasive disease was however challenged in 
one small study (Fukushima, M., et al, 1985) which 
detected HPV 16 DNA in only 17% of invasive cancers
compared to 83% of CIN lesions. Most studies also 
suggested that HPV 16 DNA was detected in its episomal 
form in CIN but was found integrated into the host cell 
chromosome in invasive cancers. The physical state of HPV 
16 DNA in benign and invasive genital tumours was reported 
by Durst, M., et al, (1985). They probed invasive tumours 
and cloned virus/cell junction fragments to demonstrate 
integration of the viral genome into the host cell 
chromosome in these lesions. Di Luca, D., et al (1986) 
showed that integration of the viral genome was also found 
in CIN lesions and suggested that integration had 
prognostic significance of progression to malignancy.
The fourth HPV subtype associated with genital malignancy, 
HPV 18, was detected in 25% of malignant tumours from 
Africa and Brazil and 2 out of 13 cancers in Germany.
There was no evidence of hybridization to condylomata or 
cervical dysplasias (Boshart, M., et al, 1984). This 
suggested that HPV 18 DNA was associated with more severe 
lesions and Barnes, W., et al, (1988), in a study of 30 
squamous carcinomas of the cervix, reported evidence of a 
direct correlation between the presence of HPV 18 DNA and 
nodal involvement in clinically diagnosed staged IB 
disease. They suggested that HPV 18 was related to more 
aggressive tumours than HPV 16. Alternatively, Millan,
D.W.M. , et al, (1986) detected HPV 18 DNA in 4 out of1 26
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punch biopsies from CIN lesions, 2 of which showed 
evidence of integration of the viral DNA.
Two other HPV subtypes are related to genital neoplasia in 
a minority of cases. HPV 31 is related to HPV 16 with 
30-40% base pair sequence homology and has been detected 
in 20% of mild to moderate dysplasias and 6% of invasive 
tumours in one study (Lorincz, A.T., et al, 1986) and in 
6% of tumours in the study of Barnes, W., et al (1988).
HPV 33, also related to HPV 16, was reported in 2 of 29 
CIN lesions and 1 of 53 cervical carcinomas by Beaudenon, 
S., et al (1986). Thirdly, HPV 35 has been isolated in 1% 
of anogenital intraepithelial neoplasia and in 4% of 
anogenital cancers in one study (Lorincz, A.T. et al,
1987). Finally, two new subtypes HPV 39 and HPV 42 have 
been identified in association with penile bowenoid 
papules and vulval papillomas respectively (Beaudenon, S., 
et al, 1987).
The majority of these prevalence studies, however, did not 
include data on normal control patients. One which did 
(McCance, D.J., et al, 1985a) reported an 18% incidence of 
HPV 16 in colposcopically and histologically apparently 
normal cervices. Toon, P.G., et al (1986) studied 106 
patients with smears showing non specific inflammatory 
changes and found CIN in 12.3% of cases and HPV DNA in
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22.6% of cases. It is not clear, however, what proportion 
of cases with CIN also exhibited HPV DNA. Furthermore in 
a second group of 104 controls with normal cervical 
cytology, 11.5% exhibited HPV DNA. In a small study in 
Birmingham, (Cox, M.F., et al, 1986) 38% of 
colposcopically and cytologically normal control cervical 
biopsies contained HPV DNA. Later, this same group 
(Meanwell, C.A., et al, 1987) detected HPV DNA sequences 
in 35% of a group of normal control cervices. They also 
reported that 66% of biopsies from invasive cancer of the 
cervix hybridized to HPV DNA. Interestingly, when an age 
discrepancy in the two groups was controlled for, there 
was no significant difference between cases and controls. 
These data suggested that the association between HPV 16 
and cervical neoplasia is age mediated.
In Germany, over 9,000 women were screened for evidence of 
HPV DNA by a dot blot technique on cells collected by 
cervical scraping (De Villiers, E-M., et al, 1987). They 
established that the prevalence rate for HPV 16 DNA 
infection on the human ectocervix was 10%. Dot blot 
hybridization is subject to a number of methodological 
difficulties and the authors suggested that they may have 
undercalled the true prevalence by 10-20%. They further 
stated that it would be beneficial to compare dot-blot and 
Southern blot results to establish the sensitivity and
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specificity of their assay.
In general, therefore, the available evidence suggests 
that 10%-35% of the healthy female population harbour HPV 
DNA on the cervix.
Studies of healthy women (external controls) are important 
to establish the prevalence of infection in the community. 
Ferenczy, A., et al (1985) examined the normal vulval skin 
adjacent to vulval condylomata acuminata and found HPV DNA 
in 45% of cases. This study emphasised the importance of 
two control groups when analysing the prevalence of HPV 
DNA in tissue samples, that is, an external control from 
apparently normal women and tissue from apparently normal 
tissue adjascent to abnormal tissue - an internal control. 
Macnab, J.C.M., et al (1986) reported a parallel study 
involving samples from invasive cancer of vulva and cervix 
along with internal controls. They found hybridization to 
HPV 16 DNA sequences in 84% of tumours but also found HPV 
16 DNA sequences in 73% of histologically normal tissue 
within 2cm to 5cm of the tumours.
The detection of HPV DNA in the genital tract is therefore 
common. In patients with genital tract neoplasia the 
prevalence is high but the viral genome is not confined to 
histologically abnormal epithelium and is frequently found 
in adjacent normal tissue.
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4.7 Evidence from studies of integration and
transcription of HPV DNA in vivo and in vitro and 
of HPV DNA in morphological cell transformation in 
vitro
HPV 16 and HPV 18 have been studied to establish whether 
the viral genome is found in the plasmid state or 
integrated into the host cell chromosome in tumours and 
cell lines derived from cervical cancers. The 
transcription patterns of the viral genomes have also been 
studied along with the ability of HPV DNA to transform 
cultured cell lines.
When HPV 18 was characterised it was found that the viral 
genome was integrated into the host cell chromosome in 
invasive cancers and in cell lines derived from cancer of 
the cervix (Boshart, M., et al, 1984). Further analysis 
revealed that HPV 18 sequences from the E6/E7/E1 region 
were consistently preserved and that deletion of the E2 to 
L2 region occurred in some cases (Schwarz, E., et al,
1985). Pater, M.M., and Pater, A., (1985) analysed 8 cell
lines derived from squamous carcinomas of the cervix and 
confirmed that the El, E6 and E7 open reading frames 
(ORFs) were consistently preserved. It is possible that 
integration into the E2 and L2 ORFs disrupts the viral 
genome in such a way that enhanced expression of the E6 
and E7 ORFs occurs which may have a role in malignant 
transformation of cells (Schneider Maunorury, S., et al,
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1987). The consistent pattern of integration which is 
also found with HPV 16 allows transcription of not only 
the E6, E7 and El viral ORFs but also allows transcription 
of flanking cellular sequences and it may be that these 
viral-cell transcripts indicate that integration of the 
viral DNA into the host cell chromosome may be important 
in a multi-step mechanism of carcinogenesis (El Awady,
M.K., et al, 1987). Integration of the HPV genome into 
the cell chromosome is consistent, while the site of 
integration in the cell chromosome appears to be randomly 
selected (Mincheva, A., et al, 1987).
In addition to identifying integration of the viral 
genome, Schwarz, E., et al, (1985) also detected mRNA 
sequences derived from the E6, E7 and El ORFs of HPV 18 in 
3 cell lines. Lehn, H., et al, (1985) however, was able 
to identify mRNA in only one of four cervical carcinomas 
which exhibited integrated HPV 16 sequences. Smotkin, D., 
and Wettstein, F.O., (1986) also reported transcription of
the E6 and E7 ORFs of HPV 16 in a cancer cell line (CaSki) 
and in a cervical cancer. Thereafter, the consistent 
expression of the E6 and E7 ORFs of HPV 16 and HPV 18 in 
cancer cell lines was confirmed [Schneider-Gadicke, A., 
and Schwartz, E., (1986); Seedorf, K., et al, (1987); and
Androphy, E.J., et al, (1987)]. In contrast to the E6 and 
E7 ORFs the E2 to E5 ORFs are not expressed due to the
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integration in the E1/E2 region of the viral genome. Such 
integration separates the E2-E5 ORFs from the viral 
promotors in the control or regulatory region of the 
genome. The E5 ORF has a transforming role in BPV 1 (See 
fig. 2, opposite p.44) so Bubb, V., et al (1988) have 
sequenced the E5 ORF of HPV 16 and predicted that the E5 
protein is probably functionally associated with the cell 
membrane. As the E5 protein is not expressed when HPV DNA 
is integrated into the host genome it is probably not 
required for maintenance of the transformed phenotype.
Bubb and co-workers therefore postulated that suppression 
of production of the E5 protein might be important to 
avoid a host immune response against it. Thus both 
expression of some ORFs and suppression of others may be
implicated in a complex process of oncogenesis.
A distinct mechanism of cell transformation by HPV 18 DNA
was suggested by Swift, F.V., et al, (1987) who
characterised a long-range acting enhancer sequence GA1 in 
the Hela genome. GA1 is located within the integrated 
genome of HPV 18. This enhancer sequence surprisingly 
shows narrow cell type specificity being active in some 
cervical cancer cell lines but inactive in tumours derived 
from other cell types.
The ability of cloned HPV DNA to cause morphological
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transformation of mouse C127 cells was reported by Watts, 
S.L., et al (1984) using cloned HPV 1 and HPV 5 DNA.
These transformed cells could produce tumours in athymic 
nude mice. Morphological transformation with 
papillomavirus from condylomata acuminata of human uterine 
cervix cells in an in vivo system using athymic nude mice 
has been described (Kreider, J.W., et al, 1985). HPV 16 
DNA produces morphological transformation in NIH 3T3 cells 
which are tumorogenic in athymic nude mice (Yasumoto, S., 
et al, 1986) and the E6/E7 region alone from HPV 18 DNA is 
sufficient for transformation of NIH 3T3 and Rat-1 cells 
(Bedell, M.A., et al, 1987). However, transfection of 
human keratinocytes from the foreskin with HPV 16 did not 
result in tumorogenic cell lines although it did extend 
the lifespan of these cells (Pirisi, L., et al, 1987). HPV 
16 DNA E6 and E7 ORFs resemble immortalising oncogenes 
such as c-myc, and as such will cooperate with 
transforming oncogenes such as the EJ-ras gene in 
producing cell transformation (Matlashewki, G., et al,
1987). In addition, enhancement of HPV 18 E6 and E7 
transcription is accompanied by cell proliferation 
whereas inhibition of E6 and E7 transcription by 
antisense RNA leads to decreased cell growth 
(Knebel-Doeberitz, M., et al, in press, cited by Rosl,
F., et al, 1988). Using 5-azacytidine, a potent
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demethylating agent, Rosl et al provided evidence that 
this enhancement of the E6 and E7 transcription might be 
controlled by host genes at a cellular level in 
non-tumorogenic hybrid cell lines.
These data provide compelling evidence of a role for HPV 
in the oncogenic process in vitro and in immunocompromised 
laboratory animals. There is, however, no in vitro system 
which mimics the early stages of cervical dysplasia nor is
there direct evidence for a role of these HPV gene
produces in human genital carcinogenesis in vivo.
5. The association between HPV and vulval cancer
Genital warts has been recognised as a sexually 
transmitted disease since ancient times. The epidemiology 
of the infection parallels that of gonorrhoea. Oriel, 
J.D., (1971) reviewed the natural history of genital warts
and stated that untreated warts sometimes remained for
long periods but spontaneous regression was documented. He 
considered malignant transformation to be a rare 
complication. There are, however, numerous case reports 
in the literature of malilgnant transformation of genital 
warts and Zur Hausen, H., (1977) estimated that about 5%
of vulval carcinomata arise "within persisting genital 
warts". Some authors have claimed that genital warts are, 
in fact, premalignant conditions (Charlewood, G.P., and
Shippel1, S., 1953).
Immunoh1stochemlca1 and DNA-DNA hybridization data on the 
detection of HPV in condylomata acuminata and vulval 
premalignancy and malignancy has tended to be reported 
along with data about more common cervical lesions.
Kurman, R.J., et al (1981), reported positive staining for 
papillomavirus antigen in 50% of cases of vulval 
condylomata. Crum, et al, (1982) used
immunohistochemistry to study 68 VIN lesions for evidence 
of papillomavirus antigen. Thirty nine of these lesions 
were also subjected to microspectrophotometry. They found 
a negative correlation between aneuploidy and detection of 
papillomavirus antigen and reasoned that HPV required 
maturation of epithelial cells for its full reproductive 
cycle. They then surmised that, as condylomata acuminata 
were polyploid lesions and VIN lesions were aneuploid, an 
as yet undiscovered cofactor mediated conversion of one to 
the other. They did not point out that their data could 
equally suggest that VIN and condylomata acuminata were 
two quite separate lesions which shared the same site. HPV 
6 DNA was characterised from biopsies of condylomata 
acuminata (Gissman, L. and Zur Hausen, H., 1980), the 
viral DNA was cloned (De Villiers E-M., et al, 1981) and 
the HPV 6 DNA was used to probe other wart biopsies to 
show that 93% of vulval condylomata acuminata DNA
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hybridized to HPV 6 (Gissman, L., et al, 1982a). This 
group failed to demonstrate HPV 6 DNA in 2 vulval 
carcinomas but later showed hybridization of HPV 16 DNA to 
DNA from 2/7 (18.6%) of vulval carcinomata (Durst, M., et 
al, 1983). Similarly, Singer, A. and McCance, D., (1985) 
mentioned the detection of integrated HPV 16 DNA sequences 
in 6 of 9 vulval carcinomata. HPV 33 DNA has recently 
been found in association with a minority of cases of 
Bowen's disease (hyperplastic vulval dystrophy)
(Beaudenon, S., et al, 1986).
These studies did not include control tissues, however, 
but Di Luca, D., et al, (1986) detected HPV 16 DNA in 2/10 
vulval carcinomata, 5/5 VIN 3 lesions, 0/6 condylomata 
acuminata and 0/6 internal control biopsies. In contrast, 
Ferenczy, A., et al, (1985), detected HPV DNA sequences in 
9/20 (45%) of internal control tissues adjacent to vulval 
condylomata. Similarly, Macnab, J.C.M., et al, (1986)
detected HPV DNA sequences in 9/11 vulval carcinomas as 
well as in all of the 3 internal control samples which 
were available. Evidence for a role of HPV in the genesis 
of vulval neoplasia is therefore scantier than its very 
much more common counterpart on the cervix. The presence 
of HPV on the vulva seems to be a common event but vulval 
cancer is rare. The studies of Ferenczy and Macnab 
demonstrate the importance of adequate control tissues.
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6. The role of oncogenes in carcinogenesis
All vertebrate cells harbour a number of genes which have 
the potential to become transforming genes or oncogenes. 
The genes which have the potential to become oncogenes are 
called proto-oncogenes (c-onc genes).
The first group of oncogenes were identified in 
retroviruses. This ability of DNA sequences to cause 
malignant change in cells was first demonstrated by Rous 
in 1910, who showed that the retrovirus, Rous sarcoma 
virus (RSV), caused sarcomata in chickens. Over 60 years 
later it was shown that cell transformation was caused by 
the RSV v-onc gene named v-src (Stehelin, D., et al,
1976). The prefix "v" indicates that the oncogene is of 
viral origin whereas c-onc has the prefix "c" indicating 
an oncogene of cellular origin. The majority of known 
oncogenes are v-onc genes. Most c-onc genes show homology 
between themselves and retroviral sequences suggesting an 
overlap between viral and cellular oncogenes. An example 
of homology between v-onc and c-onc genes is that found 
between the T24 bladder oncogene and the v-bas oncogene 
(Santos, E., et, 1982).
Cellular oncogenes are highly conserved throughout 
evolution and are thought to perform functions essential 
to the normal cell in the control of cell growth and
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development which, when disturbed, contribute to the 
malignant phenotype (Bishop, J.M., 1981). There are now 
well over 20 proto-oncogenes recognised, most of which 
represent single copy sequences of cellular DNA. The ras 
gene is an exception being a constituent of a multigene 
family.
Proto-oncogenes can be activated in a number of ways.--
a. A proto-oncogene may undergo a mutation which would 
result in an abnormal oncogenic gene product. An example 
of this is the point mutation substituting a guanosine 
base for a thymidine base which is responsible for the 
activation of the T24 bladder carcinoma oncogene (Reddy,
E.P., et al, 1982).
b. A proto-oncogene may become oncogenic when its 
products are expressed at higher concentrations than 
normal. A mutation could produce a tandem duplication of 
a proto-oncogene. Gene amplification could then occur by 
successive unequal sister chromatid exchanges in different 
cell cycles until sufficient protein is produced to 
transform the cell (Pall, M. L., 1981).
Proto-oncogenes can also be upregulated by promotor 
insertion (Hayward, K. S., et al, 1981) or enhancer 
insertion (Weber, F., & Schaffner, W., 1985). 
Translocations can result in proto-oncogene upregulation.
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Taub, R. , et (1982) demonstrated that the c-mvc oncogene 
has been translocated Into the immunoglobulin heavy chain 
locus in some Burkitt's lymphomas. This brings c-mvc
under the influence of enhancer elements in the heavy
chain locus (Boss, M.A., 1983).
c. A proto-oncogene may be expressed at an inappropriate
time in the cell cycle. The c-myc gene is tightly
regulated in the cell cycle being undetectable in resting
cells but expressed at high levels in the G1 phase (Kelly,
}
K., et al, 1983). In Burkitts lymphomas this mechanism 
may be augmented by gene translocation as the c-myc gene 
is no longer switched off during B-cell differentiation in 
its new locus (Leder, P., et al, 1983).
d. A proto-oncogene might be expressed in an 
inappropriate cell type leading to unmasking of its 
oncogenicity. Evidence for this mechanism is difficult to 
find as the individual patterns of proto-oncogene 
expression in different cell types are not well defined 
and some proto-oncogene products like c-src, c-myc and 
c-ras are almost ubiquitous (Hunter, T., 1984).
The c-myc oncogene appears to have a close association 
with the the development of certain tumour types. The 
abnormalities associated with it include: chromosomal 
translocation in Burkitt's Lymphoma (b & c above);
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proviral insertion adjacent to c-myc in chicken B-cell 
lymphomas and c-myc amplification in some human cancers, 
eg. colon cancer, promyelocytic leukaemia, large and small 
cell lung cancers and breast cancer (Rabbitts,
T.H.,1987).
The c-myc and c-Ha-ras proto-oncogenes have recently been 
studied in connection with neoplasia of the uterine 
cervix. There is a correlation between the number of 
c-myc transcripts and the overall rate of cellular 
proliferation in epithelial cells which raises the 
possibility of a role of this oncogene in epithelial 
neoplasia (Stewart, T.A., et al, 1984). Riou, G.F., et al 
(1985) investigated 37 stage I and II cervical carcinomas 
for the presence of HPV DNA and the oncogenes c-myc and 
c-Ha-ras. HPV DNA sequences were detected in 33 samples 
and upregulation of both c-myc and c-Ha-ras correlated 
strongly with aggressive disease. They postulated that 
HPV DNA and activated cellular oncogenes are involved in 
tumour progression. Later, the same group studied 
expression of the c-myc gene in 72 specimens of stage I 
and II squamous cancer of the cervix. They identified 
over-expression of the c-myc gene in 25 and showed a 
highly significant correlation between over-expression and 
early relapse of disease (Riou, G.F., et al, 1987). The 
level of c-myc expression could thus be a significant
-74-
prognostic factor in invasive disease and this finding 
lends support to a putative role of this oncogene in 
cervical carcinogenesis. In contrast, a study of 27 
cervical carcinomas and 8 control tissue samples failed to 
reveal any evidence of upregulation of the c-myc oncogene 
(Ikenberg, H., et al, 1987). In a similar study Gariglio, 
P., et al (1987) described 35 late cervical cancers (Stage 
III and IV). They found HPV 16 DNA sequences in 31%. 
Amplification of c-myc was detected in 32 samples. 
Rearrangement of c-myc alone was seen in 2 cases and both 
amplification and rearrangement of c-myc was detected in 
15 cases. The authors describe the absence of HPV 16 DNA 
and alteration of the c-myc oncogene in normal control 
tissues but do not define the nature of these control 
tissues. Furthermore, from the data presented there seems 
to be a poor correlation between hybridization to HPV 16 
DNA sequences and amplification and/or rearrangement of 
the c-myc oncogene.
The results of Riou et al do, however, raise the 
possibility that HPV DNA and its transforming gene 
products may act in concert with the c-myc oncogene in 
malignant transformation of cervical cells and this 
association deserves further study.
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7• The role of host immune systems
The host immune system is a major defence mechanism 
against cancer. Patients with preinvasive and invasive 
cervical cancer have enhanced cell mediated immune 
responses as measured in vitro by leucocyte cytotoxicity 
testing (Dini, M.M., et al, 1980). Patients who are 
immunosuppressed to prevent allograft rejection are 10-100 
times more likely to develop a malignancy (Penn.. I.,
1974). Cordiner, J.W., et al (1980) reported an increased 
incidence of CIN on the cervices of immunosuppressed renal 
transplant women and emphasised the need for close 
follow-up in such cases. Sillman, F., et al (1984) 
studied a group of 20 immunosuppressed women with CIN for 
evidence of HPV by immunohistochemistry. All 20 had HPV 
infections and 12 of the patients had persistent or 
recurrent CIN at follow-up. HPV infection and CIN are 
therefore common findings in immunosuppressed women.
Cigarette smoking is second only to HPV infection as a 
specific risk factor for the development of CIN. 
Interestingly, a reversible alteration in the 
immunoregulatory T cells OKT3+, 0KT4+ and 0KT8+ has been 
recognised in smokers compared to control non-smokers 
(Miller, L.G., et al, 1982). This raises the possibility 
that the mechanism of smoking as a co-factor in the
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development of cervical malignancy might be mediated via 
alterations in local immunosurvei1 lance.
In recent years nature has provided an-interesting and 
growing group of women who are immunosuppressed by human 
immunodeficiency virus (HIV). Bradbeer, C., (1987) 
assessed a group of 11 women attending an S.T.D. clinic 
with HIV infection and found evidence of CIN in 9 cases. 
The mode of transmission of HIV seems to be important as 
Spurrett, B., et al (1988) reported evidence of CIN in 
only 1 out of 6 women who acquired their HIV infection 
non-sexually. This would suggest that a sexually 
transmitted agent, possibly HPV, is also required 
(Crocchiolo, et al, 1988).
In addition to evidence that the systemic immune status of 
the patient may be relevant to the development of 
malignancy, recent attention has centred on the possible 
role of local immunocompetent cells on the cervix. 
Langerhans1 cells are antigen presenting cells which 
stimulate a T cell response to the neoplastic process and 
are widely detected in cervical squamous epithelium 
(Morris, H.H.B., et al, 1983a). Morris, H.H.B., et al 
(1983b) also studied the distribution of Langerhans' cells 
and T lymphocytes in HPV infection and CIN by an 
immunohistochemical technique using monoclonal
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antibodies.
They found that tissue associated with HPV infection had 
depleted or absent Langerhans' cells compared to normal 
tissue. The authors suggested that HPV may have a direct 
local immunosuppressive effect and thereby increase the 
risk of malignant transformation. It seems that if there 
is a defect in the local immune response which contributes 
to the generation and progression of CIN, it is likely to 
be in the afferent limb of that response.
Similar findings and conclusions were reported by McArdle, 
J.P., & Muller, H.K., (1986) using an antibody to the S100 
protein of Langerhans' cells. Langerhans' cells which 
stain for the S100 protein comprise 35% of the total 
Langerhans' cell population on the cervix and appear to be 
depleted to a greater extent than other subpopulations in 
HPV infection (Tay, S.K., et al, 1987a). In both this 
study and a second study of the numbers of the T4+ and T8+ 
subsets in HPV infection and related CIN, (Tay, S.K., et 
al, 1987b) this group used as control tissue biopsies from 
women who had "normal" cervices. These external controls 
numbered 20 in the first study but only 6 in the second 
study. No attempt was made to study internal control 
biopsies in normal tissue adjacent to acetowhite 
epithelium.
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3L. THE PRESENT STUDY
The present study aimed to utilize DNA-DNA hybridization 
to : -
1. Determine the relationship between HPV DNA
detection and cytological, histological, 
colposcopic and immunohistochemical detection of 
HPV infection;
2. Determine the prevalence of HPV 6, 11, 16 and 18
genomes present in DNA extracted from abnormal 
punch biopsies and internal controls from women 
attending the colposcopy clinic for treatment for 
abnormal cervical cytology along with the 
prevalence of HPV subtypes in DNA extracted from 
the cervices of normal external control women;
3. Determine the prevalence of HPV 6, 11, 16 and 18
DNA in biopsies from patients with invasive 
carcinoma of the cervix and matched control 
biopsies in the West of Scotland;
4. Determine the prevalence of HPV 6, 11, 16 and 18
DNA in biopsies of patients with preinvasive and 
invasive disease of the vulva and matched control 
biopsies in the West of Scotland;
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5. Determine the relationship between the age of
patients, the detection of HPV DNA in the genital 
tract, and the histological diagnosis;
6. Determine the relationship between the presence of
HPV DNA and local immunosurvei11ance assessed by 
Langerhans1 cell content in CIN biopsies;
7. Determine the relationship between hybridization
of biopsy DNA to the c-myc proto-oncogene, the 
histology of the biopsy, and hybridization of 
biopsy DNA to HPV DNA;
8. Determine the effectiveness of laser ablation of
the transformation zone in removing HPV DNA from 
the cervix in cases of histologically proven CIN;
9. Determine the sensitivity and specificity of dot
blot hybridization as a method for mass screening 
of the population for cervical HPV infection and, 
in the light of Study 8 above, the value of such a 
screening programme.
These approaches and their background will now be
described.
1. The relationship between different methods of
detection of HPV infection
The histological diagnosis of HPV infection has been
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defined in detail (Fletcher, S., 1983). The prognostic 
significance of the cytological diagnosis of HPV infection 
of the cervix is clearly important for patient follow-up 
(Mitchell, H., et al, 1986).
The ability of colposcopy to differentiate between HPV 
infection and CIN remains controversial [Reid, R., et al 
(1984); Kirkup, W., et al (1982)]. Sixty percent of 
condylomata acuminata stain for PV antigen by 
immunohistochemistry, whereas 48% of cervical dysplasias 
stain for PV antigen (Kurman, R.J., et al, 1981). HPV DNA 
is detected in 60%-90% of condylomata acuminata, CIN and 
invasive cancer (Singer, A. and McCance, D., 1985). Given 
the high cost and methodological difficulties with DNA-DNA 
hybridization it is useful to determine the 
inter-relationship between these diagnostic methods in the 
same tissues. If a histopathologist or cytopathologist 
could consistently diagnose HPV infection on the cervix, 
there would be no need to resort to DNA-DNA hybridization 
analysis to diagnose cervical HPV infection. Thus studies 
of the natural history of HPV infection or population 
screening for HPV infection would not require DNA studies. 
DNA-DNA hybridisation analysis would, of course, still be 
required for differentiating viral subtypes and for 
studies of the physical state and transcriptional activity 
of HPV DNA.
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This work was done in collaboration with Dr Laura Cassidy 
who performed the immunohistochemical assays, and the 
histopathology department of the Royal Infirmary, Glasgow, 
who provided histological diagnoses.
2 - Incidence of HPV DNA in colposcopically abnormal
tissues matched internal control tissues and
external control tissue of the uterine cervix.
The prevalence of HPV DNA in premalignant disease of the 
cervix has been discussed in the literature review. Few 
of these workers have studied control tissues.
Ferenczy, A., et al (1985) and Macnab, J.C.M., et 
al (1986) have clearly shown that HPV DNA can be detected 
in apparently normal tissue adjacent to condylomata 
acuminata and invasive genital cancer respectively. The 
key-stone of the relationship between HPV and invasive 
disease of the genitalia has been the detection of HPV DNA 
in malignant tissue. In order to assess the significance 
of that association two control biopsies are required i.e. 
internal and external controls.
Secondly, HPV type 6 and 11 have been associated with 
condylomata acuminata and mild CIN lesions (Gissman, L., 
et al, 1983) whereas HPV 16 and 18 are associated with 
severe ciN and invasive cancer (Crum, C.P., et al, 1985).
A geographic variation in HPV DNA subtype exists. The
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prevalence of HPV 16 DNA in genital cancer in Germany is 
twice that found in Kenya and Brazil (Durst, M., et al, 
1983). HPV 6 was detected in 28% of CIN lesions of all 
grades in England (McCance, D.J., et al, 1985). It is 
relevant, therefore to determine whether the apparent 
prognostic significance of HPV DNA subtypes can be 
explained by geographic variation in the prevalence of 
each HPV subtype.
This work was done in collaboration with Dr Laura Cassidy 
who collected some of the specimens and the histopathology 
departments of the Royal Infirmary and Western Infirmary, 
Glasgow.
3. and 4. The aims of sections 3 and 4 coincide with that 
of section 2 and will not be discussed further.
5. The relationship between age of the patient and
HPV DNA detection
Much epidemiological evidence exists to suggest a 
sequential relationship between HPV infection, development 
of CIN and progression to invasive cancer of the cervix 
(Singer, A., McCance, D., 1985). Meanwell, C.A., et al 
(1987) suggest that this relationship is less clear and 
that HPV infection increases in prevalence with the 
patients' ages as, of course, does cervical cancer. They 
further suggest that the epidemiological evidence for
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young age being an adverse prognostic factor in invasive 
disease may be misleading (Meanwell, C.A., et al, 1988). 
Clearly, age must be controlled for in prevalence studies 
of HPV infection. In this study the age of the patients 
were recorded so that this factor could be related to the 
presence of HPV DNA and histological diagnosis.
6. The relationship between Langerhans1 cell numbers
and HPV DNA sequence detection
The relationship between systemic or local 
immunosuppression and cervical neoplasia has been 
described (Introduction, A,4.7). Morris, H.H.B., et al 
(1983) further described a difference in the host immune 
responses between CIN and HPV lesions on the cervix as 
assessed by immunohistochemistry. The relationship between 
Langerhans' cell number in normal and abnormal tissues of 
the cervix has not been assessed nor has the association 
between Langerhans' cell numbers and HPV DNA subtypes. 
These experiments aimed to elucidate this relationship and 
explore the possibility that the proposed oncogenic effect 
of HPV DNA may be mediated by changes in the afferent loop 
of the local immuno-regulatory system. This work was done 
in collaboration with Dr Robert Hawthorn who assayed the 
Langerhans' cell number and made the histological 
diagnoses and with Dr R. Burnett who independently 
assessed the histological diagnoses.
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7■ The relationship between hybridization to the
c-mvc proto-oncogene and detection of HPV DNA
sequences
There are many experimental data to suggest a role for 
oncogenes in carcinogenesis (Introduction, A,6). Riou,
G., et al (1987) demonstrated a correlation between c-myc 
oncogene expression and carcinoma of the cervix. The 
association between HPV and genital tract malignancy is 
established. It is necessary to establish a mechanism 
whereby HPV might cause cancer. One mechanism might be 
related to up-regulation of cellular oncogenes by HPV DNA 
gene products, the most likely being the E6, E7 and El 
proteins. This study aimed to explore the relationship 
between the oncogene, c-myc, HPV DNA detection and 
histological grading of biopsies.
8. Treatment of HPV infection on the cervix by laser
ablation
Laser ablation of the transformation zone effectively 
treats CIN lesions at the first attempt in 90% of cases in 
the Western Infirmary, Glasgow (J.W., Cordiner, personal 
communication). Treatment of HPV infection in the absence 
of CIN has been advocated (Singer, A., et al, 1984). The 
success of such a policy may depend on the presence of 
latent HPV DNA outwith the treatment area (Ferenczy, A., 
et al, 1985). HPV DNA is widely detected in the male and
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female genital tracts (Introduction, A,4.6). Any 
screening programme for detection of HPV DNA in the female 
genital tract must have an effective available treatment 
response to positive results. It is essential, therefore, 
to assess the efficiency of treatment in achieving the 
eradication of the viral genome from the affected 
tissues.
9. Dot blot hybridization screening for HPV DNA
Wickenden, C., et al, (1985) described a technique of dot 
blot hybridization of DNA retrieved from cells harvested 
by cervical scraping as a method of screening for wart 
virus infection. This technique was used to study the 
prevalence of HPV infection on the cervix in Germany (De 
Villiers, E-M., et al, Lancet, 1987). Southern blot 
hybridization is the most sensitive and specific method of 
HPV DNA detection but it is expensive in materials and 
man-hours. Dot blot hybridization is a quicker, less 
expensive method of screening but suffers from problems of 
sensitivity and specificity due to background 
hybridization to non-viral vector and cellular sequences. 
Any acceptable screening test must be sensitive and 
specific. These experiments were designed to explore 
these features of dot blot hybridization.
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MATERIALS
1 . Cloned viral DNA. c-myc DNA and plasmid vectors
The viruses used in this study were the 8kb genomes of 
Human Papillomavirus (HPV) subtypes 6, 11, 16 and 18 
kindly supplied by Dr Lutz Gissman.
HPV 6, 11 and 16 genomes were inserted into the Bam HI 
site of the E.Coli plasmid pBR322.
HPV 18 was inserted into the ECoRI site of pBR322.
The whole human c-myc gene has been shown to lie within 
an 8kb Hindlll-EcoRl DNA restriction fragment (Gazin, C. 
et al, 1984). The probe used in this study comprised the 
3' end of the c-myc oncogene from exon 3 to include lkb 
of the cellular flanking sequence cloned into the Clal 
and EcoRl sites of pBR322. This probe was kindly 
supplied by Dr J. Neil.
2. Bacteria culture media
Bacteria were propagated in L-Broth (LB) which consisted 
of 1% (w/v) Bacto-tryptone (Difco), 0.5% (w/v) yeast 
extract (Difco) and 0.17M NaCl at pH 7.5.
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3. Standard buffer solutions
Triton lysis 
buffer
HBS
TNE
TE
1 X TBE 
SSC
1 X E
Dye Ficoll
Cell Lysis 
buffer
1 X Electro­
elution buffer
NTB
Denhardts
Solution
62.5mM EDTA, 50mM Tris-Hcl (pH 8.0) 2% 
Triton-X-100
(Hepes Buffered Saline) 140mM NaCl,
0.75mM Na2 HP04, 25mM Hepes 
(N-2-hydroxyethy1piperazine N-2 ethane 
sulphonic acid) pH 7.1
5mM EDTA, 50mM Tris HC1(pH 7.4), 150mM 
NaCl
ImM EDTA, lOmM Tris HC1
89mM Tris-borate, 89mM Boric Acid
150mM NaCl, 15mM Trisodium citrate, pH 
7.4
30mM NaH2 P04, ImM EDTA, 36mM Tris-HCl (pH
7.8)
150mM Na2HP04, lOmM EDTA, 180mM Tris (pH
7.8)
50mM Tris-HCl, lOmM EDTA, lOOmMNaCl, 0.4% 
SDS, pH 8.0.
5mM NaAc, ImM EDTA, 40mM Tris HC1 pH 7.5.
Nick translation buffer, 50mM Tris-HCl (pH
7.8). 5mM MgC12, ImM dithiothreitol 
(DTT).
0.02% (w/v) Ficoll, 0.02% (w/v)
polyvinylpyrol1idone, 0.02% bovine serum 
albumin (BSA)
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DNase dilution 50% glycerol, lOmg/ml BSA, 5MNaCl, 1M 
buffer Tris-HCl (ph 7.5), 250mM EDTA, 1M DTT.
4. Chemicals
Agarose, salmon sperm DNA, bovine serum albumin, 
polyvinylpyrol1idone and Triton-X-100, were obtained from 
Sigma (London) Chemical Company Ltd.,
Kingston-upon-Thames, London, U.K.
Tricloroacetic acid (T.C.A.), and caesium chloride were 
purchased from Koch-Light Laboratories Ltd., Colinbrook, 
Bucks, U.K.
Ficoll (average molecular weight 400,000) and Sephadex G50 
were purchased from Pharmacia Fine Chemicals, Uppsala, 
Sweden.
Bacto-tryptone and Difco yeast extract were purchased from 
Difco Laboratories, Detroit, Michigan, U.S.A.
Ethanol (analytical grade) was purchased from James 
Burroughs Ltd., London, U.K.
All other chemicals were purchased from BDH Chemicals 
Ltd., Poole, Dorset, U.K. and were of analytical or 
reagent grade.
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5. Radi ochemica1s
All radiochemicals were obtained from the Radiochemical 
Centre, Amersham, Bucks, U.K. The specific activities of 
the 5’-alpha-32p deoxyribonucleoside triphosphates were 
3,000 Ci/mmol.
6. Enzymes
All restriction endonucleases and DNA polymerase I were 
purchased from Bethesda Research Laboratories, Rockville, 
Maryland, U.S.A.
Deoxyribortuclease (bovine pancreas) was obtained from 
Sigma (London) Chemical Company Ltd.,
Kingston-upon-Thames, London, U.K.
Proteinase K and Klenau were purchased from Boeringer 
Mannheim, GmbH, West Germany.
7. Miscellaneous Material
Kodirex X ray film, X-omat S film, Dx80 developer:- Kodak 
Ltd., London U.K.
Amfix:- May and Baker Ltd., Dagenham, U.K.
Dupont Cronex Lighting Plus Intensifying Screens:- 
Dupont, Newton, Connecticut, U.S.A.
Plastic centrifuge tubes:- Falcon Incorporated, Oxhard, 
California, USA.
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Visking dialysis membrane:- Medical International Ltd., 
London, U.K.
Whatman chromatography paper, 3mm sheets and 2.5cm 
circles:- Whatman Ltd., Maidstone, England.
U.K. Gene Screen Plus (TM) Hybridization transfer membrane 
sheets NEF-976:- New England Nuclear, Dupont UK Ltd., NEN 
Products Division, Stevenage, Herts, U.K.
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METHODS
Fig. 3
A colpophotograph of a cervix showing acetowhite epithelium on 
the anterior lip. There is no obvious abnormal vascular 
pattern. Paired biopsies were taken from such lesions.
Internal control biopsies were taken from apparently normal 
areas of the transformation zone eg. the posterior lip in this 
case.
1. Tissue sample collection
All samples were taken from the lower genital tracts 
(cervix, vagina or vulva) of patients with their prior 
informed consent. Approval was gained for the study from 
the Ethical Committee of the Western Infirmary, Glasgow.
a . Cervical Intra-epithelial Neoplasia (CIN) samples
Biopsies were taken from patients referred to the 
colposcopy clinic with abnormal cervical cytology and with 
colposcopically apparent cervical abnormalities 
(acetowhite epithelium with or without punctate or mosaic 
vascular patterns).
Paired colposcopically directed punch biopsies were taken 
from adjacent areas of colposcopically apparently abnormal 
epithelium and from adjacent colposcopically apparently 
normal areas of epithelium in the cervical transformation 
zone (Fig. 3)
Separate biopsy forceps were used to collect samples from 
the abnormal and normal tissues to avoid 
cross-contamination. One biopsy of each pair (one 
abnormal biopsy and one normal internal control biopsy) 
was snap frozen at —70 deg.C. in liquid nitrogen to await 
DNA extraction. The other biopsy of each pair was 
processed for histological diagnosis and analysis for the
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presence of papillomavirus antigen.
A second subset of CIN samples was analysed for 
hybridization to HPV DNA only.
b . Invasive cervical cancer (Ca Cx) samples
These biopsies were obtained either at the time of
examination under anaesthesia prior to radiotherapy or at 
the time of radical hysterectomy. Biopsies from
radiotherapy patients were punch biopsies. Biopsies of
healthy vaginal epithelium were used as internal controls.
Biopsies from hysterectomy patients were taken from fresh
specimens. Again, samples of healthy vaginal epithelium
were used as internal controls. All samples were snap
frozen in liquid nitrogen.
c. Vulval intra-epithelial neoplasia (VIN) and vulval 
carcinoma (Vu Ca) samples
These samples were obtained at the time of excision biopsy 
(VIN samples) or radical vulvectomy (VuCa samples).
Interna 1 control tissue was from histologically normal 
adjacent vulval epithelium. All samples were snap frozen 
in liquid nitrogen.
d . External control samples
These samples were taken by punch biopsy from the
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transformation zone of the cervix in women who were 
undergoing laparoscopic sterilization. All the women gave 
no history of cervical disease, gave no history of genital 
warts in themselves or their sexual partners, had never 
had an abnormal smear and had negative cervical cytology 
within three months of the biopsies being taken. All 
samples were snap frozen in liquid nitrogen.
2• Extraction of Cellular DNA
Biopsies were finely chopped with a fresh scalpel blade 
and digested with 200ug/ml proteinase K in cell lysis 
buffer for 2 hours at 37 deg.C. on a rotator. The 
preparation was extracted twice with TE saturated phenol 
and chloroform to remove unwanted cellular proteins and 
debris and dialysed overnight at 4 deg.C against 0.1 x 
SSC. The preparation was precipitated in ethanol in the 
presence of 0.2M sodium acetate at -20 deg.C overnight. To 
reduce the number of manipulations and consequent loss of 
DNA because the yield of nucleic acids was low (5 - 300ug 
DNA per sample depending on biopsy size) the samples were
not treated with RNAse. RNA, which migrates ahead of DNA
on gel electrophoresis, was cut from the gel prior to 
blotting.
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3. Preparation of denatured salmon sperm DNA
Salmon sperm DNA was dissolved in sterile distilled water 
by gentle rotation at room temperature for several hours. 
After phenol and chloroform extractions, the DNA was 
ethanol precipitated and resuspended in 1 X TE buffer to 
give a final concentration of lOmg/ml. The DNA was boiled 
for 10 minutes and sonicated using a sonic probe to ensure 
denaturation. Small aliquots were stored at -20 deg.C.
4. Estimation of DNA concentration
The concentration of high molecular weight (MW) cellular 
DNA was rapidly estimated by agarose gel electrophoresis 
in mini-gels. Small samples of DNA were electrophoresed 
with known standard concentrations of lambda DNA on 0.6% 
(W/V) agarose gels in TBE electrophoresis buffer 
containing ethidium bromide. The DNA was visualised by UV 
transillumination of the gels and the concentration 
determined by visual comparison of the sample fluorescence 
with that of the standards.
The concentration of low MW DNA e.g. carrier salmon sperm 
DNA was estimated by optical density (OD) measurements at 
260nm. The absorption at 260nm of various dilutions of 
the DNA sample was measured using quartz microcuvettes in 
a Perkin Elmer double beam R4 spectrophotometer. The
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concentration was estimated assuming that 1 OD unit is 
equal to 40ug/ml of single stranded DNA. The purity of 
the DNA could be assessed by calculating the ratio between 
the readings at 260nm and 280nm (OD 260/OD 280). For pure 
preparations of DNA this ratio is 1.8.
5. Restriction Endonuclease Digestion of DNA
All restriction endonuclease digestions were performed in 
the buffers recommended by the suppliers for each enzyme. 
Digestion of high MW cellular DNA was accomplished with an 
estimated 4 fold excess of enzyme overnight at 37 deg.C. 
lOug of cellular DNA was digested from each sample.
6. Agarose gel electrophoresis 
Method (a)
Agarose gel concentrations of 0.6% (W/V) were employed in 
this study. The agarose was dissolved by boiling, cooled 
to about 50 deg.C. and 0.5ug/ml ethidium bromide was added 
before pouring. Horizontal gels run in E buffer were 
routinely used on glass plates 16.5cm x 26.5cm. The 
digested DNA samples were loaded with 1/10 volume 
Dye-Ficol1 and electrophoresed at room temperature at 
about 2V/cm for 2-3 days to ensure tight bands of DNA 
fragments. In addition to sample DNA, gels were loaded 
with appropriate HPV DNA reconstruction samples as
-98-
positive controls.
to
HPV DNA reconstructions equivalentA10 copies per cell of 
HPV 6, 11, 16 and 18 subtypes were used on each gel. Lack 
of space on gels prevented use of further reconstructions, 
so, reconstructions containing 0.2, 1, 10 and 100 copies 
per cell of each subtype were electrophoresed and blotted 
separately to be included in the relevant hybridization 
experiments.
Reconstructions of lOug of salmon sperm DNA were used with 
the addition of appropriate quantities of HPV DNA as 
calculated by the equation:-
Mol wt of cellular DNA genome lOug
Mol wt of HPV DNA genome x
4 X 10,z lOug
5 X 10^ x
= > x = 1.25 X 10"'*’ ug
(Where x = wt of HPV DNA equivalent to 1 copy of HPV DNA 
per copy of total cellular DNA).
A digest of salmon sperm DNA alone was used as a negative 
control track. Gels were photographed under either long 
wave or short wave UV transi1lumination using Polaroid 
type 665 or 667 film.
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Method (b)
As the majority of digests performed on cellular DNA used 
the restriction enzyme Bam HI the purpose of 
electrophoresis was primarily to separate the 8kb HPV DNA 
fragment and the 4kb pBR322 vector fragments from each 
other and from other cellular DNA fragments. This 
resulted in few bands (usually 2) per track when blots 
were subsequently probed with radiolabel led HPV DNA. This 
simplicity was exploited to reduce the time required to 
process samples by preparing 0.6% agarose in TBE and 
making 3 "minigels" per 16.5cm x 26.5cm plate. Three 
well combs were placed evenly along the plate before 
pouring the gels. The higher voltages used and the 
shorter distance of DNA migration involved allowed three 
times as many samples to be processed per gel in 6-8 
hours without penalty. Once the DNA had migrated the 
required distance the gels were cut into 3 easily handled 
"minigels".
7. Southern blot transfer
Two modifications of Southern blotting (Southern, E.M., 
1975) were used and compared.
(i) Dupont method
This is the method recommended by Dupont in the use of
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Gene Screen Plus synthetic transfer membrane. High MW 
DNA was digested and electrophoresed with control tracks 
in E buffer as described. The photographed agarose gels 
were cut to the appropriate size. The gels were 
submerged in 0.2M HC1 at room temperature and agitated 
gently for 30 minutes to depurinate them. They were then 
washed in distilled water and the DNA was denatured by 
gentle shaking in a solution of 0.4M NaOH and 0.6M NaCl 
for 30 minutes. The gels were then neutralised in 1.5M 
NaCl and 0.5M Tris (pH 7.5) for 30 minutes.
Each gel was transferred to a sheet of Whatman 3mm paper 
on a glass plate supported in a tray of 10 X SSC. A sheet 
of Gene Screen Plus, presoaked for 15 minutes in 10 X SSC 
was placed "B" side down over the gel followed by 6 pieces 
of Whatman 3mm filter paper cut 2mm smaller than the gel 
size. A weighted stack of dry paper towels was placed on 
top. The blot was left for 16-24 hours at room 
temperature to allow complete transfer of the single 
stranded DNA to the membrane.
After transfer the blots were immersed in an excess of 
0.4M NaOH for 30-60 seconds to ensure complete 
denaturation of immobilized DNA. The blots were then 
placed in a neutralizing solution of excess 0.2M Tris HC1 
(pH 7.5) and 2 X SSC. Subsequently the membranes were 
dried at room temperature on filter paper. This process
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was used for gels prepared by electrophoresis method (a).
(i i) Alkaline transfer
This combined a method described by Chomczynski, P. and 
P.K. Qasba (1984) for alkaline conditions of transfer and 
a method described by Landers T. (1982) of blotting 
minigels.
Samples were loaded and electrophoresed in agarose 
minigels in TBE buffer. After the minigels were cut and 
prepared they were gently agitated in 0.2M HC1 at room 
temperature for fifteen minutes. The minigels were then 
washed in distilled water and placed in an alkaline 
transfer solution of 0.4M NaOH and 0.6M NaCl with gentle 
agitation for 30 minutes. Then the minigels were placed 
on a stack of 8 sheets of Whatman 3mm paper cut to the 
same size as the minigel and pre-saturated in transfer 
solution. Gene Screen Plus was then placed "B" side down 
on the minigels. 1 piece of dry Whatman 3mm paper was 
placed on the membrane followed by a 3cm stack of cut 
paper towels. A beaker with 250ml of water was used as a 
weight and transfer was complete after 90 minutes. The 
miniblots were neutralized in 0.5M Tris HC1 (pH 7.0) and 
1M NaCl. The acid treatment was employed because it 
improved transfer of high MW DNA in method (i).
Comparison of transfer by the alkaline method with and
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without acid treatment, however, showed that this step 
was unnecessary.
8. Slot blot transfer
This method used a commercial slot blot apparatus 
(Schleicher and Schuell) to rapidly probe undigested 
cellular DNA for the presence of HPV DNA. It is 
equivalent to the more familiar dot blot process using 
lozenge shaped wells instead of circular wells.
A sheet of Whatman's 3mm paper was presoaked in 10 X SCC 
and placed on the base-plate of the slot blot apparatus. A 
piece of Gene Screen Plus similarly presoaked in 10 X SCC 
was placed "B" side up on the Whatmans paper and the top 
plate of the apparatus with the wells in it was then 
positioned to complete the assembly.
Three micrograms of undigested cellular DNA was diluted to 
20ul in TE buffer and inserted into the wells with gentle 
suction applied across the membrane. Rat embryo DNA 
negative controls, pBR322 plasmid controls and positive 
control reconstructions containing 0.1, 1 10 and 100 
copies of HPV DNA per cell of HPV 6, 11, 16 and 18 were 
applied to each blot.
Slot blots were washed in 0.4M NaOH and 0.6M NaCl for 20 
minutes to denature the DNA and then neutralised in 0.5M
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Tris HC1 (pH 7.5) and 1M NaCl for 20 minutes.
Following hybridization and autoradiography, the copy 
number of HPV DNA per sample was estimated using automated 
densitometry. However there was little improvement in 
accuracy of copy number estimation by this method over 
simple visual estimation of copy number.
9. Preparation of plasmid DNA
This method is based on that described by Clewell and 
Helinski (1970).
An overnight culture was prepared from seed stocks and 
used to innoculate 2 litres of LB plus lOOug/ml 
ampicillin. The bacteria were grown with vigorous shaking 
to an OD of 0.8 at 630mm. Chloramphenicol was then added 
to a final concentration of lOOug/ml (to inhibit bacterial 
multiplication and increase the number of plasmids per 
cell). The cultures were reincubated for 16-24 hours at 
37 deg.C. The bacterial cells were pelleted at 8000rpm 
for 15 minutes at 4 deg.C and resuspended in 16ml of cold 
sucrose—tris (25% sucrose in 50mM Tris—HC1 pH 8.0). The 
bacterial suspension was distributed into 4 tubes chilled 
to 4 deg.C. Each tube was treated with 2ml of lysozyme 
(5mg/ml) for 5 minutes at 4 deg.C., followed by 3ml of 
250mM EDTA (pH 8.0) for 5 minutes at 4 deg.C. and then 9ml 
of Triton lysis mix for 20 minutes at 4 deg.C. Cell
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debris was removed by centrifugation at 15,000rpm at 4 
deg.C. The lysate was extracted once with phenol 
saturated with TE buffer (pH 8.0) and chloroform and 
dialysed against TE buffer at 4 deg.C. with at least 2 
changes. The nucleic acids were precipitated with 
isopropanol at room temperature in 0.3M NaAc and the 
precipitate resuspended in TE buffer. The plasmid DNA was 
purified by centrifugation to equilibrium in caesium 
chloride/ethidium bromide gradients. Gradients were 
prepared to give a density of 1.55g caesium chloride per 
ml with 500ug/ml ethidium bromide and centrifuged in a 
Sorval TV865B rotor on an OTD 50 ultracentrifuge for a 
minimum of 16 hrs at 15 deg.C. The DNA bands were 
visualised by transillumination in long wave UV light and 
the plasmid DNA collected by tube puncture. Ethidium 
bromide and caesium chloride were removed by extracting 
three times with isopropanol saturated with caesium 
chloride solution followed by extensive dialysis against 
TE buffer at 4 deg.C. The DNA was ethanol precipitated 
and resuspended in TE buffer to give a concentration of 
lmg/ml .
10. Recovery of DNA from agarose gels
Cloned HPV DNA sequences were excised from vector 
sequences and purified twice by agarose gel
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electrophoresis. After the appropriate restriction enzyme 
digestion, the fragments were separated on a 1% (W/V) 
agarose slab gel containing 0.5ug/ml ethidium bromide and 
then visualised by long wave UV transillumination. The
required DNA band was cut from the gel and the DNA 
electroeluted using a microelution kit (ISCO Ltd). The
agarose containing the DNA was cut into small fragments 
and added to the sample well. The DNA was electroeluted 
in electroelution buffer at 100V until all the DNA was 
concentrated on the dialysis membrane over the smaller 
collection well. The DNA was collected in a small volume, 
re-electrophoresed through a 1% (W/V) agarose gel and 
electroeluted a second time. The ethidium bromide was 
removed from the DNA by passing it through a Dovex AG-50w 
x 8 column suspended in TNE and the collected DNA 
precipitated with two volumes of ethanol and resuspended 
in TE to a concentration of lmg/ml.
11. Labelling of DNA probes by nick translation
DNA probes were labelled Ln vitro by nick translation 
essentially as described by Rigby, P.W.J., et al (1977).
HPV DNA is A-T rich and was labelled with [alpha 32P] d 
ATP and [alpha 32P3 d TTP. 0.25ug DNA were nick
translated in a final volume of 50ul containing 0.01% BSA,
1 X NTB, 0.04mM cold d GTP and 0.04mM cold d CTP. 2 x 10~C
mg/ml of DNase was added, the tube was incubated for a few 
minutes at 37 deg.C. and then placed on ice. 30uCi of 
each [alpha 32P] deoxynucleoside triphosphate and 2 units 
of DNA polymerase 1 were added and the mixture incubated 
at 15 deg.C. for about 90 minutes.
The same method was used for radio1abe11ing the c-myc 
probe.
Isotope incorporation was measured by spotting duplicate 
filter papers with lul of the reaction mixture. The DNA 
was precipitated and the unbound counts removed from one 
filter paper disc by three 5 minute washes in 5% (W/V) TCA 
at 4 deg.C.
The disc was then rinsed with ethanol and dried. Both the 
washed and unwashed discs were counted for 32P in 
scintillant fluid (5g PPO per litre of toluene) and the 
percentage isotope incorporation calculated.
Unincorporated deoxynucleoside triphosphates were removed 
by a spun column technique. A 1ml syringe was packed 
with a glass wool plug and a Sephadex G50 column. The 
50ul probe was made up to a volume of lOOul with TE 
buffer, added to the column and spun at lOOOrpm for 90 
seconds. Incorporated deoxynucleoside triphosphates were 
collected in an eppendorf tube. lul of the DNA probe was 
added to 500ul of water and counted for 32P. The probe
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efficiency was calculated. Probes with efficiencies of 
1-5 x 10*cpm/ug DNA were used for blot hybridization.
Radiolabelled probes, single stranded salmon sperm DNA 
(0.5ug per ul) and unlabelled plasmid pBR322 (lug) were 
boiled to denature them.
12. HPV DNA blot hybridizations
Nucleic acid hybridisation has been used for many years to 
determine the degree of homology between DNA sequences.
The hybridisation rate is maximal at approximately 25deg. 
below the hybrid melting temperature (Tm). Tm is related 
to salt concentration and the proportion of the nucleic 
acids guanosine and cytosine in the DNA sequence 
(Schildkraut, C. & Lifson, S. 1965). The Tm is also 
affected by the presence of formamide and is reduced by 
approximately 0.6deg. per 1% formamide. The Tm is 
decreased by approximately ldeg. per 1% base pair 
mismatch.
These physical properties are utilised in the 
hybridisation and washing conditions to determine the 
stringency of the experiment. Low stringency conditions 
will allow hybridisation between DNA sequences which are 
similar but have less than 50% base pair sequence 
homology. High stringency conditions will allow
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hybridisation between similar DNA sequences which have 
more than 50% base pair homology. Thus the HPV DNA 
subtypes can be differentiated.
a . Non-strinqent hybridization
The blots were prehybridized in 20% formamide, 5 X SSC, 5 
X Denhardt's solution, 0.08M HEPES, 0.5% SDS and 0.5mg/ml 
of denatured salmon sperm DNA for 4 hours at 42 deg.C. 
Hybridization was carried out for 3 days at 42 deg.C. in a 
similar solution, in which the denatured salmon sperm DNA 
was replaced by the denatured radiolabelled probe. 
Prehybridization and hybridization were carried out in a 
total volume of 10ml in a sealed polythene bag submerged 
in a plastic box in a shaking water bath.
In the case of blots prepared by the alkaline transfer 
method, the hybridization protocol was modified by 
reducing the pre-hybridization time to 15-30 minutes and 
the hybridization time to 6-8 hours with no loss of 
efficiency. After hybridization, blots were washed in 2 
X SSC and 0.1% SDS 3 times for 30 minutes at 48 deg.C.
(HPV Tm -38deg.)
b. Stringent hybridization
The method described for non stringent hybridization was 
used except 50% formamide was used in both
pre-hybridization and hybridization mixes. After 
hybridization the blots were washed in 2 X SSC and 0.1% 
SDS 3 times for 30 minutes at 68 deg.C.(HPV Tm -18deg.)
All hybridization experiments involving the c-myc probe 
were carried out under stringent conditions as described 
for HPV DNA hybridizations except the washing temperature 
was 65deg. C. (Tm -8deg).
After washing, the membranes were never allowed to dry out 
to avoid irreversible binding of the DNA probe to the 
blot. The blots were placed between 2 layers of cling film 
and autoradiographed by exposure at -70 deg.C to flashed 
and non-flashed Kodak X-Omat H film used in conjunction 
with a Dupont phototungstate intensifier screen.
Before rehybridization, probes were removed by washing 
the membrane in 0.4M NaOH for 30 minutes at 42 deg.C. The 
membrane was then transferred to 0.1 X SCC, 0.1% SDS, 0.2M 
Tris-HCl (pH 7.5) for 30 minutes at 42 deg.C. Thereafter 
blots were re-autoradiographed to ensure that the probe 
had been removed prior to reprobing.
13. Histological diagnosis of tissue samples
Biopsies from adjacent areas of tissue were processed for 
routine histological examination using haematoxylin and 
eosin staining in the pathology departments of the Western
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Infirmary, Royal Infirmary and Stobhill Hospital, 
Glasgow.
14. Papilloma Virus Antigen Studies
A subgroup of 27 patients with colposcopically apparent 
cervical abnormalities had biopsies from colposcopically 
apparently normal and colposcopically apparently abnormal 
tissue analysed for presence of papilloma virus antigen by 
Dr Laura Cassidy. The antigen studies were performed with 
an indirect peroxidase-antiperoxidase technique (Gupta, 
J.W., et al, 1981). Each specimen was fixed in Bouins' 
solution, embedded in paraffin, and examined 
histologically. Non-stained sections were dewaxed in 
xylene and dehydrated in serial alcohol solutions. 
Endogenous peroxidase was quenched with 0.5% hydrogen 
peroxide in methanol. The sections were incubated in 
normal swine serum to reduce non-specific background 
staining. Group specific bovine papillomavirus antiserum 
(Dako) was added in dilutions of 1/250 to 1/1000 and 
incubated overnight. Bridging antibody (swine antirabbit 
IgG) was applied for 30 minutes followed by the addition 
of peroxidase - antiperoxidase complex at 1/20 dilution 
for 10 minutes. The peroxidase reaction was developed 
with diaminobenzoic acid giving a dark brown intranuclear 
precipitate in cells in which the HPV antigen was
-ill-
expressed. Haematoxylin was used as a counter stain.
15. Lanqerhans1 Cell Studies
A subgroup of 23 patients, having been referred to the 
colposcopy clinic with abnormal cervical cytology, had 
biopsies taken from colposcopically abnormal and 
colposcopically normal areas of the cervical 
transformation zone as previously described (Methods,
l.a). These biopsies were analysed for evidence of local 
immunodeficiency by Dr Robert Hawthorn (Hawthorn, R., et 
al, 1988). Biopsies were examined histologically and 
abnormal biopsies were available for hybridization to HPV 
DNA sequences.
For Langerhans' cell studies seven micron frozen sections 
were cut on a Bright Microtome, collected on gelatinised 
slides and stored at -20 deg.C. until use. Every fifth 
section was stained with haemotoxylin and eosin to confirm 
the histological diagnosis. Immunohistochemical staining 
was performed within on week of collection.
An indirect immunoperoxidase method using a mouse 
monoclonal antibody to T—6 antigen (NA1/34 SERALAB), and 
to MHC class 1 (W6/32 SERALAB) and class 11 antigens 
(DA6/231 MRC EDINBURGH) was utilised. The frozen sections 
were air dried at room temperature, fixed in acetone, 
washed in Tris Buffer Saline (TBS pH 7.4) and treated with
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3% hydrogen peroxide. Normal rabbit serum (diluted 1.5:1 
in Tris Buffer pH 7.4) was overlaid. Sections were then 
incubated with the monoclonal antibody (diluted 1:100 in 
TRIS Buffer) for 1 hour after the normal rabbit serum had 
been poured off. Incubation with 1:20 peroxidase 
congugated rabbit-anti-mouse antibody (P260 Dakopatts) 
(diluted in 1:1 Tris Buffer : normal human serum) for 45 
minutes followed. A 10 minute incubation with 3'3' 
diaminobenzidene (0.5 mg/ml) to which one drop of 100% 
H202 had been added was used to develop the reaction. 
Appropriate control sections were run in parallel. Washes 
in Tris Buffered Saline (pH 7.4) with 3 changes were 
performed before and after incubation with the primary 
antisera and after incubation with the second antibody.
All incubations with antisera were in moist chambers at 
room temperature.
Sections were counterstained with blued haemotoxy1 in, 
dehydrated and mounted in Histomount for microscopy.
The distribution and morphological detail of the 
Langerhans' cells were carefully recorded for both the 
normal and abnormal biopsy in each case. Langerhans' cell 
counts per 100 basal cells were made from representative 
areas of each biopsy using an Olympus microscope at 250 
times magnification.
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RESULTS
1• Experimental Conditions
1.1 The sensitivity of Southern Blotting
HPV DNA may be present at very low copy numbers in both 
preneoplastic and neoplastic tissues in the female genital 
tract so that the sensitivity of the test required to be 
maximised. The experiments were performed in a manner 
which routinely detected viral DNA at a level of over 0.2 
copies per cell. A sensitivity as low as 0.1 copies per 
cell was achieved in some experiments.
Viral DNA was more easily detected by transferring larger 
amounts of cellular DNA for probing. The small size of 
some biopsies limited the amount of DNA available for 
experiments. A successful compromise between these 
conflicting requirements was achieved by transferring lOug 
cellular DNA per sample for Southern blots and 3ug 
cellular DNA per sample for slot blots.
To increase the efficiency of transfer of high MW 
fragments the DNA was "acid nicked" or depurinated by 
washing gels in 0.2M HC1 prior to denaturing in the first 
method used (method i, p.100). Experiments with and 
without "acid nicking" using alkaline transfer (method ii, 
p.102) revealed that this step was not necessary as
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transfer of 8-9kb DNA fragments was unaffected by omitting 
"acid nicking". The effect of "acid nicking" is to 
partially cleave the high MW DNA into smaller fragments 
which bind more efficiently to the membrane.
The hydrolysis reaction is not allowed to proceed too far
to produce fragments of less than 300bp which are too
short to bind efficiently to the membrane. The
experimental sensitivity was further increased by
labelling the cloned DNA fragments used as probes in the
hybridization reactions to high specific activities with
alpha 32P deoxynucleoside triphosphates. Probes were used
3?with a minimum specific activity of 1 x 10 cpm/ug DNA.
1.2 The speed of processing of samples
The original method of processing prepared cellular DNA 
comprised:-
a) an overnight restriction enzyme digest
b) 2-3 days gel electrophoresis
c) an overnight Southern blot
d) prehybridization for 6 hours
e) hybridization for 3 days
Thus an experiment would take 7—8 days to prepare for 
autoradiography. A maximum of two 12 track gels could be
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comfortable processed at one time with 7 samples and 5 
control tracks on each gel. The modifications introduced 
which comprised large gels using TBE buffer and 3 gel 
combs spaced along the gel; alkaline transfer: and rapid 
hybridization resulted in the following time scale
a) an overnight digest
b) 6 hour minigel electrophoresis
c)- 30 minutes minigel denaturation
d) 90 minutes alkaline transfer
e) 30 minutes prehybridization
f) an overnight hybridization (16 hours)
This experiment could be efficiently completed in 40 
hours. Six 12 track minigels could be processed with 7 
samples and 5 control tracks per minigel. The differences 
in these labour intensive experiments resulted in 
considerable saving of man-hours and costly materials. As 
the blots were to be reprobed with each of the HPV DNA 
subtypes (HPV 6, 11, 16 and 18) positive control 
reconstructions of each viral DNA subtype were required on 
each gel. Full reconstructions comprising 0.1, 1, 10 and 
100 viral DNA copies per cell would have left no room for 
sample DNA. Therefore representative 10 copy per cell 
reconstructions of HPV 6, 11, 16 and 18 were used on each 
gel. Inr order to demonstrate detection of viral DNA at 
low copy numbers, separate strips of membrane containing
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full reconstructions of the relevant viral DNA subtype 
were included in the sealed polythene bags in 
hybridization experiments. In the case of blots which 
were reprobed with the c-myc probe, separate c-mvc 
reconstructions comprising 100, 10, 1 and O.lpg of DNA 
were used as positive control tracks.
1.3 Selection of hybridization transfer membranes
Punch biopsies provide only small amounts of tissue from 
which limited amounts of DNA could be extracted. The 
smallest punch biopsies were only a few millimetres in 
diameter and provided as little as lOug total DNA 
although most provided 50ug to lOOug. Only one biopsy of 
abnormal or control tissue was available from each 
patient. The study hoped to provide data on all four 
relevant HPV DNA subtypes. This was accomplished using 
reprobable nylon-based transfer membranes for Southern and 
slot blot analysis. These membranes are durable, withstand 
washing at high temperatures and can be successfully 
reprobed a number of times. Gene Screen plus (TM) 
hybridization transfer membranes were used because they 
have the above qualities and they are designed to increase 
the efficiency of transfer of high MW DNA fragments from 
electrophoresis gels.
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1.4 Method of DNA transfer
Both Southern and slot blot transfer methods were used and 
compared. Southern blots have the advantage that sample 
DNA can be digested by restriction enzymes and the 
fragments separated by gel electrophoresis before 
transfer. This allows analysis of the physical state of 
the viral DNA (either existing as a plasmid or integrated 
into the host cell genome). Secondly, electrophoresis 
allows detection of a true 8kb band and also allows 
further digestion to prove that the band is a particular 
HPV subtype. Every effort was made to purify the viral 
sequences from the vector by twofold electrophoretic 
separation in preparation of the probes but Macnab,
J.C.M., et al, (1986), Cameron, I.R., et al, (1985) and 
Park, M., et al, (1983) have shown that some contamination
with plasmid vector is inevitable. The main drawbacks of 
Southern transfer are that it is a relatively long process 
compared to slot blots and that larger quantities (lOug) 
of scarce cellular DNA are required. Slot blots, however, 
are rapid, easy to perform, and require only 3ug of 
cellular DNA. The drawbacks of slot blots are that they 
give no information on the physical state of the viral DNA 
and background hybridization of non-viral, pBR322 plasmid 
vector sequences, which cannot be differentiated from 
hybridization of viral sequences occurs. Furthermore, they
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cannot be used to prove that the viral subtype probed for 
has a characteristic restriction pattern.
1.5 Conditions for Southern blot hybridizations
The stringency of hybridization of radiolabelled DNA 
probes to sample DNA is controlled by the salt 
concentration, the percentage of formamide in the 
hybridization mix, and by the hybridization and washing 
temperatures. The presence of 1% formamide in the 
hybridization solution reduces the Tm (melting temperature 
of DNA) by 0.6 deg.C. thus promoting dissolution of the 
bonds between the single stranded DNA probe and homologous 
single stranded cellular DNA. Low stringency conditions 
of 20% formamide with blots being washed at 48 deg.C. 
(Tm-38deg) allows hybridization of DNA with low base 
pair homology. High stringency conditions of 50% 
formamide and washing at 68 deg.C. (Tm-18deg.) allows 
hybridization of DNA with very high base pair homology 
only. Cross-hybridization of a probe from one viral 
subtype with another viral subtype in the sample can 
therefore be differentiated from true hybridization of DNA 
of the same viral subtype. HPV 6 and 11 share 
approximately 80% base pair homology (Dartmann, K., et al, 
1986) and cross-hybridization between these related 
subtypes occurs. This feature was exploited using low and
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high stringency washes to reduce the amount of probing 
required. If a sample was negative for HPV 11 DNA at low 
stringency it was inevitably negative for HPV 6 DNA also 
and probing with HPV 6 was unnecessary. HPV 6/11 DNA, HPV 
16 DNA and HPV 18 DNA were more readily differentiated as 
they have low base pair homology.
1.6 Cloned DNA fragments used in hybridization
reactions
All samples were probed with HPV 6, 11, 16 and 18 DNA.
The DNA was inserted into the E.Coli plasmid pBR322. These 
viral subtypes were used as probes because DNA from female 
genital tract premalignancy and malignancy have been found 
to hybridize to them with great frequency (Introduction,
A, 4.6 & 5) Selected samples were probed with c-myc. This 
oncogene was used because it has been reported to be 
involved in other human neoplasia. Additionally, there 
are conflicting reports of c-myc rearrangement and 
amplification in cervical cancers (Introduction, A, 6).
2. Hybridization Experiments on Tissue Biopsies
2.1 Human Female Genital Tract Tissue and Controls
Biopsies were taken from patients as described (Methods,
1) at the Western Infirmary, Royal Infirmary, Stobhill 
Hospital and the Royal Beatson Memorial Hospital, Glasgow.
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One subgroup of CIN biopsies with internal controls were 
examined histologically and analysed for the presence of 
papillomavirus antigen by Dr Laura Cassidy (Results, 2.2) 
prior to hybridization studies. Other subgroups of CIN 
(Results, 2.3), cervical carcinoma (Results, 2.5), VIN 
(Results, 2.6), vulval carcinoma (Results 2.7), and 
external control biopsies (Results, 2.4) were analysed for 
the histological diagnosis and presence of HPV DNA 
sequences only. A selection of samples were analysed by 
both slot blot and Southern blot (Results, 2.11) to 
compare these methods. A third subgroup of biopsies from 
CIN patients were analysed for evidence of HPV DNA both 
before and after laser therapy for CIN lesions (Results, 
2.10). A fourth subgroup of CIN patients had biopsies 
analysed for histological diagnosis, HPV DNA by slot blot 
hybridization, and Langerhans1 cell status (Dr Robert 
Hawthorn) (Results, 2.9). Finally HPV DNA hybridization 
data for the whole study with patients' ages and 
histological diagnoses were collated (Results, 2.8). Four 
types of control tissue were used. Two were experimental 
controls comprising rat embryo (RE) DNA, which was 
extracted from approximately 17 day old embryos from an 
inbred Hooded Lister rat colony maintained in this 
Institute, as a negative control; and reconstructions of 
HPV DNA types 6, 11, 16, 18 and the c-myc probe previously
Table la
Hist(A) Virus P .V .Aa HPV 16(S) HPV 18(NS)
(A/N) (A/N) (A/N)
Virus only (n=6) 6 0/0 3/3 0/0
CIN 1 (n=6) 4 2/1 4/3 1/0
CIN 2- (n=10) 10 3/1 6/4 1/0
CIN 3 (n=5) 2 1/1 4/3 2/0
total (n=27) 22 6/3 17/13 4/0
100% 81% 22%/ll% 63%/48% 15%/0%
Table lb
Hist (N) HPV 16 (S)
Normal (n=15) 7 (47%)
Virus only (n=9) 5 (56%)
CIN 1 (n=3) 1 (33%)
total (n=27) 13 (48%)
Tables la & lb
Data collated from Appendix 1.
Hybridization to HPV 16 and 18 was detected. There was poor 
correlation between colposcopic appearances, histological 
diagnosis of virus infection, detection of papillomavirus 
antigen and hybridization to HPV DNA.
Key
Hist (A)
Hist (N)
Virus
P . V . Ag 
(A/N)
HPV 16(3) 
(A/N)
HPV 18(NS) 
(A/N)
= Histological diagnosis of colposcopically 
abnorma1 t issue.
= Histological diagnosis of colposcopically normal 
tissue.
= Histological or cytological evidence of virus 
infection.
= Biopsies with evidence papillomavirus antigen 
(abnormal biopsies/normal biopsies)
= Hybridization to HPV 16 DNA (stringent 
conditions) (abnormal biopsies/normal biopsies)
= Hybridization to HPV 18 DNA (non stringent
conditions) (abnormal biopsies/normal biopsies)
described as positive controls. The other two controls 
were tissue controls comprising internal controls from 
apparently normal tissue adjacent to genital premalignancy 
or malignancy and external control tissue from cervices of 
cytologically normal women.
2.2 Study comparing colposcopic appearances,
histological diagnosis, papillomavirus antigen 
status and hybridization to HPV DNA seguences.
The data derived from this group of 27 patients is 
presented in Appendix 1 and tables la and lb. The 
histological diagnosis of colposcopically abnormal tissue 
ranged from evidence of virus only in the absence of 
dysplasia [that is, koilocytotic atypia, individual cell 
keratinisation, multinucleation, parakeratosis, acanthosis 
and papillomatosis; (Anderson, M.C., 1985)] to CIN 3, 
(tables la and lb and fig 4). Twelve samples of 
colposcopically apparently normal tissue were reported as 
showing histological features of virus infection and three 
of these were classified as CIN 1 plus virus. Altogether 
22 of the 27 (81%) women with colposcopic abnormalities 
were reported as having histological and/or cytological 
evidence of viral infection (Table la).
Six (22.0%) of abnormal biopsies were positive for 
papillomavirus antigen (95% confidence interval 6.4% to 
37.6%) compared with three (11%) of normal specimens
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Fig. 4
Histological section 
of CIN with marked 
viral changes. The 
basement membrane is 
arrowed (bm). Koilocytes 
(K) abound in the 
superficial layers.
(H & E )
(Courtesy of D. Millan).
Fig. 5 Histological section of CIN stained for papillomavirus 
antigen (PV Ag). PV Ag stains dark brown and is found near the 
surface away from the basement membrane (bm). (Courtesy of L. 
Cassidy)
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(95% confidence interval -0.8% to 22.8%) (table la)
(fig 5).
Hybridization to HPV 16 DNA sequences under stringent 
conditions was found in 17 (63%) abnormal biopsies 
(95% confidence interval 44.8% to 81.2%) and 13 (48%) 
colposcopically normal internal control specimens (95% 
confidence interval 29.2% to 66.8%)(Tables la, & lb)
( fig.6). The different rates of detection in abnormal 
and normal biopsies is not statistically significant (chi 
squared = 0.675; 0.5>p>0.1, Yates correction).
In three cases in which hybridization to HPV 16 was not 
detected under stringent conditions, hybridization to HPV 
18 was detected under non-stringent conditions only. In 
one further case in which hybridization to HPV 16 was 
detected under stringent conditions, HPV 18 was also 
detected under non-stringent conditions only. This may 
represent a mixed HPV-16/HPV-18 infection or cross 
hybridization between the HPV-18 probe and HPV 16 in the 
sample or it may represent cross hybridization to another 
HPV subtype.
No colposcopically normal biopsy hybridized to HPV 18.
The difference in hybridization to HPV 18 DNA in abnormal 
and normal biopsies is not statistically significant
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Fig 6
Autoradiograph of Bam HI digested DNA extracted from CIN and 
normal tissues. Panels 1-4 show lOug DNA (digested with 
BAM HI) extracted from histologically confirmed lesions of CIN 
(A = abnormal) and from histologically confirmed normal 
adjacent internal control tissue (N = normal) from four 
different patients. The HPV 16 radiolabelled probe hybridizes 
to inserts in CIN and normal samples under stringent 
conditions. Specimens 1A, IN and 2N contain HPV DNA 
potentially integrated into different sites in the cell 
genome. In specimen 1 the genome copy number in the abnormal 
tissue exceeds that in the normal tissue. In specimens 2, 3 
and 4 the reverse is the case. Track ct is negative control 
rat embryo DNA and rclO is a positive control track comprising 
10 copies of HPV DNA present in control DNA per cell. The 8kb 
molecular weight marker is indicated.
12 4 a
(chi squared = 2.43; 0.5>p>0.1, Yates correction). HPV 11 
DNA failed to hybridize to any samples in this group. The 
80% base pair homology shared by HPV 6 and HPV 11 means 
that HPV 6 was also not present in this group. In total 
20 (74.1% : 95% confidence interval 57.6% to 90.6%) of 
the colposcopically abnormal samples from this group 
hybridized to HPV 16 or HPV 18 or both probes. The 
difference between hybridization to all HPV subtypes in 
normal and abnormal biopsies is not statistically 
significant (chi squared = 2.80; 0.1>p>0.05, Yates 
correction).
Six (30.0% : 95% confidence interval 10.0% to 50.0%) of 
the 20 HPV DNA positive cervices were detected by 
staining for papillomavirus capsid antigen. This 
indicates that the entire genome may not be transcribed 
in all cells with HPV DNA and that this is an insensitive 
method of detecting HPV infection. It is somewhat 
surprising that papillomavirus antigen was detected in 
abnormal biopsies more frequently than in normal 
biopsies. Viral replication occurs in terminally 
differentiating squamous epithelium and capsid production 
is a function of the late region of the viral genome.
CIN is characterised by a lack of differentiation of 
epithelial cells and one would expect that the late 
region of the viral genome would be less often expressed
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in such de-differentiated tissues compared to normal 
tissue.
Samples which hybridised to the HPV 16 DNA probe under 
stringent conditions sometimes produced one to three 
bands on digestion, even with a fourfold excess of the 
restriction enzyme Bam HI (fig 6). This suggests that the 
HPV DNA is integrated at multiple sites in the host cell 
chromosome in both CIN and normal tissue. Durst, M., et 
al (1983) reported integration of HPV 16 DNA into cell 
DNA in invasive cancer by cloning virus-cell junction 
fragments. Also, by digesting cell DNA samples with both 
a restriction enzyme which cuts HPV and a combination of 
cut and non-cut enzymes, they detected submolar bands 
representing virus-cell junction fragments. Insufficient 
DNA precluded detailed study of integration in all the 
samples, but in one case (case 1 Sample A; fig. 6) a 
sample of cell DNA was digested with the restriction 
enzyme Pst 1 alone (HPV contains recognition sites for 
Pst 1) and a second sample was digested with the 
restriction enzymes Pst 1 plus Xho 1, Sst 1 and Hind III 
(HPV DNA does not contain recognition sites for Xho 1,
Sst 1 and Hind III). Six submolar bands were identified 
suggesting that the HPV genome was inserted into three 
sites in the host chromosome in this sample of CIN 
(fig. 7). In some cases - for example case 1 (fig 6) -
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Fig 7
Autoradiograph of further restriction digests of Sample 1A 
(fig 6). All three tracks are hybridized to radiolabelled 
HPV 16 DNA under stringent conditions.
Track (a) is the Bam HI digested sample (fig 6). Track (b) is 
sample DNA from the same lesion digested with Pst 1. This 
shows presence of six submolar bands. Track (c) is the sample 
DNA digested with Pst 1 plus the non-cut enzymes Hind 111 
Sst 1 and XhOl showing loss of the submolar bands. This 
indicates integration of the HPV DNA into three sites on the 
host cell chromosome. Size markers are to the left of the 
tracks.
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Table 2
Histology Virus
6/11 16 18 Total
Virus only (n=2) 2 0 0 2(100%) 2(100%)
CIN 1 (n=l) 1 0 0 0 0
CIN 2 (n=4) 2 0 2(50%) 0 2(50%)
CIN 3 (n=14) 10 1 (7%) 8(57%) 3(21%) 12(86%)
total (n=21) 15 1(4.8%) 10(48%) 5(24%) 16(76%)
Normal Internal
controls (n=ll) 0 0 5(45%) 0 5(45%)
HPV DNA hybridization data collated from the patients listed 
in Appendix 2. All subtypes were detected under stringent 
conditions. All internal controls were histologically normal. 
Virus = histological evidence of virus infection.
the genome copy number in the abnormal biopsy 
specimen exceeded that in the normal specimen. By 
contrast, however, other patients showed a higher HPV copy 
number in control tissues than in colposcopically abnormal 
tissue - for example, case 2 (fig 6). Thus the site on the 
cervix of maximum colposcopic abnormality is not 
necessarily the site at which the maximum viral genome 
copy number is found. Maximum copy number may reflect 
replicating DNA.
2.3 Study comparing colposcopic appearances.
histological diagnoses and detection of HPV DNA 
seguences.
As with the study of the first 27 patients, this group of 
21 patients had paired punch biopsies taken for 
histological examination and HPV DNA probing. It was 
possible to take internal control biopsies from the 
transformation zone in 11 of these, all of which proved to 
be histologically normal (table 2).
HPV 6/11 was detected in one (4.8%) case (95% confidence 
interval - 4.3% to 13.9%). Hybridization to HPV 18 DNA 
was also detected under stringent conditions in this 
patient. Cross-hybridization is not likely between HPV 
6/11 and HPV 18 under these conditions and it is probable 
that a mixed infection is present. This patient (CN 48A)
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is interesting in that she was the recipient of a renal 
transplant and had recurrent CIN 3 and widespread vulval 
warts.
HPV 18 DNA was detected in 5 (23.8%) cases 
(95% confidence intervals 5.6% to 42.0%) of which 2 were 
cases which were histologically virus only and the other 
three were CIN 3. HPV 18 DNA was not detected in 
histologically normal tissue. The difference in 
detection between abnormal and normal biopsies is not 
statistically significant (chi squared 1.56, 0.5>p>0.1, 
Yates correction).
HPV 16 DNA was again the predominant HPV subtype detected, 
being found in 10 (47.6%) CIN biopsies (95% confidence 
intervals 26.3% to 68.9%) and 5 (45.5%) histologically 
normal biopsies (95% confidence intervals 16.1% to 
74.9%). In total therefore, HPV DNA was detected in 
16/21 (76.2%; 95% confidence interval 58.0% to 98.4%) 
abnormal biopsies and 5/11 (45.5%; 95% confidence interval 
16.1% to 74.9%) normal biopsies. This difference in HPV 
DNA detection in normal and abnormal biopsies is not 
statistically significant (chi squared = 1.56, 0.5>p>0.1, 
Yates correction).
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2.4 Study of HPV DNA hybridization to clinically
and cvtologically normal external control
patients
Thirty patients had biopsies taken at the time of 
laparoscopic sterilization. None of these women gave a 
history of abnormal cervical cytology and all had negative 
cervical cytology within three months of biopsy. None of 
them gave a history of genital warts in themselves or 
their sexual partners. The patients were not examined 
colposcopically nor were their biopsies examined 
histologically. They, therefore, comprise an unselected 
external control group representing the apparently normal, 
sexually active female population as defined by present, 
cytological, screening methods. The mean age of the group 
was 38.2 years with an age range of 26-50 years. Two 
samples (6.6%; 95% confidence intervals -2.3% to 15.5%) 
were found to hybridize to HPV 6 DNA under stringent 
conditions. Two further samples (6.6%; 95% confidence 
intervals -2.3% to 15.5%) were found to hybridize to HPV 
DNA under stringent conditions. Thus, in total, 4/30 
samples (13.3% ; 95% confidence intervals 1.2% to 25.4%) 
hybridized to HPV DNA sequences in the study group.
Hybridization to HPV 18 was not detected.
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Table 3
Tissue Hybridization to HPV DNA
16 18 total
Abnormal (n=31) 16(52%) 2(6.5%) 18(58%)
Normal (n=18) 4(22%) 1(5.6%) 5(28%)
Hybridization of HPV 16 and 18 DNA to invasive cervical 
carcinomata and vaginal epithelial internal control biopsies 
under stringent conditions. HPV 6/11 were not detected.
2.5 Study of biopsies from cases of invasive
carcinoma of the cervix along with internal 
control biopsies from vaginal epithelium 
comparing histological diagnosis and 
hybridization to HPV DNA seguences.
Patients undergoing radiotherapy or radical hysterectomy 
for histologically diagnosed invasive cancer of the cervix 
had paired biopsies removed in the same fashion as 
previously described. Biopsies were obtained from 31 cases 
of invasive cancer. Internal control biopsies from vaginal 
epithelium were available in 18 cases. All but one of the 
31 patients had squamous carcinomas, the thirty second 
being an adenocarcinoma (table 3). Sixteen (51.6%) of the 
cancers hybridized to HPV 16 DNA sequences (95% confidence 
intervals 34.0% to 69.2%) and 4 (22.2% ; 95% confidence 
intervals 3.0% to 41.4%) vaginal internal controls also 
hybridized to HPV 16 DNA. Two (6.5%) cancers hybridized 
to HPV 18 DNA (95% confidence intervals -2.2% to 15.2%) 
and one (5.6%) internal control hybridized to HPV 18 DNA 
(95% confidence intervals -5.0% to 16.2%). Overall, the 
different rates of hybridization to HPV DNA sequences are 
not statistically significant (chi squared = 3.07, 
0.5>p>0.1, Yates correction).
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Table 4
Case Age Histology Hybridization 
to HPV 16
(S)
VN01 A 52 VIN I +
VN01 N n —
VN02 A 27 VIN II/III +
VN02 N n —
VN03 A 41 Bowen’s disease +
VN03 N n +
VN04 A N/K VIN III _
VN04 N n —
VN05 A 59 VIN II/III +
VN05 N n —
HPV DNA hybridization data on biopsies taken from clinically 
abnormal and clinically normal areas of patients with vulval 
premalignant lesions. Hybridization to HPV 16 only (stringent 
conditions) was detected.
Prefix VN = patient with pre malignant vulval lesions 
Suffix A = biopsy from clinically abnormal tissue 
Suffix N = biopsy from clinically normal tissue 
VIN = vulval intra-epithelial neoplasia
2•6 Study of HPV DNA hybridization to biopsies from
non metastatic vulval epithelial abnormalities 
and histologically normal adjacent vulval 
epithelium.
Biopsies from 5 patients were available for study. The 
histological diagnosis ranged from Bowen's disease to VIN 
3 (Table 4). Histologically normal vulval epithelium was 
available for use as an internal control in each case. 
Hybridization to HPV 16 DNA was detected in 4/5 (80%) of 
abnormal biopsies (95% confidence interval 44.9% to 
115.1%) and in 1/5 (20%) of normal biopsies 
(95% confidence interval -15.1% to 55.1%). Hybridization 
occurred under stringent conditions. Hybridization to HPV 
6/11 and 18 DNA was not detected in this group. The mean 
age of the group was 44.8 years with a range of 27 to 59 
years.
2.7 Study of hybridization of HPV DNA to biopsies from
cases of invasive sguamous carcinoma of the vulva 
along with internal control tissue from 
histologically normal adjacent vulval epithelium.
Biopsies were collected from specimens at radical 
vulvectomy. Abnormal biopsies were taken from 
histologically diagnosed lesions and control tissue was 
taken from the skin edge of the specimen. In one case, 
Vu03, an exophytic wart in the specimen was also biopsied 
and in Vu05 control tissue was not collected.
-131-
Table 5
Hybridization to HPV 
Case Age 16 DNA (S)
VU01 A 70 -
VU01 N —
VU02 A 65 —
VU02 N —
VU03 A 62 +
VU03 N +
VU03 V +
VU04 A 66 +
VU04 N +
VU05 A 55 +
HPV DNA hybridization data on biopsies taken from 
histologically diagnosed squamous carcinoma of the vulva with 
paired internal control biopsies taken from histologically 
normal epithelium at the edge of specimens produced at radical 
vulvectomy. HPV 16 DNA only was detected (stringent 
conditions)
Prefix VU = squamous crcinoma of vulva
Suffix A = histologically abnormal biopsy
Suffix N = histologically normal biopsy
Suffix V = histologically diagnosed exophytic wart
Hybridization to HPV 16 DNA was detected under stringent 
conditions in 3/5 (60% ; 95% confidence intervals 17.1% to 
102.9%) of abnormal biopsies and in 2/4 
(50% ; 95% confidence intervals 1.0% to 99.0%) of 
internal controls. The difference in hybridisation to 
HPV DNA sequences in abnormal and normal tissues is not 
statistically significant (chi squared = 0.14, p>0.5,
Yates correction). HPV 16 DNA was detected in the 
exophytic wart (Vu03V) (Table 5 )(fig 8). Hybridization 
to HPV 6/11 and 18 DNA was not detected in this group.
The mean age was 63.6 years and range was 55-70 years.
A detailed analysis of such small numbers is , of course, 
of limited value. However, it is interesting to note 
that samples Vu03 and Vu04 produced multiple bands on 
hybridization to HPV 16 DNA. This restriction pattern is 
compatible with integration of the viral genome into the 
host cell chromosome. In the case of Vu04 the same 
pattern is found in the sample and control tracks. In 
the case of Vu03, a single 8kb band is detected at low 
copy number in the interna 1 control biopsy but multiple 
bands are detected in the tumour and exophytic wart 
biopsies. This exophytic wart is therefore associated 
with integrated HPV16 DNA and not episomal HPV6/11 DNA 
and may represent a case of vulval cancer arising from a 
vulval wart as suggested by Zur Hausen, H. (1977).
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Fig 8
Three cases of invasive squamous cancer of the vulva (Vu 03,
04 and 05). The cell DNA has been digested with Bam HI and 
the samples probed with radiolabelled HPV 16 DNA under 
stringent conditions. Vu03A (abnormal biopsy) is over-exposed 
but contains several bands. Vu03V (exophytic wart) 
demonstrates a similar restriction pattern. Vu03N 
(histologically normal internal control) contains a single 8kb 
band at very low copy number. There are also multiple bands 
in Vu04A and Vu04N but only one 8kb band in Vu05.
Track ct comprises negative control rat embryo DNA. Track 
rclO comprises 10 copies of HPV DNA present in control DNA per 
cell. The 8kb molecular weight marker is indicated.
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Table 6
Histology of 
Abnorma1 
Biopsy
Ac
Range
je
Mean
Hybr:
6/11
Ldizat
sequer
16
:ion t< 
ices (£ 
18
> HPV DNA 
3 + NS) 
Total
v (n=8) 21-42 28.3 0 3 2 5 (63%)
CIN (n=21) 24-46 32.2 0 10 4 13* (62%)
CIN+V (n=38) 19-52 30.0 1 19 11 28* (74%)
total (n=67) 19-52 30.5 1 32 16 46 (69%)
CaCx (n=31) 26-86 54.6 0 16 nc, 18 (58%)
VN# (n=5) 27-59 44.8 0 4 0 4 (80%)
VuCa (n=5) 55-70 63.6 0 3 0 3 (60%)
External
Controls
(n=30) 26-50 38.2 2 2 0 4 (13%)
* 4 biopsies hybridized to more than one HPV DNA subtype.
# VN = all vulval non-invasive abnormalities
Summarised results comparing age (range and mean), 
histological grade in biopsies from colposcopically or 
macroscopically abnormal tissue and hybridization to HPV DNA 
sequences (stringent and non-stringent).
2.8 Study of the relationship between the age of the
patients, the histological diagnosis and HPV DNA 
detection.
The data described in this section are derived from the 
patients in Appendix 1, Appendix 2, Appendix 3, Appendix 4 
and table 4, and table 5. These data comprise the total 
study group of female patients (table 6) bar one case of 
vaginal intra-epithe 1ial neoplasia (Results, 2.13). A 
total of 138 patients were studied comprising the full 
range of cervical premalignancies and malignancies, vulval 
premalignancies and malignancies; and external control 
patients. Internal control biopsies were available for 
study in selected cases as described (Table 6).
Of the non-invasive cervical biopsies a total of 46/67 
(69%; 95% confidence interval 58.0% to 80.0%) and 18/38 
of the interna 1 control biopsies (47.4%; 95% confidence 
interval 31.5% to 63.3%) hybridized to HPV DNA sequences 
under stringent and non stringent conditions. The 
different rates of detection in these two groups of 
biopsies is not statistically significant (chi squared = 
3.77, 0.1>p>0.05, Yates correction). However, the 
difference between HPV DNA detection in non-invasive 
cervical lesions and external controls [4/30 (13.3%; 95% 
confidence intervals 1.1% to 25.5%)] is statistically 
significant (chi squared = 23.4, p<0.001, Yates
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Correction). Furthermore, the study group were 
significantly younger than the control group (p<0.001, 
student t test).
Similarly, as has been described (Results, 2.5) there is 
no statistically significant difference between 
hybridization to HPV DNA in invasive cervical cancer 
biopsies and internal controls (chi squared = 3.07, 
0.5>p>0.1, Yates correction). There are, however, 
significantly higher rates of HPV DNA detection in 
cervical cancer biopsies compared to external controls 
(chi squared = 11.4, 0.01>p>0.001 Yates correction). In 
these two groups of patients, the study group was 
significantly older than the control group (p<0.001 
student t test). In contrast to the study of 
Meanwell, C.A. et al (1987) this suggests that HPV DNA 
detection is not related to the age of the patient but to 
the presence or absence of the neoplastic process.
When comparing HPV DNA detection in each of the three 
groups, i.e. mild premalignant abnormalities, severe 
premalignant abnormalities, and invasive cancer; no 
statistically significant difference was detected (chi 
squared = 1.518, DF = 2, p>0.5). Secondly, if the 
premalignant lesions are separated into CIN without HPV 
DNA and CIN with HPV DNA no significant age difference is
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detected ( p>0.5, student t test). Thirdly, if the 
invasive cervical lesions are separated into those which 
do hybridize to HPV DNA and those which do not, no 
statistically significant age difference is manifest 
(0.5>p>0.1, student t test).
From these data it can be concluded that HPV DNA is 
detected equally in all grades of cervical lesion and 
there is no increased prevalence of HPV DNA associated 
with increasing age in this study. Similarly, there is 
no evidence that HPV DNA detection is associated with a 
prognosis of progression to invasive cancer at an earlier 
age. The prevalence of HPV DNA detection in cases 
compared to external controls does, however, confirm the 
association between HPV DNA and cervical neoplastic 
disease.
It is well recognised that invasive cancer of the cervix 
affects an older age group than does pre-invasive disease 
of the cervix. Thus it is not surprising that the 
patients with invasive disease were significantly older 
than those with pre-invasive disease (p<0.001, student t 
test). However, there is no such age difference between 
patients with mild premalignant abnormalities (virus only 
and CIN 1) compared to those with severe premalignant 
abnormalities (p<0.5, student t test). This is entirely
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Fig. 9
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Histological section of CIN stained for Langerhans1 cells (L) 
which stain dark brown. Blued haematoxylin was used as a 
counterstain. 
bm = basement membrane.
(Courtesy of R. Hawthorn.)
consistent with the concept of progression of disease at 
least from CIN 2 or 3 to invasive cancer.
An assessment of the ability of a routine diagnostic 
histology service to diagnose HPV infection (against the 
gold standard of hybridization to HPV DNA) in 
non-malignant cervical lesions can be made from the data 
in table 6. Of the 67 lesions studied the histologist 
reported evidence of viral infection in 46 cases.
HPV DNA was detected in 45 cases. Histological assessment 
offers a sensitivity of 72%, a specificity of 40% a 
positive predictive value of 74% and a negative 
predictive value of 38%.
2.9 Study comparing histological diagnosis, local
immunocompetent cells (Langerhans1 cells) and 
hybridization to HPV 16 and 18 DNA sequences
This subgroup of 23 patients, referred to the colposcopy 
clinic with abnormal cervical cytology, had biopsies 
taken from colposcopically and histologically abnormal 
transformation zone and normal ectocervical tissue, for 
analysis of Langerhans’ cell numbers quantified per 100 
basal cells (Dr R. Hawthorn) (fig 9). Abnormal 
biopsies were stored at -20 deg.C . for later HPV DNA 
studies. Because of the very small size of the biopsies 
and possibly because of the storage conditions, only 
small amounts of total cellular DNA (5 - 30ug) were
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Table 7a
Hybridization to HPV sequences
Histolocry n 16 (s) 18 (s) total
2 1 0 0 0
2+v 7 3 4 7 (100%)
3 10 2 3 5 (50%)
3+v 5 4 1 5 (100%)
total 23 9 (39%) 8 (35%) 17 ( 74%)
(2= CIN2 ;3— <CIN3 ;+v= virus infection).
Data collated 
hybridization
from Appendix 4 
data.
comparing histology and HPV DNA
Table 7b
Wi1coxon 95%
Paired Confidence
Subtype Copy No Sian Test Intervals (%)
HPV 16 10-50 p=0.500 18.4 to 78.4
HPV 16 >50 p=0.054 4.60 to 54.4
HPV 18 10-50 p=0.006 19.7 to 50.5
HPV 18 >50 p=0.054 13.2 to 66.9
Negative p=0.023 -79.4 to -5.20
HPV 16 >10 p=0.500 10.8 to 57.0
HPV 18 >10 p=0.006 27.5 to 46.4
HPV 16+18 >10 p=0.054 -38.7 to 46.4
Analysis of Langerhans' cell numbers (normal biopsy minus 
abnormal biopsy) and HPV DNA subtype and copy number detected 
by DNA hybridization in the abnormal biopsy. A highly 
significant correlation exists between HPV 18 DNA and reduced 
Langerhans' cell, numbers. A significant correlation exists 
between high copy numbers of HPV 16 DNA and reduced 
Langerhans' cell numbers.
retrieved from these biopsies. Southern blot analysis 
was not possible so slot blot analysis was used. 
Hybridization between total cellular DNA and HPV DNA 
sequences at levels greater than 10 copies per cell only 
were accepted as positive results because of the poor 
specificity of slot blots at levels below 10 copies per 
cell. Data on individual patients is recorded in 
Appendix 4. The histological diagnosis and hybridization 
to HPV DNA sequences are compared in the Table 7a; and a 
statistical analysis of the Langerhans’ cell number in 
the abnormal biopsy (expressed as an increase or decrease 
with respect to the normal internal control biopsy) 
compared with the HPV DNA hybridization data is found in 
Table 7b. There is a good correlation between 
histological diagnosis and detection of HPV DNA sequences 
(100%) but HPV DNA is also detected in 50% of biopsies 
which showed no histological evidence of virus infection, 
(table 7a).
There is a significant (p = 0.059) association between 
hybridization to HPV 16 DNA at >50 copies per cell and 
reduced Langerhans’ cell number in the abnormal biopsy 
compared to the normal biopsy. There is also a highly 
significant (p<0.001) association between hybridization 
to HPV 18 DNA at >10 copies per cell and reduced 
Langerhans’ cell number in the abnormal biopsy compared
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Table 8.
Colposcopic appearance 
of cervix
Hybridization to 
HPV 16 DNA (stringent)
Abnormal (CIN)
Normal (internal control) 
Normal (post-laser)
12/15 (Q0%) 
9/15 (53%) 
5/15 (33%)
Pre and post laser biopsies.
Hybridization data from Appendix 5 collated.
to the normal biopsy. (Table 7b).
2.10 Study of hybridization between cervical cell DNA
and HPV DNA seauences before and after laser
therapy for histolocrical ly proven CIN lesions.
Fifteen patients from the groups detailed in Appendices 1 
and 2 were available for repeat biopsy four months 
following laser therapy for histologically diagnosed CIN. 
The relevant patients details are recorded in Appendix 5. 
Biopsies were taken from colposcopically normal and 
abnormal tissue prior to laser therapy. The whole 
transformation zone was vapourised to a depth of at least 
7mm. At four months the patients were found to be 
colposcopically and cytologically normal. Biopsies were 
taken from the same area of the cervix in which the CIN 
lesion originally lay. The results are found in Table 8.
Five biopsies (33%) hybridized to HPV 16 DNA. Four of 
them came from the cervices of patients whose original 
abnormal biopsies hybridized to HPV 16 DNA. The fifth 
came from a cervix in which no hybridization to HPV 16 
DNA was detected in the abnormal biopsy but hybridization 
was detected in the normal biopsy. These positive 
post-laser biopsies may represent infection from genital 
tissue outwith the treatment area or they may represent 
re-infection from infected sexual partners after 
intercourse following laser therapy.
Table 9a
Positive by:
Copy No Slot Blot Miniblot
>100 7 7 (100%)
10-99 23 22 ( 95%)
1-9 27 15 ( 56%)
0.1-0. 9 29 10 ( 34%)
Negative 27 1#
total 113 55 ( 49%)
* As % of slot blot positives
# HPV DNA detected at 10-99 copies per cell as a result of
operator error (wrong DNA sample loaded)
Comparison between slot blot and miniblot showing true 
positive rate of slot blots over range of copy numbers 
(stringent conditions). 27 samples were negative for HPV DNA
on slot blot analysis of which one was a false negative on 
miniblot testing#.
Table 9b
Copy No. (SB) Sensitivity % Specificity % PPV% NPV%
>100 (n=7) 100 100 100 100
> 10 (n=30) 97 96 97 96
> 1 (n-57) 100 67 67 96
>0.1 (n=86) 100 43 63 66
Sensitivity and specificity of slot blots compared to "gold
standard" miniblots (stringent conditions)
2.11 Study comparing the specificity and sensitivity
of slot-blot analysis with Southern blot analysis 
in detecting hybridization between cellular DNA 
and HPV DNA sequences.
One hundred and thirteen biopsies from preneoplastic, 
neoplastic, internal control and external control tissue 
in the study groups yielded sufficient DNA for 
comparison of the sensitivity of slot blot and Southern 
blot analysis. Total cellular DNA was digested with 
Bam HI and transferred to Genescreen plus by the 
minigel/miniblot method. All results are for 
hybridization detected under stringent conditions. The 
sensitivity and specificity of the miniblots was 
established by using reconstructions consisting of 0.1,
1, 10 and 100 copies of the HPV genome together with 
normal cervical DNA, CIN and cancer DNA samples 
containing known amounts of the HPV genome and negatives 
with no evidence of the HPV genome. An experimental 
sensitivity which regularly detected 1 copy per cell and 
often detected 0.1 copies per cell was achieved for 
miniblots making them a valid "gold standard" for 
assessment of the performance of slot blots.
The results show (Tables 9a and 9b) that at high copy 
number the sensitivity and specificity of slot blots is 
good but at copy numbers below 10 copies per cell [56/86 
(65%) of slot blot positive biopsies] the specificity is
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low (45%) as is the positive predictive value (45%). The 
false positive results probably arise from cross 
hybridization between amplified cell DNA and vector 
pBR322 sequences, with homology between virus and 
cell DNA sequences and with inability to purify a virus 
insert completely (fig. 10) (Macnab, J.C.M., et al,
1986, Cameron, I.R. et al, 1985 and Park, M. et al,
1983).
The specificity and positive predictive values at low 
copy numbers (0.1 to 9 copies per cell) which are 
frequently found in CIN lesions are poor (65% of slot 
blot positive biopsies in this study in which the 
specificity = 45% and the positive predictive value =
45%) .
2.12 Study of hybridization between the c-mvc
oncogene probe and invasive genital cancers with 
internal and external control biopsies
Biopsies from 22 invasive cancers of the cervix (stage lib 
to stage IV) from the group reported in Results, Section
2.5 were available for study. In 8 cases histologically 
normal vaginal epithelium was available to provide 
internal controls. Three vulval cancers from the group 
reported in Results, Section 2.7 were studied with 
internal control biopsies available in two cases.
Eighteen externa 1 control biopsies from the group
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Fig. 10
Autoradiographs of a slot blot probed with radiolabelled HPV 
16 DNA sequences under non-strinqent (48 deg. C) and stringent 
(68 deg. C) conditions. Row 3 comprises HPV 16 DNA 
reconstructions of 0.1, 1, and 10 copies per cell (Al, A2 & A3 
respectively). Rows 1, 2 & 4 comprise similarly arranged HPV 
6, 11 and 18 DNA reconstructions respectively. At low 
stringency, there is substantial cross-hybridization between 
viral subtypes in the reconstruction slots and non-specific 
hybridization to background sequences in the sample slots 
(rows 5 -24). At high stringency, samples which are positive 
at high copy number (eg. sample A9) are easily identified. 
Positivity at low copy number is, however, much more difficult 
to determine (eg. sample CIO). Slot A24 comprises a rat 
embryo DNA control track.
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reported in Results, Section 2.4 were also probed with 
the c-myc probe.
All the biopsies were previously analysed for the presence 
of HPV 6/11, 16 and IS DNA sequences. Only HPV 16 and 18 
DNA sequences were detected.
HPV 16 DNA sequences were detected in 11/22 cervical 
cancers (50%; 95% confidence interval 29.9% to 70.1%) and 
HPV 18 DNA sequences were detected in a further 2/22 
cases (9.1%; 95% confidence intervals -2.9% to 21.1%).
HPV 16 DNA sequences were detected in 1/8 internal 
control vaginal biopsies (12.5%; 95% confidence interval 
-10.4% to 35.4%). HPV 18 DNA was not detected in any of 
these biopsies. HPV 16 DNA sequences were detected in 
all three vulval cancers and in both internal control 
biopsies. HPV 18 DNA sequences were not detected in any 
vulval tissue.
Neither HPV 16 nor HPV 18 DNA sequences were detected in 
any of the external control biopsies.
The criteria of a 4 fold amplification of c-myc in the 
cancer biopsies compared to control tissues was used 
(Riou, G.F.. 1987). The copy number was estimated using 
automated densitometry. This was possible because the 
cancer and control samples were processed on the same
\
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autoradiography plate so that there was no problem 
comparing band densities. There was no evidence of 
amplification of the c-myc oncogene in the tumour or 
control biopsies (internal and external) irrespective of 
whether or not HPV DNA sequences were detected (fig. 11).
In two cases of invasive cancer of the cervix an extra 
band of approximately 8kb size was detected on 
hybridization with the c-myc probe (fig. 11). In one of 
these cases, a corresponding internal control biopsy was 
analysed and no extra band was detected. There was no 
evidence of this band in any of the external control 
specimens, the internal control specimens or any other 
tumour samp1es.
It is possible that this represents rearrangement of the 
c-myc oncogene. Further detailed restriction 
digests would be required to clarify this point. 
Alternative explanations include non-specific 
hybridization to vector pBR322 sequences or residual 
hybridization of radiolabelled HPV 16 DNA which did not. 
wash off the blot prior to re-probing with the c-myc 
probe. The first explanation is unlikely because the 
bands in question co-migrate with the 8kb HPV 16 DNA band 
and are therefore not the same size as the 4kb vector 
and, additionally, an excess of unlabelled pBR322 was
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Fig. 11
Autoradiographs of tissue DNA samples hybridized to 
radiolabelled HPV 16 DNA and radiolabelled c-myc DNA under 
stringent conditions. All sample DNA was digested with 
Bam HI. Sample CO is a biopsy from the cervix of an external 
control patient who showed no evidence of hybridization to HPV 
DNA. Sample 3 is a biopsy from an invasive cervical cancer 
which also hybridized to HPV 16 DNA. Automated densitometry 
failed to demonstrate a four-fold amplification of the c-myc 
oncogene in tumour DNA versus externa 1 control DNA (below). 
Samples 1 and 2 hybridized to HPV 16 DNA sequences at high 
copy number and also displayed an unusual restriction pattern 
on probing with the c-myc DNA sequences indicating a possible 
re-arrangement of the c-myc oncogene in these tumours. The 
negative control track rat embryo DNA is designated ct. RclO 
comprises an HPV 16 DNA reconstruction at 10 copies per cell. 
C-mycs recs comprises positive control c-myc reconstructions 
of 100, 10, 1 and 0.1 pg c-myc DNA respectively.
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used in the hybridization experiments to block unwanted 
hybridization of radiolabelled probe to vector sequences. 
Furthermore, there was no evidence of detectable 
quantities of residual vector sequences in the separate 
c-myc reconstructions which were hybridised in the same 
polythene bags as the sample blots. The second 
explanation is also unlikely because the 8kb 
bands in the blot hybridized to HPV 16 DNA are minor 
elements of the very strong signal demonstrated in the 
tracks. It would therefore be expected that if the 
problem lay with incomplete washing of the blots to 
remove the HPV 16 probe then these stronger elements of 
the signal would also remain. Furthermore, all blots 
were subjected to check autoradiography after probes were 
washed off to ensure that no residual probe remained.
2.13 Other tissues studied for evidence of 
hybridization to HPV DNA sequences.
Biopsies from two other patients were available for 
study. One case of vaginal intra-epithe1ial neoplasia 
grade 3 (VAIN 3) occurred in a 61 year old lady who had 
undergone cone biopsy of cervix for CIN 3 one year 
previously. The CIN 3 lesion was incompletely excised.
Hybridization to HPV 16 DNA was detected at low copy 
number under stringent conditions in the histologically
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normal vaginal epithelium control but not in the VAIN 3 
biopsy. The second case was a biopsy from a squamous 
carcinoma of the penis kindly supplied by Dr P Walker, 
Royal Northern Hospital, London. Despite multiple 
attempts, it proved impossible to adequately purify the 
total cellular DNA for successful restriction enzyme 
analysis.
Slot blot analysis under stringent conditions, however, 
showed hybridization to HPV 16 DNA at a level of several 
hundred copies per cell.
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DISCUSSION
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This study has used Southern Blot analysis to study the 
relationship between HPV and the neoplastic process in 
the human female genital tract.
The methodology of Southern Blot analysis has been 
studied and improvements in efficiency have been 
identified and tested. I have studied the sensitivity and 
specificity of other methods of diagnosis of HPV infection 
and related these findings to the clinical management of 
patients, the feasibility of screening for and treatment 
of HPV infection of the genital tract, and the 
difficulties of prospective study of the natural history 
of genital HPV infection. Through the use of appropriate 
tissue controls and the study of all grades of neoplasia, 
the relationship between detection of HPV DNA in normal 
tissue and different stages of the neoplastic process 
have been more closely defined.
The remaining experimental work has studied the 
relationship between HPV DNA and other cellular mechanisms 
which may be involved in cell transformation, i.e. local 
immuno-survei1 lance and activation of a cellular oncogene.
These data will be discussed in order. A discussion of 
the possible role of HPV in carcinogenesis and suggestions 
for the future clarification of that role will be 
presented.
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1. The methods of identification of HPV infection in
the female genital tract.
1•1 Southern blot analysis
The increasing interest in HPV in genital tract neoplasia 
has led to demands for rapid, reliable identification of 
HPV infection and accurate subtyping of the viral DNA 
involved. This has been stimulated by the apparently 
different oncogenic potential of HPV 6/11 as opposed to 
HPV 16 and 18, [Gissman, L., et al ( 1982a and 1983 ) ; 
Crum, C.P., et al, ( 1984 and 1985 ) .: Boshart, M.L. , et 
al, ( 1984 ); zur Hausen, H., ( 1987)].
Southern blot hybridization is expensive in man hours and 
materials. In this study, several individual 
modifications have been combined to reduce the time 
required to process samples. This has been achieved 
without sacrificing the benefits of Southern blotting in 
the study of viral DNA. The simple pattern of restriction 
fragments produced by digestion with the restriction 
enzyme BamHl allowed the running of 3 short length 
electrophoresis rows on one agarose gel as described 
(Methods, 6b). Thus the 8kb HPV linear genome could be 
identified at copy numbers down to 0.2 to 0.1 copies per 
cell and differentiated from cross-hybridization to 
non-viral fragments with a high degree of sensitivity and
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specificity. This method was used as a
"gold standard" for comparison with other methods.
Bam HI digestion produced several bands in a number of 
cases suggesting integration of the viral genome into the 
host cell chromosome. These cases were identified for 
further study if indicated. When more than one band is 
identified it might be suggested that the restriction 
pattern represents hybridization to super-coiled circular, 
nicked circular and linear forms of plasmidial HPV DNA 
(McCance, D.J., et al, 1983). The addition of a four fold 
excess of Bam HI enzyme minimised this risk. There was 
seldom sufficient cellular DNA available for detailed 
study but further strong evidence for integration of the 
viral genome into the host cell chromosome was achieved in 
one case of CIN 3 by digestion of the sample DNA with 
restriction enzymes which do, and restriction enzymes 
which do not, cleave the 8kb linear genome and are called 
"cut" and "non-cut" enzymes to demonstrate the presence 
of sub-molar bands corresponding to hybridization to 
virus—cell junction fragments. This method of 
identifying integration of the viral genome into the host 
cell chromosome was validated by Durst, M., et al (1985) 
who performed these experiments on genital tumours in 
parallel with caesium chloride/ethidium bromide gradient 
centrifugation, two dimensional agarose gel
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electrophoresis and cloning of virus-cell junction 
fragments. The possible role of integration of the viral 
genome into the host cell chromosome will be discussed 
(Discussion, 7).
These studies demonstrate the ability of variations of 
Southern blot hybridization to accurately identify HPV DNA 
and to provide information about the physical state of the 
viral DNA in human genital tissue cells. The different 
subtypes of HPV DNA were identified in this study by use 
of the reprobable membrane Genescreen Plus (TM) and the 
relevant probes under conditions of high stringency.
1.2 Slot blot hybridization analysis
Whilst the studies in Section 1.1 improved the efficiency 
of sample analysis, they also demonstrated that Southern 
blot analysis remains unsuitable for large scale 
diagnostic or screening programmes. A second problem with 
Southern blots is that tissue biopsies are usually 
necessary to provide sufficient cell DNA for detailed 
analysis. As an alternative, Wickenden, C., et al (1985) 
suggested the use of dot blot hybridization (analogous to 
slot blot hybridization) as a screening test. They 
pointed out that sufficient DNA for analysis was collected 
by non-invasive cervical scrapes rather than biopsy.
Their results were compared to clinical, colposcopic and
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cytological findings. The validity of this comparison will 
be discussed later (Discussion 1.4/5). Their small study 
identified HPV 6 DNA in 10% of women with CIN and 10.5% of 
cytologically and colposcopically apparently normal women.
A numerically impressive study was conducted on 9295 
smears from German women comparing dot blot hybridization 
to HPV DNA and cytological evidence of virus infection (De 
Villiers, R.M. , et al, 1987). This group again detected 
HPV DNA in 10% of cytologically normal women but reported 
hybridization to HPV DNA in 35-40% of women with CIN. The 
authors cited the much higher rates of HPV DNA detection 
by Southern blot analysis in CIN and cervical cancer which 
have been reported in independent studies as evidence that 
dot blot hybridization is a relatively insensitive method 
of HPV DNA detection. They surmised that the true 
prevalence of HPV DNA in the female population may be as 
high as 30%. Finally the authors commented that careful 
validation studies using different methods of HPV analysis 
were needed to substantiate this possibility.
One hundred and thirteen biopsies from genital tract 
tissues were studied (Results 2.11) comparing slot blot 
hybridization with the "gold standard" Southern blot. 
Identically extracted DNA samples using similar 
radiolabel led HPV 16 DNA probes were used. The results
indicate that 55% of samples with an HPV DNA copy number 
between 0.1 and 9 copies per cell were slot blot positive 
but were scored as negative by the Southern blot 
technique. This represents a positive predictive value of 
slot blots of only 45% when screening for HPV DNA at less 
than 10 copies per cell. Samples with a copy number of 
0.1 to 9 copies per cell comprised 65% of the slot blot 
positive results. Thus detection of HPV DNA 
by slot blots at low copy number which occurred in over 
half of the cases was poor, demonstrating the low 
specificity and positive predictive value of slot blots 
rather than low sensitivity. It is likely that these 
findings are due to problems with cross hybridization 
between amplified cell DNA and pBR322 vector sequences, 
with homology between virus and cell DNA sequences, and 
with inability to purify a virus insert completely.
It would seem, therefore, that, contrary to the reasoning 
of De Villiers et al, slot (dot) blot hybridization is as 
likely to overcall the true prevalence of HPV DNA on the 
cervix in a population as underestimate it. In addition 
to this, the proposed method of collection of cervical 
cells by cervical scraping will only yield cells from the 
most superficial epithelial layers. This method of 
sampling will not identify cases in which HPV DNA is lying 
latent within cells close to the basement membrane. This
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will reduce the sensitivity of a screening programme.
This test would appear to be inappropriate as a screening 
method for HPV DNA infection because of its poor 
performance at low viral copy numbers which are 
frequently present in cervical tissue.
1.3 Staining for papillomavirus antigen as a means of
identifying HPV infection in cells.
In early studies of cervical condylomas and cervical 
dysplasias, antiserum raised in rabbits against pooled 
plantar warts was used to confirm that the papillomavirus 
was the aetiological agent associated with histologically 
apparent condylomata. [Woodruff, J.D., et al, (1980); 
Shah, K.H., et al, (1980); Kurman, R.J., et al, (1981); 
Morin, C., et al, (1981)]. These studies suggested that 
papillomavirus antigen could be detected in about 50% of 
condylomatas and mild dysplasias but less often in severe 
dysplasias. In the study reported in this thesis, 
(Results, 2.2) group specific bovine papillomavirus 
antiserum was used and all grades of cervical "dysplasia" 
were studied. Twelve patients had a histological 
diagnosis of virus only or CIN 1 of which only 2 (17%) 
stained for papillomavirus antigen. Alternatively, 4/15 
(27%) of CIN 2 and CIN 3 biopsies stained for 
papillomavirus antigen. Additionally, twice as many 
abnormal biopsies stained for papillomavirus antigen as
-152-
normal internal controls (six versus three). The numbers 
involved are small but these data do not agree with the 
larger studies cited. Furthermore, the production of the 
two major capsid antigens is a function of the late region 
of the viral genome (Danos, 0., et al, 1982) and this 
region is usually only expressed in terminally 
differentiating keratinocytes. This would mean that 
higher levels of staining for papillomavirus antigen might 
be expected in differentiating epithelium compared to 
dysplastic epithelium. The corresponding HPV DNA 
hybridization data suggests that HPV is frequently present 
in the normal tissue so it seems that the normal cycle of 
viral replication is inhibited here also. HPV 16 and 18 
DNA was detected in this study whereas HPV 6/11 is 
associated with exophytic warts in which the full cycle of 
viral replication is prominent [Gissman, L., et al,
(1980); Woodruff, J.D., et al, (1980)]. Clearly, 
therefore the effects of HPV 6/11 and HPV 16 and 18 on 
tissues differ as, possibly, do the effects of host 
tissues on these two groups of viruses.
The parallel study of the prevalence of papillomavirus 
antigen and hybridization to HPV DNA subtypes also 
emphasises that staining for papillomavirus antigen is an 
inefficient method of detecting infection with HPV DNA. 
Only 6/17 (35%) HPV DNA positive biopsies from the
-153-
abnormal group also stained for papillomavirus antigen. 
This is important. Firstly, it highlights the deficiencies 
of immunohistochemical studies as a means of establishing 
prevalence rates of HPV infection in the community. 
Secondly, immunohistochemistry fails to identify cases in 
which HPV DNA is present and transcription of the early 
part of the viral genome only may be occurring. The 
available evidence suggests that, both in the bovine and 
human systems, it is transcription from the early region 
of the genome which may be important in malignant 
transformation [Campo, M.S., et al, (1985); 
Schneider-Gadicke, A., et al, (1986)].
The late region of the viral genome comprises 31% of the 
total genome length and encodes for the two major capsid 
proteins, LI and L2. The LI protein appears to be highly 
conserved among papillomavirus subtypes whereas the L2 
protein appears to be subtype specific and may be involved 
in host and tissue specificity (Schwarz, E., et al, 1983). 
However, Nakai, Y., et al, (1986) demonstrated a type
specific antigenic determinent on the LI protein of BPV1 
so it is clear that this protein also plays a role in 
subtype specificity. Recently, Patel, D., et al (in 
press) have used monoclonal antibodies to identify a type 
specific antigen in the LI protein of HPV 16. They 
suggest that, as these antibodies can be used on routine
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histological sections, they will be helpful in diagnosing 
particular HPV infections. It, however, would appear from 
the arguments cited above that the value of this test will 
be limited.
1.4 Cytology and histology as a means of identifying 
HPV infection.
The early work of Meisels A., et al, (1977 and 1980) 
established the criteria for cytological and histological 
diagnosis of HPV infection. They identified the koilocyte 
as the pathognomonic feature of HPV infection along with 
other more subtle changes. In these publications the 
authors emphasised the difficulty of diagnosing the 
atypical condyloma both cytologically and histologically 
because it "mimics" dysplasia. In a later review (Meisels 
A., & Morin, C., 1985) they further emphasised the 
different diagnostic features of HPV infection and CIN and 
discussed the diagnostic difficulties posed by mixed 
lesions.
Other reviews (e.g. Kurman, R.J., et al, 1985) changed 
the emphasis of Meisel's and Morin’s reports and suggested 
that HPV infection and dysplasia were part of a continuum 
of the same disease. Alternatively, Fletcher, S., (1983)
in a detailed review of the histological appearances of 
HPV infection, cervical dysplasias and mixed lesions
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emphasised:-
a. the difficulties of diagnosing HPV infection
b. the fact that these two entities could be regarded as 
coexisting at the same site rather than being 
sequential and
c. that HPV infection could make the diagnosis of the 
grade of dysplasia more difficult with the tendency 
being to assign a higher grade to the dysplasia than 
was actually present.
Alternatively, Pilotti, S., et al (1981) reported a 
tendency to underestimate the cytological "diagnosis" of 
CIN when koilocytosis was prominent.
These findings serve to emphasise the limitations of 
cytology as a "diagnostic" tool in the differentiation and 
grading of HPV and CIN lesions. Even histological 
assessment of the lesions suffer from inter-observer 
variation. Anderson, M.C., (1985) reviewing the
histological criteria for diagnosing HPV infection stated 
that many of the individual features including 
koilocytotic atypia may not be HPV-specific and it is 
rather the sum of several features which allows a 
diagnosis of HPV infection. This necessary latitude in 
interpretation of histological and cytological appearances 
allows an inexactitude in diagnosis in the less 
characteristic lesions and gives rise to inter-observer
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variation. Indeed the same observer may grade the same 
lesions differently on different occasions. Furthermore, 
it is the common experience of histopathologists and 
cytopathologists that if there is diagnostic difficulty, 
lesions tend to be assigned higher grades than lower 
ones.
This study (Results 2.2) has found that routine cytology 
and histology reporting in city laboratories has 
overcalled the prevalence of HPV infection on the cervix 
by 18%. Furthermore, the correlation between detection of 
HPV DNA and histological identification of HPV infection 
in individual biopsies is poor (7/16:47% of histologically 
normal internal control biopsies and 8/15:53% "virus only" 
biopsies). Similarly, in the collated data (Results 2.8, 
Table 6), only 32/46 (69%) of histologically diagnosed 
lesions with evidence of virus infection actually 
contained HPV DNA.
Thus, overall, as a measure of prevalence of HPV DNA, the 
histological assessment of a biopsy offers a sensitivity 
of 71%, a specificity of 36%, a positive predictive value 
of 70% and a negative predictive value of 38% compared to 
the gold standard hybridization analysis of HPV DNA. The 
validity of DNA-DNA hybridization as a gold standard 
compared to cytology and histology lies in two main areas.
Firstly, the experimental design allows identification of 
HPV DNA at very low copy numbers (down to 0.1 copies per 
cell in some experiments) under conditions of high 
stringency which preclude cross-hybridization 
with unrelated DNA sequences. Additionally, precise 
positive and negative controls are included at all stages. 
Hybridization to HPV DNA is either present or not present. 
Secondly, DNA-DNA hybridization identifies HPV DNA. 
Histology and cytology identify cellular changes 
associated with replicating virus which may or may not be 
specific to HPV and may or may not be obvious to 
individual observers. The proposed oncogenic potential of 
HPV lies in the early region of the viral genome. Thus 
unlike histology and cytology, DNA-DNA hybridization is 
precise, is not subject to observer error and identifies 
the most important component of the virus namely the viral 
genome.
1.5 Colposcopy as a means of identifying HPV lesions
on the cervix.
The identification at colposcopy of aceto-white epithelium 
is simple. The diagnosis of the nature of the aceto-white 
lesion is, however, difficult and depends on the 
subjective opinion of the colposcopist, the value of which 
depends on the colposcopist's experience. Reid, R., et al 
(1980) described colposcopic appearances which they
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considered to be associated with HPV infection and devised 
a "colposcopic index" for differentiating subclinical HPV 
infection and CIN (Reid, R., et al, 1984). In the hands 
of these highly specialised observers the correct 
approximate histological diagnosis was achieved
\
colposcopically in 96% of cases. Despite this impressive 
result they stated that the index was more useful in 
differentiating "mild" from "severe" lesions than 
differentiating "warty" and "non-warty" lesions. 
Alternatively, Kirkup, W., et al (1982) found that over 
two-thirds of patients with histological "warty 
features" did not show the colposcopic changes referred to 
by Reid et al. Similarly, Walker, P.G.. et al, (1983) 
found it impossible to distinguish between HPV infection 
and CIN. An explanation at the cellular level for the 
difficulties experienced by the latter workers was 
provided by Crum, C.P., et al (1986). This group studied 
aceto-white epithelium for evidence of HPV 16 DNA by in 
situ hybridization and demonstrated variations in 
hybridization from one area to another within a 
biopsy and variations from cell to cell within an area. 
These data would suggest that colposcopy cannot therefore 
differentiate CIN alone, from HPV alone or from CIN + HPV 
on the cervix such is the intimacy of the intermingling of 
these lesions.
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In this study, biopsies were taken from 67 areas of 
aceto-white epithelium and 38 areas of the transformation 
zone which did not display aceto-white epithelium at 
colposcopy. HPV DNA was detected in 12% of the 
colposcopically abnormal and 47.4% of the colposcopically 
normal biopsies. The results show that as a diagnostic 
test for the presence of HPV DNA, the colposcopic 
identification of aceto-white epithelium offers a 
sensitivity of 71%; a specificity of 47%; a positive 
predictive value of 67% and a negative predictive value of 
53%. These findings support the view that colposcopy is a 
useful method for the identification of areas on the 
cervix which are most likely to contain significant 
premalignant lesions (all cases of CIN 2 and CIN 3 were 
confined to the colposcopically abnormal group). The 
findings do not, however, support a role for colposcopy in 
differentiating areas of the cervix which harbour HPV DNA 
from those which do not.
1.6 Conclusion
The proposed role of HPV in genital carcinogenesis depends 
on the presence of HPV DNA and viral gene products in host 
cells. Southern blot hybridization remains the most 
sensitive and specific means of identifying and studying 
HPV DNA in host cells. Studies which base their findings
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upon other criteria for diagnosis of HPV infection 
(colposcopy, cytology, histology, and
immunohistochemistry) must be viewed with caution. This 
is particularly relevant to prospective study of the 
natural history of HPV infection as a precise knowledge of 
the start point of such a study is crucial to the accurate 
interpretation of results.
A rapid, reliable means of non-invasive identification of 
the presence of HPV DNA in host cells would be a major 
advance in prospective study of this condition. Slot 
(dot) blot hybridization of cervical scrapes is not 
sufficiently specific for this purpose.
2. Discussion of the role of screening for HPV
infection of the cervix.
An ideal screening test for any condition should possess 
the following characteristics:-
a. the test should be sensitive and specific, and it 
should have a high positive and negative predictive 
va1ue;
b. the condition screened for should be a proven precursor 
of more serious disease;
c. a treatment should be available which has low 
morbidity, has low or absent mortality, effectively 
treats the condition or prevents progression to more
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serious disease, and is acceptable to patient and 
practitioner;
d. the condition should be sufficiently common to make 
screening cost effective;
e. the test should be cheap, easy to perform and amenable 
to automation.
The performances of the available methods of detection 
of HPV infection of the cervix have been explored in 
Section 1. Current methods of HPV DNA detection rely on 
probing samples with radiolabelled or biotin labelled DNA. 
Where dot blot hybridization is relatively quick, cheap 
and potentially suitable for automation it suffers from 
low specificity and a poor positive predictive value. 
Southern blot hybridization is sensitive and specific, it 
can be made more efficient to facilitate processing of 
larger numbers of samples but is expensive in man-hours 
and materials and is not amenable to automation in its 
present form. Screening samples for viral subtypes using 
subtype specific monoclonal antibodies to capsid antigen 
is potentially cheap and easy to perform but relies on the 
presence of replicating virus and will therefore 
not identify cases where HPV DNA is present but not 
replicat ing.
There is at present no ideal screening test for the
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detection of HPV DNA in large numbers of the female 
population. There is little doubt that the presence 
of HPV DNA on the cervix is intimately associated with 
premalignancy and malignancy of the cervix. There is 
growing evidence from i_n vitro studies which propose a 
mechanism for malignant transformation by HPV DNA.
Final in vivo proof that HPV DNA is a major cofactor in 
the development of cancer is lacking. CIN is generally 
accepted as a precursor of invasive cancer. The potential 
for preventing the majority of cervical cancer was 
discussed in the Introduction, Section 1.1. It would seem 
irrational to divert scarce economic resources from 
improving the existing cytological screening programme 
designed to identify a known precancer (CIN) to provide 
a screening test for a suspected precancer (HPV). It 
might be suggested that screening for HPV DNA could be 
used to identify patients at risk of eventually developing 
cancers at an early stage. This argument is flawed on two 
counts. Firstly, HPV DNA has been detected in 60% to 90% 
of premalignant lesions (Singer, A., et al, 1984). In 
this study 68% (40/59) of CIN lesions contained HPV DNA. 
This would mean that HPV DNA screening would fail to 
identify 10% to 40% of established pre-ma1ignant lesions. 
Secondly, the best estimate of the prevalence of HPV DNA 
on the cervices of the female population suggest that 10%
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to 30% of women are affected (De Villiers, E.M., et al, 
1987). The relative rarity of invasive cancer of the 
cervix (Introduction, 1.1) indicates that the vast 
majority of these women are not in danger of developing 
cervical cancer. HPV infection involving all subtypes can 
enter a latent phase [Ferenczy, A., et al (1985); Macnab, 
J.C.M., et al (1986)]. If screening for HPV infection was 
introduced large sums of money would be required either to 
treat or intensively follow-up (with cytology, colposcopy 
and biopsy) these large numbers of healthy women. This 
would have the effect of diluting the surveillance of 
patients most at risk, that is, those with CIN 2 or CIN 3 
to their potential detriment.
There is little value in introducing a screening test for 
which there is no appropriate response. Follow-up 
surveillance of up to one third of the female population 
would prove costly. This study has shown that treatment 
of the transformation zone with laser ablation fails to 
eradicate HPV DNA in one third of cases. This may be due 
to persistence of the viral DNA outwith the treatment area 
or due to reinfection from an infected male. Although 
high cure rates have been claimed for laser eradication 
of vulval and penile warts (Beilina, J.H., 1983) it would 
be impossible to eradicate HPV DNA from the whole female 
genital tract and from the penis and urethra of the male
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with laser therapy. Other methods of treatment such as 
topical antimetabolites (Weimar, G.W., et al, 1978) or 
interferon (Androphy, E.J., 1986) may prove more useful.
It has been suggested that vaccination against HPV 
infection might, be appropriate. Antibodies raised against 
the LI or El gene products have been suggested (Crawford, 
L., 1986). Bubb, V. et al (1988) showed that the 
structure of the putative protein encoded for by the E5 
region of the HPV DNA subtypes 6, 11., 16, 18, & 33 
exhibits a conserved hydrophobic structure which may 
interact with the cell membrane. It may be that this 
protein will be a suitable target for a vaccine. A 
recombinant DNA vaccine against BPV appears to offer 
protection in cattle (Pilacinski, W.P., et al, 1985). The 
value of such a vaccine in reducing the incidence of 
invasive cancer of the cervix would be difficult to prove 
and large, long-term placebo controlled trials would be 
required to control for the many other variables involved. 
The likelihood of such trials being mounted seems low.
In summary therefore, screening for and treatment of HPV 
DNA infection of the human female genital tract is 
inappropriate at present. It is likely to provide little 
benefit for a large cost and result in over investigation 
and over treatment of large numbers of healthy women.
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There is no evidence to suggest that it will reduce the 
incidence of invasive cancer of the cervix. It would 
divert resources away from improving a system of cervical 
cytology screening which has been shown to substantially 
reduce the incidence of invasive cancer when it is 
properly organised.
3. The value of internal and external control tissues
in assessing the relationship between genital 
tract neoplasia.
Early studies of the prevalence of HPV DNA in the human 
female genital tract either did not study control biopsies 
or examined very few. Later studies of apparently normal 
external control women showed that the prevalence of HPV 
DNA subtypes on the cervix was 10% - 35% (see 
Introduction, 4.6 for review). This contrasts with a 
prevalence of 60%-90% in neoplastic tissues of the genital 
tract in published studies. In this study 70/108 (65% : 
95% confidence interval 56% to 74%) biopsies from 
neoplastic tissue and 4/30 (13% : 95% confidence interval 
1% to 25%) external control biopsies hybridized to HPV DNA 
subtypes (table 6). This difference is statistically 
significant (chi squared = 23.0, p<0.001, Yates 
correction).
The use of adequate external control biopsies is important 
on two counts. Firstly, it establishes the association
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between human female genital neoplasia and the presence of 
HPV DNA. Secondly, it allows assessment of the prevalence 
of HPV DNA in the genital tracts of the apparently normal 
population. The implications of the prevalence of HPV DNA 
in the population for screening and treatment have been 
discussed (Discussion, 2).
The importance of internal control biopsies was identified 
by Ferenczy, A., et al, (1985) and Macnab, J.C.M., et al,
(1986). These two studies showed that HPV DNA could be 
detected in apparently normal tissue adjacent to 
condylomata acuminata and malignant tissue respectively.
No statistically significant difference was detected 
between abnormal biopsies and internal control biopsies in 
studies in this thesis.
The presence of HPV DNA in a tissue does not in itself 
indicate that a tissue will be histologically abnormal nor 
can HPV DNA induce neoplasia on its own. The frequent 
detection of HPV DNA in internal controls supports the 
role of other locally active cofactors in a multistage 
process of neoplastic transformation. Such cofactors, for 
example, may be operating in one area of the cervical 
transformation zone but not in another which results in 
the particular location of a premalignant lesion on the 
cervix. Secondly, Ferenczy, A., et al, (1985) established 
a relationship between the detection of latent HPV DNA and
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recurrence of condylomata acuminata. It may be that the 
detection of HPV DNA in internal controls associated with 
premalignant or malignant lesions means that this tissue 
is susceptible to malignant transformation at a later 
date. This may be one mechanism of recurrence of CIN after 
apparently successful local ablation of existing lesions. 
The numbers in this study are insufficient to provide 
follow-up data relating the presence of HPV DNA in 
internal controls to subsequent recurrence of disease but 
such a study might be valuable in predicting which women 
are more susceptible to recurrence of CIN.
On the vulva, the management of vulval premalignancy 
poses management dilemmas because of its multifocal nature 
(McCance, D.J., et al, 1985b) and tendency to recur after 
local treatment (Douglas, C.P., 1983). It may be that the 
application of anti-viral agents to the vulva following 
local ablation of established VIN lesions would reduce the 
incidence of recurrent disease in cases in which 
hybridization to HPV DNA in abnormal and normal tissue is 
detected. A controlled trial involving four arms 
comprising two treatment arms for cases with and without 
hybridization to HPV DNA and two non-treatment control 
arms with and without HPV DNA could answer this question 
and provide strong evidence of a central role of HPV DNA 
in cell transformation in humans.
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Data on the association between detection of HPV DNA in 
internal controls related to invasive cancer are_scarce. 
One small study has failed to detect any relationship 
between the presence or absence of HPV 16 DNA in tissue 
distant to malignant disease of the cervix and vulva and 
recurrence of disease or long-term survival (Walkinshaw,
S.A., et al. 1987). It is likely that if the presence of 
HPV DNA in control tissue does predispose to invasive 
cancer in adjacent, normal tissue it would act through the 
development of new primary disease. This effect would be 
easily obscured by recurrence of disease due to spread of 
malignant cells from the original primary tumour. By 
definition, such spread is not possible in premalignant 
disease so comparison of the prognostic implications of 
HPV DNA in control tissue related to premalignant and 
malignant disease is not appropriate.
It is interesting to note that HPV 6/11 DNA sequences 
were detected in only one case of CIN (in a patient who 
had been referred to Glasgow from the North-West of 
England) and two local ladies who were external controls. 
The lack of detection of HPV 6/11 DNA in the West of 
Scotland is confirmed by other studies. Fletcher, K. 
(reported in Murdoch, J.B. et al, 1988) detected HPV 6/11 
DNA in only 2/43 CIN samples and Millan, D.W.M. et al
(1986) reported detection of only one case of
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hybridization to HPV 11 DNA in a study of 26 cases of 
acetowhite cervical epithelium. Thus in the West of 
Scotland the cumulative rates of detection of HPV 6/11 DNA 
in cases of cervical acetowhite epithelium is 3/136 
(2.2%). These data are quite different to the findings 
of McCance, D.J. et al (1983) who reported a 28% detection 
rate of HPV 6 DNA in CIN lesions in the London area. This 
would suggest that there is a marked geographical 
difference in the prevalence of HPV 6/11 DNA sequences 
within the United Kingdom.
Finally, HPV 16 DNA has been detected widely in abnormal 
and normal biopsies in this study. In contrast HPV 18 DNA 
was detected in 2 "virus only" biopsies, 1 case of CIN 1,
5 cases of CIN 2, 9 cases of CIN 3 and 2 cases of invasive 
cancer of the cervix. HPV 18 DNA was detected in only one 
interna 1 control related to an invasive cancer of the 
cervix and no external control biopsies (Results, Tables
I,2,3,7a). Thus, in total, HPV 18 DNA is detected in 
19/98 abnormal biopsies (19.4%:95% confidence intervals
II.6% to 27.2%) and in 1/65 internal controls (1.5%:95% 
confidence intervals -1.4% to 4.4%)
(chi squared = 9.97, 0.01>p>0.001, Yates correction). The 
author knows of no reports of hybridization to HPV 18 DNA 
in normal external control tissue, although it has been 
described in 1 case of "chronic inflammation" and one case
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of histological "viral changes" (Mi 11 an, D.W.M., et al, 
1986). This suggests that HPV 18 DNA is more closely 
associated with malignant transformation than even HPV 16 
DNA and that its detection could have prognostic 
significance for the patient. This possibility is 
supported by a study of invasive cervical cancer (Barnes, 
W. et al, 1988) which also showed that, while HPV 18 DNA 
is detected less often than HPV 16 DNA, there is an 
association between the detection of HPV 18 DNA, young age 
of the patient, poor tumour cell differentiation and 
secondary nodal spread.
Thus, unlike mass screening of the normal population for 
HPV DNA, the selective study of specific tissues from 
patients conventionally diagnosed as having premalignant 
or malignant genital disease would contribute to their 
management and follow-up. This could be achieved by 
identifying patients who would benefit from specific 
antiviral therapy or closer monitoring.
4. The relationship between detection of HPV DNA.
histological diagnosis of a lesion and the age of 
the patient.
In a study of 47 patients with invasive carcinomas of the 
cervix, Meanwell, C.A.. et al (1987) detected an 
association between the age of the patients and the 
detection of HPV 16 DNA. They suggested that patients
-171-
over 40 years were significantly more likely to have 
tumours which hybridized to HPV 16 DNA than those under 40 
years. They postulated that the association between HPV 
16 DNA and cervical cancer was age-mediated and that this 
did not support an aetiological role for HPV DNA. 
Alternatively, McCance, D.J., et al (1985) showed that HPV 
DNA was commonly detected in young women with CIN (mean 
age 29 years, range 18-39 years).
In this study no association between the age of the 
patient and detection of HPV DNA was noted. No 
significant difference was found in the detection of HPV 
DNA in invasive cancers between those patients under 40 
years (n=5) and those patients over 40 years (n=26) (chi 
squared = 0.348, p>0.5, Yates correction). The patients 
with premalignant lesions of the cervix were significantly 
younger than the externa 1 control group (p<0.001, Student 
t test). The external control group were in turn 
significantly younger than the group with invasive cancer 
(p<0.001, Student t test). There was no statistically 
significant difference between detection of HPV DNA in 
patients with mild premalignant lesions ("virus only" and 
CIN 1); patients with severe premalignant lesions (CIN 2 
and CIN 3); and patients with invasive cancer (chi squared 
= 1.518, DF=2, p>0.5). There was a statistically 
significant difference between HPV DNA detection in
-172-
patients with abnormal tissue (premalignant or malignant) 
external control patients (chi squared = 22.9, 
p<0.001). These data show that there is no association 
between hybridization to HPV DNA and the age of the 
patient in this study. There is, however, a highly 
significant association between hybridization to HPV DNA 
and the presence of a neoplastic abnormality. These data 
do not support the findings of Meanwell. C.A., et al
(1987). There is no evidence of a statistically 
significant difference in the ages of patients whose 
lesions show hybridization to HPV DNA and those who do not 
[either premalignant lesions (p>0.5, student t test) or 
malignant lesions (0.5>p>0.1, student t test)]. This 
suggests that patients with HPV plus CIN do not have a 
worse prognosis than those with CIN alone. If the 
presence of HPV DNA did result in a worse prognosis for 
malignant transformation of cervical cells it would be 
expected that patients with premalignancy and malignancy 
associated with HPV DNA would be younger than those 
without HPV DNA. Prospective randomised controlled trials 
would be required to prove this. The methodological 
difficulties of trials with an end-point of CIN 3 have 
been discussed (Introduction, 4.1). A prospective trial 
with an end-point of invasive disease would be unethical.
These data, therefore, suggest that patients with HPV plus
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CIN should not be treated differently to patients with CIN 
alone. The arguments for improving screening of the 
population for CIN and not introducing a further tier of 
screening for HPV DNA in the population have been 
discussed (Discussion, 2). These results suggest that 
attention should continue to be focused on treating CIN 
irrespective of the presence of HPV DNA as CIN is the 
final common pathway towards invasive disease and 
treatment of CIN is most likely to interrupt progression 
of disease.
5. The relationship between detection of HPV DNA and
local immmuno-supression on the cervix.
In this part of the study the detection of HPV DNA in CIN 
biopsies was achieved using slot blot analysis. Slot 
blot analysis was used because of the very small 
quantities of total cellular DNA available for study.
This was due to the very small size of biopsies and, 
possibly, to the storage conditions following the 
histological processing for Langerhans1 cell counting.
The specificity of slot blots has been shown to be poor 
with copy numbers below 10 copies per cell (Results,
2.12) so only biopsies with HPV DNA copy numbers greater 
than 10 copies per cell were accepted as positive 
(sensitivity 97%, specificity 96% positive predictive 
value 97%; negative predictive value 96%).
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Langerhans' cells were detected in histological biopsies 
using staining for surface T6 (CD1) antigen using NA1/34 
(human thymocyte antigen) as this is one of the most 
sensitive methods for their detection in squamous 
epithelium. Some workers [Tay, S.K., et al, (1987); 
McArdle, J.P., et al, (1986)] have used the S100 antigen 
as a marker but this detects only 35% of Langerhans' 
cells. In this study Langerhans' cell counts from the 
histologically normal ectocervix were used for comparison. 
The numbers of Langerhans' cells on the ectocervix are 
valid internal controls because their numbers are similar 
to those found in the normal transformation zone [Morris,
H.H.B., et al, (1983a); Edwards, J.N.T., et al (1985)].
The results from this study show that Langerhans' cells 
are significantly decreased in CIN compared to controls in 
the presence of HPV 18 DNA even at low copy numbers. In
the presence of HPV 16 DNA the Langerhans' cells are
reduced at high copy numbers only. This may be because 
the Langerhans' cells are truly decreased or because the 
surface antigens are being blocked or altered by the 
presence of HPV or its gene products. It is also possible 
that the Langerhans' cells are inhibited from migrating
into the epithelium or are encouraged to migrate out of
the epithelium more rapidly than normal. The depletion 
of Langerhans' cells may be a function of both the subtype
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of HPV DNA present and the copy number. It may be that 
HPV DNA gene products have an immuno-suppressive effect 
which releases the neoplastic process from inhibition by 
Langerhans' cells. Alternatively, local 
immunosuppression, possibly as a result of smoking 
(Barton, S.E., et al, 1988) may facilitate infection by 
HPV DNA with subsequent neoplastic transformation by early 
viral gene products.
This study provides evidence for a mechanism of 
interaction of the two most important specific risk 
factors for malignant transformation on the cervix (HPV 
DNA and smoking via local immunosuppression). It may be 
that this interaction is facilitated by the nature of the 
transformation zone as this is an area of increased 
mitotic activity and cell generation. Whether or not 
other environmental cofactors play a part in the 
process remains to be shown.
6. The role of the c-myc oncogene in female genital
tract cancer.
The c-myc gene product is thought to play an important 
role in the regulation of cell proliferation and synthesis 
of the c-myc protein is present throughout the cell cycle 
(Henriksson, M., et al, 1988). Transcription of c-myc RNA 
shuts off when cells stop dividing so c-myc expression
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seems to be finely coupled to the differentiation and 
divisional state of the cell. It is not surprising that 
disruptions of the gene are frequently associated with 
cancer (Rabbitts, T.H., 1987).
There is conflicting evidence as to whether amplification 
and/or overexpression of the c-myc proto-oncogene is 
associated with genital cancer [Riou, G.F., et al (1985 
and 1986); Ikenberg, H., et al (1987); Gariglio, P., et al
(1987)].
The study presented here (Results 2.13) failed to show 
any evidence of amplification of the c-myc gene in 
association with cervical or vulval cancer compared to 
controls. No attempt was made to assay the expression of 
c-myc mRNA so no comment can be made about the possibility 
of overexpression of the c-myc gene product in these 
tumours. In two cases of cervical cancer an abnormal 
BamHl restriction pattern was observed which raises the 
possiblity of a rearrangement of the c-myc oncogene. To 
clarify this point further detailed restriction analyses 
would be required. There was not sufficient time 
available during the course of this project to study this 
interesting question but further analysis of these tumour 
specimens is being carried out in the laboratory.
Such a rearrangement might release the c-myc oncogene from
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normal cellular control allowing overexpression of the 
oncogene product. Alternatively, the rearrangement could 
bring the oncogene under the control of a foreign promotor 
or enhancer element. Thirdly it is possible that the 
rearrangements could so alter the c-myc DNA sequence as to 
result in abnormal mRNA transcription which results in 
cell transformation. It would be tempting to postulate 
that HPV DNA might be involved in such changes and further 
detailed assessment of the association between the c-myc 
and HPV DNA in genital tumours is warranted.
In order to explore this possible association it would be 
necessary to study the transcriptional activity and 
physical state of HPV DNA in cancer cells. Secondly, it 
would be necessary to confirm the presence of c-myc 
rearrangements in these cells with further restriction 
digests and to analyse the transcriptional activity of the 
oncogene in the presence and absence of such 
rearrangements. This would have to be analysed in tumour 
tissue, normal interna 1 control tissue and normal external 
control tissue.
7. A possible role for HPV in cervical
carcinogenesis.
The close association between HPV 16 and HPV 18 DNA 
sequences and cervical neoplasia has prompted many workers
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to suspect that these two viral subtypes are causal agents 
in the development of cervical cancer. Powerful support 
for this argument has been supplied by studies of HPV DNA 
in cervical cancer cell lines and primary cervical cancer 
biopsies. These studies have shown a consistent viral 
integration pattern within the El and E2 ORF's of the 
viral genome (Durst, M., et al, 1985) and frequent 
transcription of the E6/E7 ORT's (Schwarz, E., et al,
1985) .
HPV 16 DNA (Pirisi, L., et al, 1986) and 18 DNA 
(Bedell, M.A., et al 1987) have been shown to 
morphologically transform human and rodent cells and the 
E6/E7 ORF1s appear to be the segments of the viral genome 
necessary for this event. A possible mechanism for cell 
transformation is the presence of a small intron within 
the E6 ORF in three cervical cancer lines
(Schneider-Gadicke, A., Schwarz. E., 1986). This results 
in the second E6 exon being read in a different reading 
frame which results in a putative protein with a distant 
relationship to epidermal growth factor. The same splice 
donor and receptor sites also exist in HPV 16 and 33 DNA 
but are absent, in HPV 6 and 11 DNA. A second mechanism 
is suggested by McCance, D.J., (1988) whereby integration
of the viral genome into the host cell chromosome may 
disrupt the production of E2 ORF proteins which result in
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uncontrolled transcription of the E7 ORF making the cells 
susceptible to other events which could lead to a 
malignant phenotype.
It is clear from studies of the prevalence of HPV DNA on 
the cervix that the presence of HPV DNA is a common event 
with transformation of cervical cells occurring fairly 
infrequently. This thesis, by showing that HPV DNA 
sequences are frequently detected in normal tissue 
adjacent to neoplasia, has supported the suggestion that 
the presence of HPV DNA alone does not result in cell 
transformation. Other co-factors appear to be required as 
is the case in the bovine papillomavirus model.
The study reported here (Results, 2.9) demonstrates a 
relationship between HPV DNA sequences and impaired local 
immunosurvei1 lance in the cervix. This may be the 
mechanism whereby smoking acts as a cofactor in cervical 
carcinogenesis (Barton, S.E., 1988), possibly by promoting 
infection with HPV subtypes which later promote cell 
transformation.
Pater, M.M., et al, (1988) suggest a possible mechanism 
whereby the oral contraceptive pill may act as a cofactor 
with HPV DNA although support for a significant role of 
the oral contraceptive on epidemiological grounds remains 
content ious.
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co-factors and cervical carcinogenesis
In an effort to reconcile the evidence for HSV as a 
significant cofactor in the genesis of cervical cancer,
Zur Hausen, H., (1982) suggested that HSV possessed
"initiator-like" functions and a synergism existed between 
HSV and the "promotor" HPV. Zur Hausen subsequently 
turned his attention to reconciling such features of viral 
oncogenesis as (a) only a small proportion of those who 
carry HPV eventually develop cancer; (b) the latency 
period between developing a viral infection and developing 
cancer may last for years and (c) the resulting cancers 
are monoclonal (Zur Hausen, H., 1986). He suggested that 
intracellular surveillance mechanisms may control 
papillomavirus infections and that cancer was a result of 
a failing host cell control of persisting viral genes.
8. A Hypothesis
It seems unlikely that a model for HPV as a possible 
cervical carcinogen would simply comprise a spectrum of 
cervical abnormalities ranging from koilocytotic atypia at 
one end to invasive cancer of the cervix at the other.
Far more likely, is a multistage process for the 
development of malignancy in which HPV DNA plays an 
important role (fig. 12).
The concept is conveniently considered using an 
intracellular "black box" in which cellular control
mechanisms such as proto-oncogenes are influenced to a 
greater or lesser degree by environmental factors such as 
HPV DNA, smoking, oral contraception and possibly other 
viruses. Depending on the interplay between host and 
environmental factors a "transforming stimulus" develops 
to which the mitotically active cells of the cervical 
transformation zone are particularly susceptible. The 
fundamental difference between the incidence of cervical 
cancer and cancer of the vulva and vagina appears to be 
this susceptibility of the host cells of the cervical 
transformation zone to malignant transformation.
Depending on the strength of that transforming stimulus 
lesions may develop which are recognised histologically as 
CIN 1, 2 or 3. It is possible that a suitable strong 
transforming stimulus might result in the development of 
aggressive tumour cells de novo which could explain the 
subset of women who appear to develop cancer very 
quickly.
Alternatively HPV infection may merely infect cells and 
produce koilocytotic atypia. Thereafter, the same or a 
different transforming stimulus could drive the 
particularly susceptible cells of the CIN lesion forwards 
towards malignancy.
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9. Future work.
This thesis has provided several lines of future work 
which can be pursued to clarify the relationship between 
HPV, other possible cofactors, and cervical neoplasia.
The numerically small study of the association between 
the detection of HPV DNA and decreased local 
immunosurvei1 lance in the cervical transformation zone 
should be repeated using larger numbers of patients. This 
study would include detailed recording of the smoking 
habits of the patients in an effort to confirm the 
findings of Barton, S.E. et al (1988). Secondly,
improved handling of tissue biopsies should yield larger
ammounts of total cellular DNA for study of the viral 
subtypes present and their physical state within cells by 
detailed restriction enzyme analysis. Additionally,
specific analysis of the transcriptional activity of the
E6/E7 ORFs of HPV genomes present in biopsies 
could be performed.
In this way, the association between smoking via local 
immunosuppression and the intracellular events thought to 
be involved in the proposed oncogenic function of HPV 
could be clarified.
Secondly, the possible role of oncogenes in cell
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transformation in the presence of HPV DNA requires to be 
studied further. The study of the physical state of HPV 
DNA, transcription of the E6/E7 ORFs, and amplification 
and overexpression of oncogenes, especially c-myc in the 
same tissues would show whether or not these prosesses 
were intimately associated with each other and would 
provide a model for intracellular events leading to cell 
transformation.
Finally, this study has shown that adequate control 
tissues are essential for the study of associations 
between the ubiquitous HPV genome and specific tissues. In 
situ studies have shown that the detection of HPV DNA 
varies even within biopsies (Crum, C.P. et al 1986). In 
order to confirm the association between HPV DNA sequences 
and cell transformation in the cervix it is now necessary 
to determine which cells actually contain viral sequences 
and what the transcriptional activity of these sequences 
is. If there is no evidence of HPV DNA in dys3<aryot.ic 
cells within a CIN lesion and HPV DNA is only to be found 
in morphologically normal cells and/or koilocytes then 
the association between HPV DNA and CIN is likely to be 
casual. If, however, transcriptionally active HPV DNA can 
be shown to be present in dyskaryocytes but not in normal 
internal and externa 1 control cells then a causal 
association is much more likely.
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Recently, the polymerase chain reaction (PCR) has been 
developed which can amplify and detect a target DNA 
molecule present only once in a sample of 100,000 cells 
(Saiki, R.K. et al, 1988). This test is approximately
1.5 x 10 times more sensitive than the most sensitive 
assay described in this thesis. Furthermore, human DNA 
minisatellite alleles up to lOkb long can be amplified 
from single cells taken from a buccal smear (Jeffreys,
A .J . et al, 1988). Young, L.S. et al (1989) have 
reported its use in detecting HPV DNA in cervical smears 
and suggest that PCR will be useful in epidemiological 
studies. If PCR could be used to clarify some of the 
questions posed above by targetting specific viral and 
oncogene DNA sequences in specific cell types within 
precancerous and cancerous lesions of the cervix, it might 
answer fundamental questions about the role of HPV 
DNA in cervical cancer.
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APPENDICES
Appendix 1
Details of patients attending the colposcopy clinic with 
colposcopica1ly abnormal, acetowhite, cervices (prefix CN) 
who had punch biopsies taken from colposcopically abnormal 
(suffix A) and colposcopically normal (suffix N) areas of 
the cervical transformation zone. The patients' ages are 
recorded in years. Analysis of the histological diagnosis 
(Hist.), cytological evidence of virus infection (Smear), 
staining for papillomavirus antigen (PV Ag.) and 
hybridization to HPV 16 and 18 DNA subtypes are presented. 
Hybridization results are for stringent conditions unless 
specified as nonstringent (NS). Hybridization to HPV 6 
and 11 DNA was not detected under stringent or 
nonstringent conditions
(Hist: 1= CIN 1; 2=CIN 2; 3= CIN3; v= evidence of virus 
infection; n= histologically normal.)
HPV DNA
Patient Age Hist. Smear PV Ag 16 18
CN01A 26 2+v + + — + (NS)
CN01N V — — —
CN02A 24 1 + — + —
CN02N V — + —
CN03A 19 2+v + + + —
CN03N 1+v + + —
CN04A 45 3 — — + —
CN04N n — + —
CN05A 30 V + — + —
CN05N n — + —
CN06A 42 V + — — —
CN06N V — — —
CN07A 34 2+v — — _ —
CN07N n — — —
CN08A 35 1+v — — — -
CN08N n - - _
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Appendix 1 (cont.)
HPV DNA
Patient Age Hist. Smear PV Ag 16 18
CN09A 23 v -
CN09N n -
CN10A 21 v +
CN10N v +
CN11A 30 3 - + + + (NS)
CN11N n +
CN12A 22 1+v + + (NS)
CN12N n -
CN13A 31 v -
CN13N n -
CN14A 35 3+v + - - +(NS)
CN14N 1+v -
CN15A 23 2+v - -
CN15N n -
CN16A 26 2+v + +
CN16N 1+v -
CN17A 30 3+v - +
CN17N v +
CN18A 30 1 +
CN18N n -
CN19A 37 1+v - +
CN19N n +
CN20A 29 2+v - + +
CN20N v -
CN21A 32 2+v - +
CN21N n +
CN22A 38 2+v - -
CN22N v -
CN23A 36 1+v - + +
CN23N v + + -
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Appendix 1 (cont.)
HPV DNA
Patient Age Hist. Smear PV Ag 16 18
CN24A 23 v + - +
CN24N v +
CN25A 29 3 - +
CN25N n +
CN26A 35 2+v - +
CN26N n +
CN27A 30 2+v - +
CN27N n +
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Appendix 2
Details of patients attending the colposcopy clinic with 
colposcopically abnormal, acetowhite, cervices (prefix CN) 
who had punch biopsies taken from colposcopically abnormal 
(suffix A) and colposcopically normal (suffix N) areas of 
the cervical transformation zone. The patients' ages are 
recorded in years. Analysis of the histological diagnosis 
(Hist.), and hybridization to HPV 16 and 18 DNA subtypes 
are presented. Hybridization results are for stringent 
conditions only. Hybridization to HPV 6/11 DNA sequences 
was not detected in CN28 - CN47
HPV DNA
Patient Age Hist. 16 18
CN28A 34 1+v - -
CN29A 24 2+v - -
CN30A 46 2 + —
CN30N n + —
CN31A 20 3+v + —
CN31N n + —
CN32A 38 3+v + —
CN32N n + —
CN33A 25 3+v + +
CN34A 31 V - +
CN35A 52 3+v - +
CN36A 31 3+v - -
CN37A 25 V - +
CN38A 36 3+v - -
CN39A 34 3+v + —
CN39N n — —
CN40A 29 3 + —
CN40N n — —
CN41A 31 3 + —
CN41N n - -
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Appendix 2 (cont.)
HPV DNA
Patient Age Hist. 16 18
CN42A 25
CN43A 25 3+v
CN43N n
CN44A 31 3+v +
CN44N n +
CN45A 31 3
CN45N n +
CN46A 29 2+v
CN46N n
CN47A 34 2 +
CN47N n
HPV DNA
Patient Age Hist. 6/11 16 18
CN48A 25 3+v + - +
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Appendix 3
Details of patients undergoing pelvic irradiation or 
radical hysterectomy for invasive cervical carcinoma 
(prefix CaCx) who had biopsies taken from histologically 
diagnosed tumour (suffix A) and biopsies from 
histologically diagnosed normal vaginal epithelium (suffix 
N) taken within 5cm of the lesion. All tumours were 
squamous cell carcinomata except for CaCxl8A* which was an 
adenocarcinoma. In CaCxlO, a pelvic lymph node which 
contained metastatic squamous cancer deposits was 
available for analysis. Hybridization to HPV 6/11 DNA 
sequences were not detected in this group. Hybridization 
to HPV 16 and 18 DNA sequences were detected under 
stringent conditions.
Patient Age HPV16 Patient Age HPV16
CaCxOlA 73 — CaCxl7A 59 +
CaCxl7N +
CaCx02A 55 +
CaCxl8A* 60 -
CaCx03A 32 + CaCxl8N -
CaCx04A 60 + CaCxl9A 65 —
CaCxl9N -
CaCx05A 65 -
CaCx20A 52 +
CaCx06A 62 — CaCx20N —
CaCx07A 44 + CaCx21A 49 _
CaCx21N -
CaCx08A 74 -
CaCx22A 64 -
CaCx09A 43 — CaCx22N —
CaCxlOA 35 — CaCx23A 56 _
CaCxlO(node) — CaCx23N —
CaCxllA 58 + CaCx24A 76
CaCx24N -
CaCxl2A 62 -
CaCx25A 26 +
CaCxl3A 54 + CaCx25N +
CaCxl3N -
CaCx26A 58 -
CaCxl4A 27 +
CaCxl4N CaCx27A 86 +
CaCx27N -
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Patient Age HPV 16 Patient Age HPV 16
CaCxl5A 28 + !CaCx28A 64 +
CaCxlSN — !CaCx28N
f
+
CaCxl6A 60 +
I
!CaCx29A 56 +
CaCxl6N — !CaCx29N —
Patient Age HPV 18
CaCx30A 50 +
CaCx30N +
CaCx31A 41 +
CaCx31N -
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Appendix 4
Details of patients who attended the colposcopy clinic 
with CIN lesions (prefix CN) who had punch biopsies taken 
from colposcopically and histologically abnormal and 
colposcopically and histologically normal areas of the 
cervical transformation zone. The age of the patient; the 
histological diagnosis (Hist.) of the abnormal biopsy; the 
copy number of HPV 16 and 18 DNA sequences detected in the 
abnormal biopsy; and the Langerhans' cell number (counted 
per 100 basal cells) in the abnormal and normal biopsies 
are recorded. HPV 16 and 18 DNA sequences were detected 
under stringent conditions. DNA copy numbers are banded 
in groups: <10; 10-50; 50-100 and >100 copies per cell.
HPV 6/11 DNA sequences were not detected in this group.
Langerhans' 
HPV DNA cell no.
Patient Age Hist. 16 18 Norma1 Abn
CN39 34 3+v 10-50 <10 7 15
CN40 26 3 10-50 <10 4 15
CN43 25 3+v 10-50 <10 8 4
CN44 31 3+v 10-50 <10 11 5
CN49 31 3 <10 <10 10 13
CN50 27 2 <10 <10 6 9
CN51 40 3 <10 <10 6 10
CN52 29 3 <10 10-50 11 5
CN53 28 2+v <10 50-100 14 10
CN54 19 2+v 10-50 <10 6 6
CN55 26 3 <10 10-50 6 4
CN56 33 2+v <10 >100 12 7
CN57 29 3+v <10 50-100 12 6
CN58 23 2+v <10 10-50 14 11
CN59 36 3 <10 10-50 7 5
CN60 34 3 <10 <10 11 21
CN61 24 2+v <10 10-50 8 5
CN62 27 2+v 50-100 <10 7 5
CN63 33 3 <10 <10 11 14
CN64 32 2+v 50-100 <10 5 4
CN65 30 3 <10 <10 9 8
CN66 35 3+V 10-50 <10 9 12
CN67 37 3 50-100 <10 10 6
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Appendix 5
Hybridization data on biopsies from colposcopically 
abnormal (suffix A) and colposcopically normal (suffix N) 
tissue prior to laser therapy for histologically confirmed 
CIN (prefix CN) plus biopsies taken from the same 
geographical area of the same cervices in which the CIN 
lesion originally lay 4 months post-laser therapy (suffix 
P) .
Laser ablation of the transformation zone was performed to 
a depth of 7mm. All post-laser cervices were 
colposcopically and cytologically normal.
Hybridization to HPV 16 DNA sequences only was detected 
under stringent conditions.
Hybridization to HPV 6/11 and 18 DNA sequences were not 
detected in this group.
Pat ient HPV 16 Patient HPV1
CN21A +* CN39A +
N + N -
P — P —
CN22A — CN40A +
N - N -
P — P —
CN25A + CN43A +
N + N -
P — P —
CN26A + CN44A +
N + N +
P + P —
CN27A + CN45A —
N + N +
P + P +
CN30A + CN46A —
N + N -
P + P —
CN31A + CN47A +
N + N -
P + P —
CN32A +
N +
P -
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